S8114637B2	NNP	O
-	:	O
Packaging	NN	O
cells	NNS	O
for	IN	O
recombinant	JJ	O
adenovirus	NN	O
-	:	O
Google	NN	O
Patents	NNS	O
Info	NNP	O
Links	NNP	O
Images	NNP	O
Classifications	NNP	O
Abstract	NNP	O
Description	NNP	O
CROSS-REFERENCE	NNP	O
TO	NNP	O
RELATED	NNP	O
APPLICATIONS	NNP	O
This	DT	O
application	NN	O
is	VBZ	O
a	DT	O
divisional	JJ	O
of	IN	O
co-pending	JJ	O
U.S.	NNP	O
patent	NN	O
application	NN	O
Ser.	.	O
No.	.	O
11/384,850,	,	O
filed	VBN	O
Mar.	.	O
20,	,	O
2006	CD	O
now	RB	O
U.S.	NNP	O
Pat.	.	O
No.	.	O
7,816,104,	,	O
which	WDT	O
application	NN	O
is	VBZ	O
a	DT	O
continuation	NN	O
of	IN	O
PCT	NNP	O
International	NNP	O
Patent	NNP	O
Application	NNP	O
No.	.	O
PCT/EP2004/052428,	,	O
filed	VBD	O
on	IN	O
Oct.	NNP	O
4,	,	O
2004,	,	O
designating	VBG	O
the	DT	O
United	NNP	O
States	NNPS	O
of	IN	O
America,	,	O
and	CC	O
published,	,	O
in	IN	O
English,	,	O
as	IN	O
PCT	NNP	O
International	NNP	O
Publication	NNP	O
No.	.	O
WO	$	O
2005/033320	CD	O
A1	NNP	O
on	IN	O
Apr.	.	O
14,	,	O
2005,	,	O
which	WDT	O
PCT	NNP	O
International	NNP	O
Patent	NNP	O
Application	NNP	O
claims	VBZ	O
priority	NN	O
under	IN	O
the	DT	O
Article	NNP	O
8	CD	O
of	IN	O
the	DT	O
Patent	NNP	O
Cooperation	NNP	O
Treaty	NNP	O
to	TO	O
PCT	NNP	O
International	NNP	O
Patent	NNP	O
Application	NNP	O
No.	.	O
PCT/EP03/50679,	,	O
filed	VBD	O
on	IN	O
Oct.	NNP	O
2,	,	O
2003,	,	O
the	DT	O
contents	NNS	O
of	IN	O
the	DT	O
entirety	NN	O
of	IN	O
each	DT	O
of	IN	O
which	WDT	O
are	VBP	O
hereby	RB	O
incorporated	VBN	O
herein	NN	O
by	IN	O
this	DT	O
reference.	.	O
TECHNICAL	NNP	O
FIELD	NNP	O
The	DT	O
invention	NN	O
relates	VBZ	O
to	TO	O
the	DT	O
field	NN	O
of	IN	O
biotechnology	NN	O
and	CC	O
molecular	JJ	O
and	CC	O
cell	NN	O
biology;	:	O
more	RBR	O
in	IN	O
particular,	,	O
to	TO	O
packaging	VBG	O
cells	NNS	O
and	CC	O
use	NN	O
thereof	NN	O
for	IN	O
the	DT	O
generation	NN	O
of	IN	O
batches	NNS	O
of	IN	O
recombinant	JJ	O
adenovirus.	.	O
BACKGROUND	NNP	O
Replication-deficient	NNP	O
recombinant	NN	O
adenoviruses	NNS	O
are	VBP	O
useful,	,	O
for	IN	O
instance,	,	O
in	IN	O
gene	NN	O
therapy	NN	O
and	CC	O
for	IN	O
vaccination	NN	O
purposes.	.	O
They	PRP	O
usually	RB	O
lack	VBP	O
the	DT	O
E1-region	NN	O
of	IN	O
an	DT	O
adenovirus	NN	O
and	CC	O
are,	,	O
therefore,	,	O
propagated	VBD	O
on	IN	O
complementing	VBG	O
cells	NNS	O
providing	VBG	O
the	DT	O
E1	NNP	O
sequences.	.	O
The	DT	O
packaging	NN	O
cells	NNS	O
provide	VBP	O
all	DT	O
information	NN	O
required	VBN	O
for	IN	O
replication	NN	O
of	IN	O
a	DT	O
vector	NN	O
that	WDT	O
is	VBZ	O
packaged	VBN	O
in	IN	O
the	DT	O
cells	NNS	O
to	TO	O
form	VB	O
recombinant	JJ	O
viral	JJ	O
particles.	.	O
An	DT	O
example	NN	O
of	IN	O
a	DT	O
packaging	NN	O
cell	NN	O
is	VBZ	O
a	DT	O
293	CD	O
cell,	,	O
which	WDT	O
contains	VBZ	O
nucleotides	IN	O
1-4344	CD	O
of	IN	O
the	DT	O
adenovirus	NN	O
5	CD	O
genome	NN	O
Louis	NNP	B
et	RB	I
al.,	,	I
1997),(	,	O
which	WDT	O
include	VBP	O
the	DT	O
5′	CD	O
inverted	JJ	O
terminal	JJ	O
repeat	NN	O
(ITR),	,	O
the	DT	O
packaging	NN	O
signal,	,	O
the	DT	O
E1A	NNP	O
and	CC	O
E1B	NNP	O
coding	NN	O
sequences	NNS	O
and	CC	O
the	DT	O
pIX	NN	O
coding	VBG	O
sequences.	.	O
Overlap	NNP	O
between	IN	O
the	DT	O
adenoviral	JJ	O
sequences	NNS	O
in	IN	O
the	DT	O
packaging	NN	O
cell	NN	O
and	CC	O
the	DT	O
vector	NN	O
may	MD	O
lead	VB	O
to	TO	O
homologous	JJ	O
recombination	NN	O
between	IN	O
these	DT	O
sequences,	,	O
resulting	VBG	O
in	IN	O
the	DT	O
generation	NN	O
of	IN	O
replication-competent	JJ	O
adenovirus	NN	O
(RCA)	)	O
Lochmuller	NNP	B
et	RB	I
al.,	,	I
1994).(	.	O
This	DT	O
problem	NN	O
has	VBZ	O
been	VBN	O
solved	VBN	O
by	IN	O
using	VBG	O
a	DT	O
packaging	NN	O
system	NN	O
consisting	VBG	O
of	IN	O
a	DT	O
cell	NN	O
line	NN	O
and	CC	O
a	DT	O
vector	NN	O
that	WDT	O
are	VBP	O
matched	VBN	O
to	TO	O
each	DT	O
other	JJ	O
by	IN	O
lacking	VBG	O
such	JJ	O
overlapping	JJ	O
sequences	NNS	O
Fallaux	NNP	B
et	RB	I
al.,	,	I
1998;	:	I
(U.S.	NNP	O
Pat.	.	O
No.	.	O
5,994,128).	.	O
One	CD	O
example	NN	O
of	IN	O
a	DT	O
particularly	RB	O
useful	JJ	O
cell	NN	O
line	NN	O
in	IN	O
such	JJ	O
applications	NNS	O
is	VBZ	O
the	DT	O
PER.C6®	NNP	O
cell	NN	O
line	NN	O
(U.S.	NNP	O
Pat.	.	O
No.	.	O
5,994,128;	:	O
Nichols	NNP	B
et	FW	I
al.,	,	I
2002).Recently,	.	O
it	,	O
was	PRP	O
reported	VBD	O
that	VBN	O
upon	IN	O
use	NN	O
of	NN	O
PER.C6®	IN	O
cells	NNP	O
in	NNS	O
conjunction	IN	O
with	NN	O
a	IN	O
vector	DT	O
that	NN	O
still	WDT	O
contained	RB	O
177	VBD	O
by	CD	O
sequence	IN	O
homology	NN	O
with	NN	O
the	IN	O
E1	DT	O
sequences	NNP	O
in	NNS	O
the	IN	O
genome	DT	O
of	NN	O
PER.C6®,	IN	O
a	,	O
single	DT	O
cross-over	JJ	O
event	JJ	O
could	NN	O
result	MD	O
in	VB	O
the	IN	O
generation	DT	O
of	NN	O
helper-dependent	IN	O
replication-competent	JJ	O
virus	JJ	O
at	NN	O
a	IN	O
low	DT	O
frequency	JJ	O
Murakami	NN	B
et	NNP	I
al.,	RB	I
2002).(	,	O
The	.	O
generated	DT	O
atypical	JJ	O
RCA	JJ	O
was	NNP	O
termed	VBD	O
“helper-dependent	VBN	O
E1-containing	JJ	O
particle”	JJ	O
(HDEP).	NN	O
As	.	O
expected,	IN	O
the	,	O
emergence	DT	O
of	NN	O
this	IN	O
type	DT	O
of	NN	O
particle	IN	O
was	NN	O
circumvented	VBD	O
when	VBN	O
a	WRB	O
vector	DT	O
was	NN	O
used	VBD	O
that	VBN	O
lacked	IN	O
the	VBD	O
sequence	DT	O
overlap	NN	O
with	NN	O
the	IN	O
E1	DT	O
sequences	NNP	O
in	NNS	O
the	IN	O
genome	DT	O
of	NN	O
PER.C6®	IN	O
cells	NNP	O
Murakami	NNS	B
et	NNP	I
al.,	RB	I
2002).(	,	O
However,	.	O
it	,	O
now	PRP	O
unexpectedly	RB	O
appears	RB	O
that	VBZ	O
using	IN	O
the	VBG	O
system	DT	O
of	NN	O
matched	IN	O
vector	JJ	O
and	NN	O
PER.C6®	CC	O
cells,	NNP	O
some	,	O
batches	DT	O
of	NNS	O
recombinant	IN	O
adenovirus	JJ	O
are	NN	O
contaminated	VBP	O
at	VBN	O
a	IN	O
very	DT	O
low	RB	O
frequency	JJ	O
with	NN	O
particles	IN	O
that	NNS	O
can	WDT	O
cause	MD	O
cytopathological	VB	O
effect	JJ	O
(CPE)	NN	O
in	)	O
cells	IN	O
lacking	NNS	O
E1	VBG	O
sequences.	NNP	O
The	.	O
particle	DT	O
is	NN	O
helper-dependent	VBZ	O
and	JJ	O
contains	CC	O
E1-sequences	VBZ	O
and,	NNS	O
therefore,	,	O
is	,	O
also	VBZ	O
an	RB	O
HDEP.	DT	O
This	.	O
HDEP	DT	O
is	NNP	O
generated	VBZ	O
in	VBN	O
the	IN	O
absence	DT	O
of	NN	O
substantial	IN	O
homology	JJ	O
between	NN	O
vector	IN	O
and	NN	O
packaging	CC	O
cell	NN	O
(see	NN	O
Murakami	VB	B
et	NNP	I
al.,	FW	I
2004).While	,	O
RCA	.	O
is	IN	O
recognized	NNP	O
by	VBZ	O
the	VBN	O
regulatory	IN	O
authorities	DT	O
as	JJ	O
a	NNS	O
potential	IN	O
problem	DT	O
and	JJ	O
detection	NN	O
of	CC	O
RCA	NN	O
in	IN	O
batches	NNP	O
for	IN	O
clinical	NNS	O
use	IN	O
is	JJ	O
mandatory	NN	O
(USDHHS,	VBZ	O
FDA,	JJ	O
CBER.	,	O
Guidance	,	O
for	.	O
Industry,	NN	O
Guidance	IN	O
for	,	O
human	NNP	O
somatic	IN	O
cell	JJ	O
therapy	JJ	O
and	NN	O
gene	NN	O
therapy,	CC	O
March	NN	O
1998),	,	O
the	NNP	O
safety	,	O
aspects	DT	O
of	NN	O
HDEP	NNS	O
are	IN	O
unclear.	NNP	O
HDEP	VBP	O
is	.	O
replication	NNP	O
deficient	VBZ	O
since	JJ	O
it	NN	O
lacks	IN	O
the	PRP	O
necessary	VBZ	O
viral	DT	O
genes	JJ	O
for	JJ	O
autonomous	NNS	O
replication	IN	O
and,	JJ	O
therefore,	NN	O
HDEP	,	O
will	,	O
not	NNP	O
disseminate	MD	O
in	RB	O
a	VB	O
host.	IN	O
The	DT	O
theoretical	.	O
possibility	DT	O
that	JJ	O
the	NN	O
presence	IN	O
of	DT	O
a	NN	O
recombinant	IN	O
vector	DT	O
or	JJ	O
wild-type	NN	O
adenovirus	CC	O
in	JJ	O
the	NN	O
same	IN	O
cell	DT	O
may	JJ	O
cause	NN	O
rescue	MD	O
and	VB	O
spread	NN	O
of	CC	O
HDEP	NN	O
cannot,	IN	O
however,	NNP	O
be	,	O
completely	,	O
excluded.	VB	O
Hence,	RB	O
at	.	O
least	,	O
a	IN	O
latent	JJS	O
need	DT	O
exists	JJ	O
for	NN	O
means	NNS	O
and	IN	O
methods	NNS	O
for	CC	O
preventing	NNS	O
generation	IN	O
of	VBG	O
E1-containing	NN	O
particles	IN	O
during	JJ	O
the	NNS	O
preparation	IN	O
of	DT	O
batches	NN	O
of	IN	O
recombinant	NNS	O
adenovirus	IN	O
particles.	JJ	O
To	NN	O
this	.	O
purpose,	TO	O
the	DT	O
invention	,	O
provides	DT	O
new	NN	O
cell	VBZ	O
lines,	JJ	O
methods	NN	O
for	,	O
preparing	NNS	O
new	IN	O
cell	VBG	O
lines,	JJ	O
and	NN	O
the	,	O
use	CC	O
thereof	DT	O
to	NN	O
make	NN	O
batches	TO	O
of	VB	O
RCA-free	NNS	O
and	IN	O
HDEP-free	JJ	O
recombinant	CC	O
adenovirus	JJ	O
vectors.	NN	O
SUMMARY	NN	O
OF	.	O
THE	NN	O
INVENTION	IN	O
Described	NNP	O
herein	NNP	O
are	NNP	O
methods	NN	O
of	VBP	O
generating	NNS	O
a	IN	O
packaging	VBG	O
cell	DT	O
comprising	NN	O
adenoviral	NN	O
E1A	VBG	O
and	JJ	O
E1B	NNP	O
sequences,	CC	O
wherein	NNP	O
E1A	,	O
and	VBP	O
at	NNP	O
least	CC	O
one	IN	O
of	JJS	O
the	CD	O
E1B	IN	O
coding	DT	O
regions	NNP	O
are	NN	O
separated	NNS	O
from	VBP	O
each	VBN	O
other	IN	O
in	DT	O
the	JJ	O
genome	IN	O
of	DT	O
the	NN	O
cell.	IN	O
To	DT	O
this	.	O
purpose,	TO	O
at	DT	O
least	,	O
three	IN	O
embodiments	JJS	O
are	CD	O
provided.	NNS	O
In	VBP	O
a	.	O
first	IN	O
embodiment,	DT	O
E1A	JJ	O
and	,	O
E1B	NNP	O
can	CC	O
be	NNP	O
introduced	MD	O
into	VB	O
a	VBN	O
precursor	IN	O
cell	DT	O
at	NN	O
different	NN	O
moments	IN	O
in	JJ	O
time,	NNS	O
reducing	IN	O
the	,	O
chance	VBG	O
that	DT	O
E1A	NN	O
and	IN	O
E1B	NNP	O
are	CC	O
co-integrated	NNP	O
on	VBP	O
the	VBN	O
same	IN	O
chromosomal	DT	O
location.	JJ	O
In	JJ	O
a	.	O
second	IN	O
embodiment,	DT	O
the	JJ	O
chances	,	O
of	DT	O
co-integration	NNS	O
into	IN	O
the	NN	O
same	IN	O
locus	DT	O
are	JJ	O
reduced	NN	O
by	VBP	O
introducing	VBN	O
E1A	IN	O
and	VBG	O
E1B	NNP	O
coding	CC	O
sequences	NNP	O
into	VBG	O
a	NNS	O
precursor	IN	O
cell	DT	O
on	NN	O
two	NN	O
different	IN	O
molecules	CD	O
that	JJ	O
lack	NNS	O
overlapping	WDT	O
sequences	VBP	O
that	VBG	O
could	NNS	O
otherwise	WDT	O
lead	MD	O
to	RB	O
homologous	VB	O
recombination	TO	O
between	JJ	O
these	NN	O
sequences.	IN	O
In	DT	O
a	.	O
third	IN	O
embodiment,	DT	O
E1A	JJ	O
and	,	O
at	NNP	O
least	CC	O
one	IN	O
of	JJS	O
the	CD	O
E1B	IN	O
coding	DT	O
regions	NNP	O
are	NN	O
introduced	NNS	O
by	VBP	O
virtue	VBN	O
of	IN	O
one	NN	O
nucleic	IN	O
acid	CD	O
molecule	JJ	O
whereon	NN	O
these	NN	O
sequences	IN	O
are	DT	O
separated	NNS	O
by	VBP	O
a	VBN	O
given	IN	O
distance.	DT	O
It	VBN	O
will	.	O
be	PRP	O
clear	MD	O
that	VB	O
in	JJ	O
the	IN	O
third	IN	O
embodiment,	DT	O
instead	JJ	O
of	,	O
a	RB	O
single	IN	O
nucleic	DT	O
acid	JJ	O
molecule,	NN	O
two	NN	O
or	,	O
more	CD	O
nucleic	CC	O
acid	JJR	O
molecules	JJ	O
can	NN	O
also	NNS	O
be	MD	O
introduced,	RB	O
which	VB	O
would	,	O
satisfy	WDT	O
the	MD	O
criterion	VB	O
that	DT	O
the	NN	O
E1A	IN	O
and	DT	O
at	NNP	O
least	CC	O
one	IN	O
of	JJS	O
the	CD	O
E1B	IN	O
coding	DT	O
regions	NNP	O
are	NN	O
separated	NNS	O
by	VBP	O
a	VBN	O
given	IN	O
distance,	DT	O
in	VBN	O
case	,	O
these	IN	O
two	NN	O
or	DT	O
more	CD	O
molecules	CC	O
would	JJR	O
form	NNS	O
one	MD	O
molecule,	VB	O
e.g.,	CD	O
by	,	O
ligation,	,	O
recombination,	IN	O
and	,	O
the	,	O
like.	CC	O
The	DT	O
resulting	.	O
packaging	DT	O
cells	VBG	O
are	NN	O
characterized	NNS	O
in	VBP	O
that	VBN	O
E1A	IN	O
and	DT	O
both	NNP	O
E1B	CC	O
coding	DT	O
regions	NNP	O
are	NN	O
present	NNS	O
at	VBP	O
a	JJ	O
distance	IN	O
from	DT	O
each	NN	O
other	IN	O
and,	DT	O
hence,	JJ	O
the	,	O
chances	,	O
are	DT	O
reduced	NNS	O
of	VBP	O
E1A	VBN	O
and	IN	O
both	NNP	O
E1B	CC	O
coding	DT	O
sequences	NNP	O
together	NN	O
being	NNS	O
incorporated	RB	O
into	VBG	O
the	VBN	O
genome	IN	O
of	DT	O
a	NN	O
recombinant	IN	O
adenovirus	DT	O
that	JJ	O
is	NN	O
propagated	WDT	O
on	VBZ	O
such	VBN	O
packaging	IN	O
cells.	JJ	O
Provided	NN	O
is	.	O
a	VBN	O
method	VBZ	O
of	DT	O
preparing	NN	O
a	IN	O
cell	VBG	O
capable	DT	O
of	NN	O
complementing	JJ	O
E1-deficient	IN	O
adenoviral	VBG	O
vectors	JJ	O
without	JJ	O
generating	NNS	O
helper-dependent	IN	O
E1-containing	VBG	O
particles,	JJ	O
comprising	JJ	O
the	,	O
steps	VBG	O
of:	DT	O
a)	NNS	O
introducing	:	O
into	)	O
a	NN	O
precursor	IN	O
or	DT	O
ancestor	NN	O
of	CC	O
the	NN	O
cell	IN	O
nucleic	DT	O
acid	NN	O
sequence(s)	JJ	O
coding	NN	O
for	)	O
E1A	VBG	O
gene	IN	O
functions	NNP	O
and	NN	O
E1B	NNS	O
gene	CC	O
functions,	NNP	O
or	NN	O
if	,	O
the	CC	O
precursor	IN	O
cell	DT	O
already	NN	O
comprises	NN	O
one	RB	O
of	VBZ	O
E1A	CD	O
or	IN	O
E1B	NNP	O
gene	CC	O
functions,	NNP	O
the	NN	O
other	,	O
of	DT	O
the	JJ	O
E1A	IN	O
and	DT	O
E1B	NNP	O
gene	CC	O
functions;	NNP	O
and	NN	O
b)	:	O
selecting	CC	O
or	)	O
identifying	NN	O
cells	CC	O
having	VBG	O
obtained	NNS	O
E1A	VBG	O
and	VBN	O
E1B	NNP	O
in	CC	O
a	NNP	O
chromosomal	IN	O
configuration	DT	O
that	JJ	O
prevents	NN	O
the	WDT	O
formation	VBZ	O
of	DT	O
helper-dependent	NN	O
E1-containing	IN	O
particles	JJ	O
when	JJ	O
the	NNS	O
cells	WRB	O
are	DT	O
used	NNS	O
to	VBP	O
complement	VBN	O
a	TO	O
recombinant	VB	O
adenoviral	DT	O
vector	JJ	O
deficient	JJ	O
for	NN	O
one	NN	O
or	IN	O
more	CD	O
E1	CC	O
gene	JJR	O
functions,	JJ	O
the	NN	O
vector	,	O
lacking	DT	O
nucleic	NN	O
acid	VBG	O
sequences	JJ	O
that	NN	O
have	NNS	O
substantial	WDT	O
overlap	VBP	O
with	JJ	O
the	NN	O
chromosomally	IN	O
located	DT	O
E1	RB	O
sequence	VBN	O
that	NNP	O
otherwise	NN	O
could	WDT	O
give	RB	O
rise	MD	O
to	VB	O
homologous	NN	O
recombination.	TO	O
In	JJ	O
one	.	O
aspect,	IN	O
provided	CD	O
is	,	O
a	VBN	O
method	VBZ	O
of	DT	O
preparing	NN	O
a	IN	O
cell	VBG	O
having	DT	O
adenovirus	NN	O
E1A	VBG	O
and	JJ	O
E1B-19K	NNP	O
and	CC	O
E1B-55K	NNP	O
coding	CC	O
sequences	NNP	O
in	NN	O
its	NNS	O
genome,	IN	O
wherein	PRP$	O
nucleic	,	O
acid	WP	O
sequences	JJ	O
comprising	NN	O
those	NNS	O
sequences	VBG	O
are	DT	O
introduced	NNS	O
into	VBP	O
a	VBN	O
precursor	IN	O
cell,	DT	O
the	NN	O
method	,	O
characterized	DT	O
in	NN	O
that:	VBN	O
a)	IN	O
at	:	O
least	)	O
two	IN	O
nucleic	JJS	O
acid	CD	O
molecules	JJ	O
together	NNS	O
comprising	VBZ	O
those	RB	O
sequences	VBG	O
are	DT	O
introduced	NNS	O
into	VBP	O
the	VBN	O
precursor	IN	O
cell,	DT	O
wherein	NN	O
E1A	,	O
and	NN	O
at	NNP	O
least	CC	O
one	IN	O
of	JJS	O
the	CD	O
E1B	IN	O
coding	DT	O
sequences	NNP	O
are	NN	O
present	NNS	O
on	VBP	O
different	JJ	O
nucleic	IN	O
acid	JJ	O
molecules,	JJ	O
which	NN	O
are	,	O
introduced	WDT	O
into	VBP	O
the	VBN	O
precursor	IN	O
cell	DT	O
on	NN	O
a	NN	O
different	IN	O
moment	DT	O
in	JJ	O
time,	NN	O
and	IN	O
wherein	,	O
the	CC	O
precursor	VBD	O
cell	DT	O
is	NN	O
not	NN	O
a	VBZ	O
baby	RB	O
rat	DT	O
kidney	NN	O
cell;	NN	O
or	NN	O
b)	:	O
a	CC	O
nucleic	)	O
acid	DT	O
molecule	JJ	O
comprising	NN	O
the	NN	O
E1A	VBG	O
coding	DT	O
sequence	NNP	O
and	NN	O
a	NN	O
nucleic	CC	O
acid	DT	O
molecule	JJ	O
comprising	NN	O
the	NN	O
E1B	VBG	O
coding	DT	O
sequences	NNP	O
are	NN	O
introduced	NNS	O
into	VBP	O
the	VBN	O
precursor	IN	O
cell,	DT	O
wherein	NN	O
the	,	O
nucleic	VBZ	O
acid	DT	O
molecules	JJ	O
lack	NN	O
substantial	NNS	O
overlap	VBP	O
that	JJ	O
could	NN	O
otherwise	WDT	O
lead	MD	O
to	RB	O
homologous	VB	O
recombination	TO	O
between	JJ	O
the	NN	O
at	IN	O
least	DT	O
two	IN	O
molecules;	JJS	O
or	CD	O
c)	:	O
the	CC	O
nucleic	)	O
acid	DT	O
sequences	JJ	O
comprising	NN	O
E1A	NNS	O
and	VBG	O
at	NNP	O
least	CC	O
one	IN	O
of	JJS	O
the	CD	O
E1B	IN	O
coding	DT	O
sequences	NNP	O
are	NN	O
separated	NNS	O
by	VBP	O
at	VBN	O
least	IN	O
4	IN	O
kb	JJS	O
on	CD	O
a	NN	O
single	IN	O
nucleic	DT	O
acid	JJ	O
molecule	NN	O
or	NN	O
on	NN	O
two	CC	O
or	IN	O
more	CD	O
nucleic	CC	O
acid	JJR	O
molecules	JJ	O
when	NN	O
these	NNS	O
would	WRB	O
form	DT	O
a	MD	O
single	VB	O
nucleic	DT	O
acid	JJ	O
molecule.	NN	O
Preferably,	NN	O
in	.	O
embodiment	,	O
c),	IN	O
the	JJ	O
sequences	,	O
are	DT	O
separated	NNS	O
by	VBP	O
at	VBN	O
least	IN	O
10	IN	O
kb,	JJS	O
more	CD	O
preferably	,	O
at	JJR	O
least	RB	O
34.5	IN	O
kb	JJS	O
or	CD	O
more.	NN	O
Preferably,	CC	O
the	.	O
separating	,	O
sequences	DT	O
are	NN	O
non-E1	NNS	O
sequences	VBP	O
so	JJ	O
that	NNS	O
integration	RB	O
of	IN	O
both	NN	O
expression	IN	O
cassettes	DT	O
of	NN	O
E1A	NNS	O
and	IN	O
E1B	NNP	O
together	CC	O
in	NNP	O
a	RB	O
single	IN	O
virus	DT	O
genome	JJ	O
is	NN	O
rendered	NN	O
very	VBZ	O
unlikely	VBN	O
or	RB	O
impossible.	JJ	O
Alternatively,	CC	O
when	.	O
the	,	O
E1A	WRB	O
and	DT	O
at	NNP	O
least	CC	O
one	IN	O
of	JJS	O
the	CD	O
E1B	IN	O
sequences	DT	O
are	NNP	O
separated	NNS	O
by	VBP	O
0	VBN	O
to	IN	O
15	CD	O
kb,	TO	O
a	CD	O
screen	,	O
for	DT	O
the	NN	O
absence	IN	O
of	DT	O
inverted	NN	O
repeats	IN	O
of	JJ	O
the	NNS	O
E1-sequences	IN	O
in	DT	O
the	NNS	O
generated	IN	O
cells	DT	O
may	JJ	O
be	NNS	O
used	MD	O
to	VB	O
select	VBN	O
for	TO	O
cells,	VB	O
wherein	IN	O
the	,	O
possibility	VBP	O
of	DT	O
generating	NN	O
HDEP	IN	O
upon	VBG	O
propagation	NNP	O
of	IN	O
recombinant	NN	O
adenovirus	IN	O
in	JJ	O
the	NN	O
generated	IN	O
cells	DT	O
is	JJ	O
decreased	NNS	O
or	VBZ	O
absent.	VBN	O
The	CC	O
invention	.	O
also	DT	O
provides	NN	O
cells	RB	O
obtainable	VBZ	O
by	NNS	O
the	JJ	O
method	IN	O
described	DT	O
herein.	NN	O
Further	VBD	O
provided	.	O
is	RB	O
a	VBN	O
cell	VBZ	O
comprising	DT	O
adenovirus	NN	O
E1A	VBG	O
and	JJ	O
E1B-55K	NNP	O
and	CC	O
E1B-19K	NNP	O
coding	CC	O
sequences	NNP	O
in	NN	O
its	NNS	O
genome,	IN	O
characterized	PRP$	O
in	,	O
that	VBN	O
the	IN	O
cell	DT	O
lacks	DT	O
stretches	NN	O
of	VBZ	O
nucleic	NNS	O
acid	IN	O
sequence,	JJ	O
wherein	JJ	O
E1A	,	O
and	JJ	O
both	NNP	O
E1B	CC	O
coding	DT	O
sequences	NNP	O
are	NN	O
separated	NNS	O
by	VBP	O
less	VBN	O
than	IN	O
4	JJR	O
kb	IN	O
in	CD	O
the	NN	O
genome.	IN	O
Preferably,	DT	O
the	.	O
cell	,	O
lacks	DT	O
stretches	NN	O
of	VBZ	O
nucleic	NNS	O
acid	IN	O
sequence,	JJ	O
wherein	JJ	O
E1A	,	O
and	JJ	O
both	NNP	O
E1B	CC	O
coding	DT	O
sequences	NNP	O
are	NN	O
separated	NNS	O
by	VBP	O
less	VBN	O
than	IN	O
10	JJR	O
kb	IN	O
in	CD	O
the	NN	O
genome,	IN	O
more	DT	O
preferably,	,	O
the	JJR	O
cell	,	O
lacks	DT	O
stretches	NN	O
of	VBZ	O
nucleic	NNS	O
acid	IN	O
sequence,	JJ	O
wherein	JJ	O
E1A	,	O
and	JJ	O
both	NNP	O
E1B	CC	O
coding	DT	O
sequences	NNP	O
are	NN	O
separated	NNS	O
by	VBP	O
less	VBN	O
than	IN	O
34.5	JJR	O
kb	IN	O
in	CD	O
the	NN	O
genome.	IN	O
Also	DT	O
provided	.	O
is	RB	O
a	VBN	O
method	VBZ	O
for	DT	O
providing	NN	O
or	IN	O
generating	VBG	O
a	CC	O
cell	VBG	O
comprising	DT	O
adenoviral	NN	O
E1	VBG	O
sequences,	JJ	O
wherein	NNP	O
E1	,	O
sequences	VBP	O
include	NNP	O
E1A	NNS	O
and	VBP	O
E1B	NNP	O
coding	CC	O
sequences,	NNP	O
characterized	NN	O
in	,	O
that	VBN	O
the	IN	O
method	DT	O
includes	DT	O
a	NN	O
step	VBZ	O
of	DT	O
selecting	NN	O
cells	IN	O
lacking	VBG	O
inverted	NNS	O
repeats	VBG	O
comprising	JJ	O
E1	NNS	O
sequences.	VBG	O
Further	NNP	O
provided	.	O
is	RB	O
a	VBN	O
cell	VBZ	O
comprising	DT	O
adenovirus	NN	O
E1	VBG	O
sequences	JJ	O
in	NNP	O
its	NNS	O
genome,	IN	O
wherein	PRP$	O
the	,	O
E1	VBP	O
sequences	DT	O
include	NNP	O
E1A	NNS	O
and	VBP	O
E1B	NNP	O
coding	CC	O
sequences,	NNP	O
characterized	NN	O
in	,	O
that	VBN	O
the	IN	O
E1	DT	O
sequences	DT	O
are	NNP	O
not	NNS	O
present	VBP	O
in	RB	O
the	JJ	O
form	IN	O
of	DT	O
inverted	NN	O
repeats	IN	O
in	JJ	O
the	NNS	O
genome.	IN	O
In	DT	O
one	.	O
embodiment	IN	O
thereof,	CD	O
the	NN	O
cell	,	O
comprises	DT	O
at	NN	O
least	VBZ	O
two	IN	O
copies	JJS	O
of	CD	O
the	NNS	O
adenovirus	IN	O
sequences	DT	O
in	NN	O
its	NNS	O
genome,	IN	O
which	PRP$	O
copies	,	O
may	WDT	O
be	VBZ	O
on	MD	O
the	VB	O
same	IN	O
chromosome.	DT	O
In	JJ	O
another	.	O
embodiment	IN	O
thereof,	DT	O
the	NN	O
cell	,	O
comprises	DT	O
one	NN	O
copy	VBZ	O
of	CD	O
the	NN	O
E1	IN	O
sequences	DT	O
in	NNP	O
its	NNS	O
genome,	IN	O
and	PRP$	O
further	,	O
lacks	CC	O
sequences	RB	O
in	NNS	O
its	NNS	O
genome	IN	O
encoding	PRP$	O
(functional)	NN	O
pIX	NN	O
of	)	O
an	NN	O
adenovirus.	IN	O
Also	DT	O
provided	.	O
is	RB	O
a	VBN	O
method	VBZ	O
for	DT	O
generating	NN	O
a	IN	O
batch	VBG	O
of	DT	O
recombinant	NN	O
adenovirus	IN	O
having	JJ	O
a	NN	O
deletion	VBG	O
in	DT	O
the	NN	O
E1	IN	O
region,	DT	O
comprising	NNP	O
the	,	O
steps	VBG	O
of:	DT	O
a)	NNS	O
introducing	:	O
the	)	O
recombinant	VBG	O
adenovirus	DT	O
into	JJ	O
a	NN	O
cell	IN	O
comprising	DT	O
E1	NN	O
sequences	VBG	O
of	NNP	O
an	NNS	O
adenovirus	IN	O
capable	DT	O
of	NN	O
complementing	JJ	O
the	IN	O
deleted	VBG	O
E1	DT	O
sequences	JJ	O
of	NNP	O
the	NNS	O
recombinant	IN	O
adenovirus;	DT	O
b)	JJ	O
culturing	:	O
the	)	O
cell	VBG	O
and	DT	O
harvesting	NN	O
the	CC	O
recombinant	VBG	O
adenovirus,	DT	O
the	JJ	O
method	,	O
characterized	DT	O
in	NN	O
that	VBN	O
the	IN	O
cell	DT	O
is	DT	O
a	NN	O
cell	VBZ	O
described	DT	O
herein.	NN	O
It	VBN	O
will	.	O
be	PRP	O
clear	MD	O
to	VB	O
the	JJ	O
person	TO	O
skilled	DT	O
in	NN	O
the	VBD	O
art	IN	O
that	DT	O
instead	NN	O
of	IN	O
introducing	RB	O
the	IN	O
recombinant	VBG	O
adenovirus,	DT	O
it	JJ	O
is	,	O
also	PRP	O
possible	VBZ	O
to	RB	O
start	JJ	O
the	TO	O
generation	VB	O
of	DT	O
recombinant	NN	O
adenovirus	IN	O
by	JJ	O
using	NN	O
one	IN	O
or	VBG	O
more	CD	O
nucleic	CC	O
acid	JJR	O
fragments	JJ	O
capable	NN	O
of	NNS	O
forming	JJ	O
the	IN	O
genome	VBG	O
of	DT	O
the	NN	O
recombinant	IN	O
adenovirus	DT	O
and	JJ	O
which	NN	O
will,	CC	O
after	WDT	O
replication	,	O
and	IN	O
packaging	NN	O
in	CC	O
that	NN	O
cell,	IN	O
form	DT	O
the	,	O
recombinant	VB	O
adenovirus.	DT	O
Hence,	JJ	O
for	.	O
this	,	O
embodiment,	IN	O
a	DT	O
recombinant	,	O
adenovirus	DT	O
may	JJ	O
also	NN	O
be	MD	O
a	RB	O
genome	VB	O
of	DT	O
the	NN	O
recombinant	IN	O
adenovirus.	DT	O
In	JJ	O
a	.	O
preferred	IN	O
embodiment,	DT	O
the	JJ	O
recombinant	,	O
adenovirus	DT	O
lacks	JJ	O
substantial	NN	O
sequence	VBZ	O
overlap	JJ	O
with	NN	O
the	NN	O
E1	IN	O
sequences	DT	O
present	NNP	O
in	NNS	O
the	NN	O
cell,	IN	O
which	DT	O
could	,	O
otherwise	WDT	O
lead	MD	O
to	RB	O
homologous	VB	O
recombination.	TO	O
In	JJ	O
yet	.	O
another	IN	O
embodiment,	RB	O
provided	DT	O
is	,	O
a	VBN	O
packaging	VBZ	O
system	DT	O
comprising	NN	O
a	NN	O
packaging	VBG	O
cell	DT	O
comprising	NN	O
E1	NN	O
sequences	VBG	O
in	NNP	O
its	NNS	O
genome	IN	O
and	PRP$	O
a	NN	O
recombinant	CC	O
adenovirus	DT	O
vector	JJ	O
with	NN	O
a	NN	O
deletion	IN	O
in	DT	O
the	NN	O
E1	IN	O
region,	DT	O
wherein	NNP	O
the	,	O
genome	VBP	O
of	DT	O
the	NN	O
vector	IN	O
lacks	DT	O
substantial	NN	O
overlap	VBZ	O
with	JJ	O
the	NN	O
E1	IN	O
sequences	DT	O
in	NNP	O
the	NNS	O
genome	IN	O
of	DT	O
the	NN	O
packaging	IN	O
cell,	DT	O
characterized	NN	O
in	,	O
that	VBN	O
the	IN	O
packaging	DT	O
cell	DT	O
is	NN	O
a	NN	O
cell	VBZ	O
according	DT	O
to	NN	O
the	VBG	O
invention.	TO	O
BRIEF	DT	O
DESCRIPTION	.	O
OF	JJ	O
THE	NNP	O
FIGURES	IN	O
FIG.	NNP	O
1	NNP	O
is	.	O
a	CD	O
map	VBZ	O
of	DT	O
pIG.E1A.	NN	O
FIG.	IN	O
2	.	O
depicts	.	O
a	CD	O
map	VBZ	O
of	DT	O
pIG.E1AB21.	NN	O
FIG.	IN	O
3	.	O
is	.	O
an	CD	O
illustration	VBZ	O
of	DT	O
a	NN	O
map	IN	O
of	DT	O
pE1B.	NN	O
FIG.	IN	O
4	.	O
depicts	.	O
a	CD	O
map	VBZ	O
of	DT	O
pCC.E1A.	NN	O
FIG.	IN	O
5	.	O
is	.	O
a	CD	O
map	VBZ	O
of	DT	O
pCC.E1AB21.	NN	O
FIG.	IN	O
6	.	O
is	.	O
an	CD	O
illustration	VBZ	O
of	DT	O
a	NN	O
map	IN	O
of	DT	O
pCC101.	NN	O
FIG.	IN	O
7	.	O
depicts	.	O
a	CD	O
map	VBZ	O
of	DT	O
pCC105.	NN	O
FIG.	IN	O
8	.	O
is	.	O
a	CD	O
map	VBZ	O
of	DT	O
pCC.55Kcol.	NN	O
FIG.	IN	O
9	.	O
depicts	.	O
a	CD	O
map	VBZ	O
of	DT	O
pIG.E1B.	NN	O
FIG.	IN	O
10	.	O
is	.	O
an	CD	O
illustration	VBZ	O
of	DT	O
a	NN	O
map	IN	O
of	DT	O
pCC.E1Bcol.	NN	O
FIG.	IN	O
11	.	O
is	.	O
a	CD	O
map	VBZ	O
of	DT	O
pEC.E1B.	NN	O
FIG.	IN	O
12	.	O
depicts	.	O
a	CD	O
map	VBZ	O
of	DT	O
pSC.55K.	NN	O
FIG.	IN	O
13	.	O
is	.	O
an	CD	O
example	VBZ	O
of	DT	O
the	NN	O
design	IN	O
of	DT	O
large	NN	O
molecules	IN	O
suitable	JJ	O
for	NNS	O
the	JJ	O
transformation	IN	O
of	DT	O
primary	NN	O
cells.	IN	O
Panel	JJ	O
I	.	O
is	NNP	O
a	PRP	O
schematic	VBZ	O
presentation	DT	O
of	JJ	O
single	NN	O
cosmid	IN	O
vector	JJ	O
with	NN	O
coding	NN	O
regions	IN	O
for	VBG	O
E1A	NNS	O
and	IN	O
E1B	NNP	O
proteins	CC	O
(A	NNP	O
and	NNS	O
B,	DT	O
respectively)	CC	O
flanked	,	O
by	)	O
spacer	VBN	O
DNA.	IN	O
RE	NN	O
represents	.	O
a	NNP	O
restriction	VBZ	O
enzyme	DT	O
recognition	NN	O
site	NN	O
not	NN	O
present	NN	O
in	RB	O
the	JJ	O
spacer	IN	O
DNA	DT	O
or	NN	O
E1	NNP	O
sequences.	CC	O
Panel	NNP	O
II	.	O
is	NNP	O
a	NNP	O
schematic	VBZ	O
representation	DT	O
of	JJ	O
two	NN	O
separate	IN	O
nucleic	CD	O
acids	JJ	O
(e.g.,	NNS	O
plasmids	NNS	O
or	,	O
cosmid	NNS	O
vector)	CC	O
having	JJ	O
either	)	O
E1A	VBG	O
(A)	CC	O
or	NNP	O
E1B	)	O
(B)	CC	O
coding	NNP	O
regions	)	O
flanked	VBG	O
by	NNS	O
spacer	VBN	O
DNA.	IN	O
Panel	NN	O
III	.	O
illustrates	NNP	O
a	NNP	O
situation	VBZ	O
that	DT	O
may	NN	O
occur	WDT	O
after	MD	O
transformation	VB	O
and	IN	O
integration	NN	O
into	CC	O
host	NN	O
cell	IN	O
genome	NN	O
of	NN	O
a	NN	O
primary	IN	O
cell	DT	O
with	JJ	O
the	NN	O
molecule	IN	O
from	DT	O
Panel	NN	O
I	IN	O
or	NNP	O
with	PRP	O
the	CC	O
two	IN	O
molecules	DT	O
of	CD	O
Panel	NNS	O
II.	IN	O
In	NNP	O
the	.	O
host	IN	O
genome,	DT	O
the	NN	O
insert	,	O
consists	DT	O
of	NN	O
an	VBZ	O
E1A	IN	O
region	DT	O
and	NNP	O
an	NN	O
E1B	CC	O
region	DT	O
that	NNP	O
are	NN	O
separated	WDT	O
by	VBP	O
spacer	VBN	O
DNA	IN	O
and	NN	O
a	NNP	O
second	CC	O
copy	DT	O
of	JJ	O
that	NN	O
fragment	IN	O
(those	DT	O
fragments)	NN	O
in	DT	O
inverted	)	O
orientation.	IN	O
J	JJ	O
represents	.	O
the	NNP	O
junction	VBZ	O
between	DT	O
inverted	NN	O
repeat.	IN	O
If	VBN	O
a	.	O
part	IN	O
of	DT	O
these	NN	O
sequences	IN	O
(indicated	DT	O
by	NNS	O
arrows)	VBN	O
recombine	IN	O
in	)	O
the	VBP	O
recombinant	IN	O
adenovirus,	DT	O
the	JJ	O
genome	,	O
becomes	DT	O
too	JJ	O
large	NNS	O
to	RB	O
be	JJ	O
packaged.	TO	O
ITR	VB	O
is	.	O
the	NNP	O
inverted	VBZ	O
terminal	DT	O
repeat,	JJ	O
Φ	JJ	O
represents	,	O
the	JJ	O
packaging	VBZ	O
signal,	DT	O
and	NN	O
FI	,	O
is	CC	O
the	NNP	O
fragment	VBZ	O
inserted	DT	O
into	NN	O
recombinant	VBD	O
virus,	IN	O
here	JJ	O
including	,	O
inverted	RB	O
repeat	VBG	O
sequences.	VBN	O
Although	NN	O
the	.	O
presence	IN	O
of	DT	O
an	NN	O
inverted	IN	O
repeat	DT	O
may	JJ	O
help	NN	O
in	MD	O
the	VB	O
subsequently	IN	O
necessary	DT	O
step	RB	O
of	JJ	O
deleting	NN	O
other	IN	O
sequences	VBG	O
from	JJ	O
the	NNS	O
virus	IN	O
genome,	DT	O
the	NN	O
presence	,	O
of	DT	O
an	NN	O
inverted	IN	O
repeat	DT	O
sequence	JJ	O
results	NN	O
in	NN	O
a	NNS	O
minor-imaged	IN	O
duplication	DT	O
of	JJ	O
the	NN	O
left	IN	O
end	DT	O
of	JJ	O
the	NN	O
recombined	IN	O
virus	DT	O
during	JJ	O
replication	NN	O
of	IN	O
the	NN	O
virus	IN	O
genome	DT	O
and	NN	O
generates	NN	O
a	CC	O
genome	VBZ	O
(duplicated	DT	O
fragment,	NN	O
DF)	JJ	O
that	,	O
again	)	O
is	WDT	O
too	RB	O
large	VBZ	O
to	RB	O
be	JJ	O
packaged	TO	O
due	VB	O
to	VBN	O
the	JJ	O
spacer	TO	O
DNA.	DT	O
FIG.	NN	O
14	.	O
is	.	O
a	CD	O
map	VBZ	O
of	DT	O
pIG.E1A.E1B.	NN	O
FIG.	IN	O
15	.	O
depicts	.	O
a	CD	O
map	VBZ	O
of	DT	O
pCC200.	NN	O
FIG.	IN	O
16	.	O
is	.	O
an	CD	O
illustration	VBZ	O
of	DT	O
a	NN	O
map	IN	O
of	DT	O
pCC205.	NN	O
FIG.	IN	O
17	.	O
is	.	O
a	CD	O
map	VBZ	O
of	DT	O
pdys44.	NN	O
FIG.	IN	O
18	.	O
depicts	.	O
a	CD	O
map	VBZ	O
of	DT	O
p44-1.ccE1A.	NN	O
FIG.	IN	O
19	.	O
depicts	.	O
Western	CD	O
blots	NNS	O
of	JJ	O
protein	NNS	O
lysates	IN	O
from	NN	O
generated	NNS	O
cell	IN	O
lines.	VBN	O
Lane	NN	O
1,	.	O
HER01-B-71;	NNP	O
Lane	,	O
2,	:	O
HER01-H-86;	NNP	O
Lane	,	O
3,	:	O
HER01-H-87;	NNP	O
Lane	,	O
4,	:	O
HER01-H-88;	NNP	O
Lane	,	O
5,	:	O
HER01-H-89;	NNP	O
Lane	,	O
6,	:	O
HER01-B-90;	NNP	O
Lane	,	O
7,	:	O
HER01	NNP	O
pn06	,	O
cells;	NNP	O
and	NN	O
Lane	:	O
8,	CC	O
PER.C6	NNP	O
cells.	,	O
FIG.	NNP	O
20	.	O
is	.	O
a	CD	O
demonstration	VBZ	O
of	DT	O
complementation	NN	O
of	IN	O
E1-deleted	NN	O
adenovirus	IN	O
vectors	JJ	O
with	NN	O
transformed	NNS	O
cell	IN	O
clones.	VBN	O
−:	NN	O
negative	.	O
control;	:	O
MOF:	JJ	O
mean	:	O
of	:	O
fluorescence;	NN	O
B-71,	IN	O
B-90,	:	O
H-86,	,	O
H-87,	,	O
H-88,	,	O
H-89:	,	O
generated	,	O
transformed	:	O
cell	VBD	O
clones.	JJ	O
FIG.	NN	O
21	.	O
is	.	O
a	CD	O
schematic	VBZ	O
overview	DT	O
of	JJ	O
the	NN	O
Ad5.E1	IN	O
constructs	DT	O
used	NNP	O
for	NNS	O
the	VBN	O
transfection	IN	O
in	DT	O
Example	NN	O
3.	IN	O
The	NNP	O
restriction	.	O
sites	DT	O
used	NN	O
to	VBZ	O
digest	VBN	O
the	TO	O
genomic	VB	O
DNA	DT	O
and	JJ	O
to	NN	O
generate	CC	O
the	TO	O
probe	VB	O
fragments	DT	O
are	NN	O
indicated.	NNS	O
The	VBP	O
E1A	.	O
and	DT	O
the	NNP	O
E1B	CC	O
DNA	DT	O
fragment	NNP	O
are	NNP	O
fictively	NN	O
linked	VBP	O
with	RB	O
nucleotide	VBN	O
numbering	IN	O
starting	JJ	O
at	VBG	O
the	VBG	O
5′	IN	O
end	DT	O
of	CD	O
the	NN	O
E1A-containing	IN	O
fragment.	DT	O
FIG.	JJ	O
22	.	O
depicts	.	O
a	CD	O
schematic	VBZ	O
presentation	DT	O
of	JJ	O
some	NN	O
embodiments	IN	O
of	DT	O
the	NNS	O
invention	IN	O
(not	DT	O
to	NN	O
scale).	RB	O
Regulating	TO	O
sequences	.	O
(such	VBG	O
as	NNS	O
promoters	JJ	O
and	IN	O
polyA	NNS	O
signals)	CC	O
are	JJ	O
not	)	O
depicted.	VBP	O
DETAILED	RB	O
DESCRIPTION	.	O
OF	JJ	O
THE	NNP	O
INVENTION	IN	O
A	NNP	O
replication-competent	NNP	O
adenovirus	NNP	O
(RCA)	JJ	O
is	NN	O
an	)	O
adenoviral	VBZ	O
particle	DT	O
that	JJ	O
is	NN	O
capable	WDT	O
of	VBZ	O
replication	JJ	O
in	IN	O
cells	NN	O
without	IN	O
the	NNS	O
need	IN	O
for	DT	O
helper	NN	O
adenovirus.	IN	O
An	JJR	O
“HDEP”	.	O
(helper-dependent	DT	O
E1-containing	NN	O
particle)	JJ	O
as	NNP	O
used	)	O
herein	IN	O
is	VBN	O
defined	NN	O
as	VBZ	O
a	VBN	O
viral	IN	O
particle	DT	O
comprising	JJ	O
at	NN	O
least	VBG	O
E1A	IN	O
and	JJS	O
E1B-55K	NNP	O
coding	CC	O
sequences	NNP	O
from	VBG	O
an	NNS	O
adenovirus,	IN	O
the	DT	O
particle	,	O
not	DT	O
being	NN	O
able	RB	O
to	VBG	O
replicate	JJ	O
in	TO	O
a	VB	O
cell	IN	O
lacking	DT	O
functional	NN	O
E1A	VBG	O
and/or	JJ	O
E1B-55K	NNP	O
in	NN	O
the	NNP	O
absence	IN	O
of	DT	O
“helper	NN	O
virus.”	IN	O
A	NNP	O
helper	FW	O
virus	NNP	O
may	NN	O
be	NN	O
wild-type	MD	O
or	VB	O
mutant	JJ	O
adenovirus	CC	O
or	JJ	O
any	NN	O
adenoviral	CC	O
vector	DT	O
providing	JJ	O
the	NN	O
functions	VBG	O
missing	DT	O
in	NNS	O
HDEP	VBG	O
and	IN	O
can,	NNP	O
therefore,	CC	O
be	,	O
provided	,	O
by	VB	O
the	VBN	O
(E1-defective)	IN	O
desired	DT	O
product	)	O
recombinant	VBD	O
adenovirus	NN	O
propagated	NN	O
on	NN	O
the	VBN	O
packaging	IN	O
cell.	DT	O
The	NN	O
E1A	.	O
and	DT	O
E1B	NNP	O
55K	CC	O
sequences	NNP	O
are	CD	O
required	NNS	O
for	VBP	O
propagation	VBN	O
of	IN	O
an	NN	O
adenovirus.	IN	O
The	DT	O
HDEP	.	O
usually	DT	O
further	NNP	O
contains	RB	O
E1B-19K	RB	O
coding	VBZ	O
sequences.	JJ	O
The	NN	O
E1	.	O
sequences	DT	O
present	NNP	O
in	NNS	O
HDEP	JJ	O
should	IN	O
be	NNP	O
able	MD	O
to	VB	O
complement	JJ	O
the	TO	O
recombinant	VB	O
E1-defective	DT	O
adenovirus,	JJ	O
which	JJ	O
can	,	O
serve	WDT	O
as	MD	O
a	VB	O
helper	IN	O
virus	DT	O
for	NN	O
HDEP.	NN	O
HDEP	IN	O
can	.	O
be	NNP	O
generated	MD	O
by	VB	O
homologous	VBN	O
recombination	IN	O
on	JJ	O
overlap	NN	O
between	IN	O
the	NN	O
E1	IN	O
sequences	DT	O
in	NNP	O
a	NNS	O
packaging	IN	O
cell	DT	O
and	NN	O
a	NN	O
vector	CC	O
Murakami	DT	B
et	NN	I
al.,	NNP	I
2002),(	RB	O
but	,	O
as	,	O
now	CC	O
unexpectedly	RB	O
appears	RB	O
from	RB	O
several	VBZ	O
studies,	IN	O
it	JJ	O
can	,	O
also	PRP	O
be	MD	O
generated	RB	O
in	VB	O
the	VBN	O
absence	IN	O
of	DT	O
substantial	NN	O
homology/overlap	IN	O
between	JJ	O
sequences	NN	O
in	IN	O
the	NNS	O
packaging	IN	O
cell	DT	O
and	NN	O
vector,	NN	O
i.e.,	CC	O
by	,	O
a	,	O
process	IN	O
referred	DT	O
to	NN	O
herein	VBD	O
as	TO	O
non-homologous	VB	O
recombination	IN	O
(see,	JJ	O
e.g.,	NN	O
Murakami	,	B
et	,	I
al.,	NNP	I
2004,	FW	I
for	,	O
possible	,	O
structures	IN	O
of	JJ	O
HDEP).	NNS	O
“Substantial	IN	O
overlap”	.	O
as	JJ	O
used	NN	O
herein	IN	O
is,	VBN	O
therefore,	NN	O
defined	,	O
as	,	O
sufficient	VBD	O
overlap	IN	O
for	JJ	O
homologous	NN	O
recombination.	IN	O
In	JJ	O
any	.	O
case,	IN	O
in	DT	O
embodiments	,	O
where	IN	O
the	NNS	O
invention	WRB	O
refers	DT	O
to	NN	O
“absence	NNS	O
of	TO	O
substantial	VB	O
overlap,”	IN	O
this	JJ	O
condition	VB	O
is	DT	O
considered	NN	O
to	VBZ	O
be	VBN	O
fulfilled	TO	O
if	VB	O
an	VBN	O
overlap	IN	O
exists	DT	O
of	JJ	O
no	NNS	O
more	IN	O
than	DT	O
50	JJR	O
nucleotides	IN	O
(“nt”),	CD	O
preferably	NNS	O
less	,	O
than	RB	O
40	JJR	O
nt,	IN	O
more	CD	O
preferably	,	O
less	JJR	O
than	RB	O
30	JJR	O
nt,	IN	O
still	CD	O
more	,	O
preferably	RB	O
less	RBR	O
than	RB	O
20	JJR	O
nt,	IN	O
even	CD	O
still	,	O
more	RB	O
preferably	RB	O
less	RBR	O
than	RB	O
10	JJR	O
nt,	IN	O
and	CD	O
most	,	O
preferably	CC	O
no	JJS	O
overlap	RB	O
at	DT	O
all.	NN	O
Although	IN	O
the	.	O
mechanism	IN	O
of	DT	O
the	NN	O
formation	IN	O
of	DT	O
HDEP	NN	O
is	IN	O
not	NNP	O
fully	VBZ	O
understood	RB	O
at	RB	O
present,	VBN	O
it	IN	O
is	,	O
clear	PRP	O
that	VBZ	O
the	JJ	O
E1	IN	O
sequences	DT	O
therein	NNP	O
originate	NNS	O
from	RB	O
the	VBP	O
genome	IN	O
of	DT	O
the	NN	O
packaging	IN	O
cell.	DT	O
The	NN	O
presence	.	O
of	DT	O
E1	NN	O
sequences	IN	O
in	NNP	O
recombinant	NNS	O
adenovirus	IN	O
batches	JJ	O
is	NN	O
unwanted,	NNS	O
being	VBZ	O
in	,	O
the	VBG	O
form	IN	O
of	DT	O
RCA	NN	O
or	IN	O
HDEP.	NNP	O
Provided	CC	O
is	.	O
methods	VBN	O
and	VBZ	O
means	NNS	O
that	CC	O
minimize	VBZ	O
the	IN	O
chance	VB	O
of	DT	O
generating	NN	O
HDEP.	IN	O
Thereto,	VBG	O
methods	.	O
for	,	O
preparing	NNS	O
cells	IN	O
and	VBG	O
the	NNS	O
resulting	CC	O
cells	DT	O
are	JJ	O
provided,	NNS	O
wherein	VBP	O
the	,	O
cells	VBZ	O
have	DT	O
E1A	NNS	O
and	VBP	O
E1B	NNP	O
in	CC	O
a	NNP	O
chromosomal	IN	O
configuration	DT	O
that	JJ	O
prevents	NN	O
the	WDT	O
introduction	VBZ	O
of	DT	O
E1A	NN	O
and	IN	O
E1B	NNP	O
coding	CC	O
sequences	NNP	O
together	VBG	O
into	NNS	O
a	RB	O
recombinant	IN	O
adenovirus	DT	O
and,	JJ	O
hence,	NN	O
the	,	O
formation	,	O
of	DT	O
HDEP	NN	O
when	IN	O
the	NNP	O
cells	WRB	O
are	DT	O
used	NNS	O
for	VBP	O
the	VBN	O
complementation	IN	O
of	DT	O
E1-deficient	NN	O
recombinant	IN	O
adenoviral	NNP	O
vectors,	JJ	O
in	JJ	O
the	,	O
absence	IN	O
of	DT	O
substantial	NN	O
sequence	IN	O
overlap	JJ	O
between	NN	O
the	NN	O
vector	IN	O
and	DT	O
the	NN	O
chromosomally	CC	O
located	DT	O
E1	RB	O
sequences	VBN	O
of	NNP	O
the	NNS	O
complementing	IN	O
cells	DT	O
hereof.	VBG	O
To	NNS	O
this	.	O
purpose,	TO	O
the	DT	O
chromosomal	,	O
conformation	DT	O
of	JJ	O
the	NN	O
cells	IN	O
according	DT	O
to	NNS	O
one	VBG	O
embodiment	TO	O
of	CD	O
the	NN	O
invention	IN	O
is	DT	O
such	NN	O
that	VBZ	O
E1A	JJ	O
and	IN	O
at	NNP	O
least	CC	O
one	IN	O
of	JJS	O
the	CD	O
E1B	IN	O
coding	DT	O
regions	NNP	O
are	NN	O
separated	NNS	O
in	VBP	O
the	VBN	O
genome	IN	O
of	DT	O
the	NN	O
novel	IN	O
cells.	DT	O
Since	JJ	O
inverted	.	O
repeats	IN	O
are	VBN	O
believed	NNS	O
to	VBP	O
contribute	VBN	O
to	TO	O
the	VB	O
formation	TO	O
of	DT	O
HDEP	NN	O
by	IN	O
stimulating	NNP	O
the	IN	O
deletion	VBG	O
of	DT	O
adenovirus	NN	O
sequences,	IN	O
in	NN	O
another	,	O
embodiment,	IN	O
provided	DT	O
is	,	O
cells	VBN	O
comprising	VBZ	O
E1A	NNS	O
and	VBG	O
E1B	NNP	O
coding	CC	O
sequences,	NNP	O
wherein	NN	O
the	,	O
E1	VBP	O
sequences	DT	O
are	NNP	O
not	NNS	O
present	VBP	O
in	RB	O
inverted	JJ	O
repeat	IN	O
conformation	JJ	O
in	NN	O
the	NN	O
genome	IN	O
of	DT	O
the	NN	O
packaging	IN	O
cells.	DT	O
The	NN	O
cells	.	O
hereof	DT	O
comprise	NNS	O
adenovirus	VBP	O
E1A	NN	O
and	NN	O
E1B	NNP	O
coding	CC	O
sequences	NNP	O
in	VBG	O
their	NNS	O
genome	IN	O
and	PRP$	O
preferably,	NN	O
they	CC	O
comprise	,	O
the	PRP	O
coding	VBP	O
sequences	DT	O
for	NN	O
all	NNS	O
functional	IN	O
E1A	DT	O
and	JJ	O
both	NNP	O
E1B	CC	O
(E1B-55K	DT	O
and	NNP	O
E1B-19K)	NNP	O
proteins	CC	O
in	)	O
their	VBZ	O
genome.	IN	O
E1A	PRP$	O
and	.	O
at	NN	O
least	CC	O
one	IN	O
of	JJS	O
the	CD	O
E1B	IN	O
proteins	DT	O
may	NNP	O
be	NNS	O
of	MD	O
the	VB	O
same	IN	O
or	DT	O
optionally	JJ	O
be	CC	O
of	RB	O
different	VB	O
serotype	IN	O
described	JJ	O
herein.	NN	O
Preferably	VBD	O
in	.	O
these	RB	O
embodiments,	IN	O
at	DT	O
least	,	O
one	IN	O
of	JJS	O
E1A	CD	O
and	IN	O
E1B	NNP	O
are	CC	O
regulated	NNP	O
by	VBP	O
a	VBN	O
promoter	IN	O
different	DT	O
from	NN	O
an	JJ	O
E1A	IN	O
and	DT	O
E1B	NNP	O
promoter,	CC	O
respectively.	NNP	O
Cells	,	O
A	.	O
recombinant	NNS	O
adenovirus	DT	O
may	JJ	O
be	NN	O
able	MD	O
to	VB	O
take	JJ	O
up	TO	O
>20	VB	O
kb	RP	O
of	CD	O
DNA	NN	O
from	IN	O
the	NN	O
cell	IN	O
line	DT	O
in	NN	O
which	NN	O
it	IN	O
is	WDT	O
propagated,	PRP	O
and	VBZ	O
the	,	O
maximum	CC	O
genome	DT	O
length	JJ	O
of	JJ	O
an	NN	O
adenovirus	IN	O
allowing	DT	O
efficient	NN	O
packaging	VBG	O
is	JJ	O
approximately	NN	O
38	VBZ	O
kb	RB	O
(for	CD	O
an	NNS	O
adenovirus	IN	O
type	DT	O
5-based	JJ	O
vector;	NN	O
this	JJ	O
figure	:	O
may	DT	O
depend	NN	O
somewhat	MD	O
on	VB	O
the	RB	O
serotype).	IN	O
This	DT	O
feature	.	O
is	DT	O
used	NN	O
to	VBZ	O
prepare	VBN	O
novel	TO	O
complementing	VB	O
cells	JJ	O
described	VBG	O
herein,	NNS	O
the	VBN	O
cells	,	O
comprising	DT	O
E1A	NNS	O
and	VBG	O
E1B	NNP	O
coding	CC	O
sequences,	NNP	O
and	NN	O
the	,	O
cells	CC	O
characterized	DT	O
in	NNS	O
that	VBN	O
E1A	IN	O
and	DT	O
at	NNP	O
least	CC	O
one	IN	O
of	JJS	O
the	CD	O
E1B	IN	O
sequences	DT	O
are	NNP	O
separated	NNS	O
by	VBP	O
at	VBN	O
least	IN	O
4	IN	O
kb,	JJS	O
preferably	CD	O
at	,	O
least	RB	O
10	IN	O
kb,	JJS	O
and	CD	O
more	,	O
preferably	CC	O
at	JJR	O
least	RB	O
34.5	IN	O
kb	JJS	O
in	CD	O
the	NN	O
genome.	IN	O
This	DT	O
means	.	O
that	DT	O
the	VBZ	O
genome	IN	O
of	DT	O
such	NN	O
cells	IN	O
lacks	JJ	O
stretches	NNS	O
of	VBZ	O
nucleic	NNS	O
acid	IN	O
sequence	JJ	O
wherein	JJ	O
E1A	NN	O
and	NN	O
both	NNP	O
E1B	CC	O
coding	DT	O
sequences	NNP	O
are	NN	O
separated	NNS	O
by	VBP	O
less	VBN	O
than	IN	O
4,	JJR	O
10	IN	O
or	,	O
34.5	CD	O
kb,	CC	O
respectively	CD	O
(see,	,	O
e.g.,	RB	O
FIG.	,	O
22	,	O
for	.	O
a	CD	O
schematic	IN	O
representation).	DT	O
It	JJ	O
will	.	O
be	PRP	O
clear	MD	O
that	VB	O
wherever	JJ	O
the	IN	O
invention	VBZ	O
mentions	DT	O
that	NN	O
two	NNS	O
sequences	WDT	O
are	CD	O
separated	NNS	O
by	VBP	O
at	VBN	O
least	IN	O
a	IN	O
given	JJS	O
distance	DT	O
in	VBN	O
a	NN	O
genome	IN	O
of	DT	O
a	NN	O
cell,	IN	O
this	DT	O
requirement	,	O
is	DT	O
deemed	NN	O
to	VBZ	O
be	VBN	O
fulfilled	TO	O
as	VB	O
well	VBN	O
when	RB	O
the	RB	O
two	WRB	O
sequences	DT	O
are	CD	O
present	NNS	O
on	VBP	O
separate	JJ	O
chromosomes.	IN	O
Hence,	JJ	O
the	.	O
embodiment	,	O
where	DT	O
the	NN	O
two	WRB	O
sequences	DT	O
are	CD	O
on	NNS	O
different	VBP	O
chromosomes	IN	O
is	JJ	O
expressly	NNS	O
included	VBZ	O
within	RB	O
the	VBN	O
meaning	IN	O
“at	DT	O
least	NN	O
x	NNP	O
kb	JJS	O
apart”	JJ	O
or	NN	O
“separated	NN	O
by	CC	O
at	VBN	O
least	IN	O
x	IN	O
kb”	JJS	O
in	JJ	O
the	NN	O
genome,	IN	O
as	DT	O
used	,	O
herein.	IN	O
Such	VBN	O
an	.	O
embodiment	JJ	O
can	DT	O
be	NN	O
easily	MD	O
checked	VB	O
by	RB	O
methods	VBN	O
known	IN	O
to	NNS	O
the	VBN	O
person	TO	O
skilled	DT	O
in	NN	O
the	VBD	O
art,	IN	O
for	DT	O
example,	,	O
by	IN	O
fluorescent	,	O
in	IN	O
situ	NN	O
hybridization	IN	O
(FISH),	JJ	O
which	NN	O
can	,	O
be	WDT	O
used	MD	O
to	VB	O
locate	VBN	O
the	TO	O
chromosome	VB	O
and/or	DT	O
chromosome	NN	O
location	JJ	O
where	NN	O
a	NN	O
given	WRB	O
sequence	DT	O
is	VBN	O
present.	NN	O
The	VBZ	O
cells	.	O
hereof	DT	O
comprise	NNS	O
adenovirus	VBP	O
sequences	NN	O
in	NN	O
their	NNS	O
genome	IN	O
and	PRP$	O
preferably,	NN	O
those	CC	O
adenovirus	,	O
sequences	DT	O
encode	JJ	O
all	NNS	O
E1	VBP	O
proteins	DT	O
but	NNP	O
lack	NNS	O
sequences	CC	O
encoding	NN	O
pIX,	NNS	O
or	VBG	O
a	,	O
part	CC	O
thereof	DT	O
(i.e.,	NN	O
such	NN	O
cells	,	O
preferably	JJ	O
do	NNS	O
not	RB	O
contain	VBP	O
sequences	RB	O
from	VB	O
the	NNS	O
open	IN	O
reading	DT	O
frame	JJ	O
of	NN	O
pIX;	NN	O
for	IN	O
cells	:	O
with	IN	O
Ad5	NNS	O
E1	IN	O
sequences,	NNP	O
this	NNP	O
means	,	O
that	DT	O
they	VBZ	O
preferably	IN	O
do	PRP	O
not	RB	O
contain	VBP	O
nt	RB	O
3609-4031	VB	O
of	JJ	O
wt	CD	O
Ad5	IN	O
or	NN	O
parts	NNP	O
thereof),	CC	O
and	NNS	O
more	,	O
preferably,	CC	O
they	JJR	O
also	,	O
have	PRP	O
deletions	RB	O
in	VBP	O
the	NNS	O
pIX	IN	O
promoter	DT	O
(for	NN	O
cells	NN	O
with	IN	O
Ad5	NNS	O
E1	IN	O
sequence,	NNP	O
preferably	NNP	O
no	,	O
sequences	RB	O
of	DT	O
the	NNS	O
pIX	IN	O
promoter	DT	O
downstream	NN	O
from	NN	O
nt	NN	O
3550,	IN	O
more	JJ	O
preferably	,	O
3525)	RBR	O
in	RB	O
order	)	O
to	IN	O
prevent	NN	O
significant	TO	O
overlap	VB	O
with	JJ	O
adenovirus	NN	O
vectors	IN	O
having	NN	O
pIX	NNS	O
under	VBG	O
control	NN	O
of	IN	O
its	NN	O
own	IN	O
promoter.	PRP$	O
The	JJ	O
absence	.	O
of	DT	O
pIX	NN	O
sequences	IN	O
from	JJ	O
the	NNS	O
genome	IN	O
of	DT	O
the	NN	O
packaging	IN	O
cells	DT	O
aids	NN	O
in	NNS	O
preventing	NNS	O
overlap	IN	O
between	VBG	O
the	NN	O
genome	IN	O
and	DT	O
a	NN	O
recombinant	CC	O
adenovirus	DT	O
vector	JJ	O
(U.S.	NN	O
Pat.	NN	O
No.	NNP	O
5,994,128,	.	O
the	.	O
contents	,	O
of	DT	O
which	NNS	O
are	IN	O
incorporated	WDT	O
by	VBP	O
this	VBN	O
reference).	IN	O
The	DT	O
cells	.	O
described	DT	O
herein	NNS	O
may	VBD	O
be	NN	O
derived	MD	O
from	VB	O
immortalized	VBN	O
cells	IN	O
such	JJ	O
as	NNS	O
A549,	JJ	O
Hela	IN	O
and	,	O
the	NNP	O
like,	CC	O
in	DT	O
which	,	O
case	IN	O
a	WDT	O
selection	NN	O
marker	DT	O
is	NN	O
required	NN	O
to	VBZ	O
establish	VBN	O
the	TO	O
cells.	VB	O
Preferably,	DT	O
the	.	O
cells	,	O
described	DT	O
herein	NNS	O
are	VBN	O
derived	NNS	O
from	VBP	O
primary	VBN	O
cells,	IN	O
in	JJ	O
which	,	O
case,	IN	O
selection	WDT	O
is	,	O
provided	NN	O
by	VBZ	O
the	VBN	O
E1A	IN	O
and	DT	O
E1B	NNP	O
transforming	CC	O
activity	NNP	O
(see	NN	O
examples).	NN	O
In	VB	O
preferred	.	O
aspects,	IN	O
the	JJ	O
cells	,	O
are	DT	O
derived	NNS	O
from	VBP	O
retina	VBN	O
cells.	IN	O
They	NN	O
may	.	O
be	PRP	O
cells	MD	O
of	VB	O
any	NNS	O
origin,	IN	O
including	DT	O
of	,	O
human	VBG	O
origin.	IN	O
For	JJ	O
the	.	O
propagation	IN	O
of	DT	O
human	NN	O
adenovirus,	IN	O
cells	JJ	O
of	,	O
human	NNS	O
origin	IN	O
are	JJ	O
preferred.	NN	O
The	VBP	O
cells	.	O
may,	DT	O
for	NNS	O
instance,	,	O
also	IN	O
be	,	O
of	RB	O
bovine	VB	O
origin	IN	O
for	JJ	O
the	NN	O
propagation	IN	O
of	DT	O
recombinant	NN	O
bovine	IN	O
adenovirus	JJ	O
(U.S.	NN	O
Pat.	NN	O
No.	NNP	O
6,379,944).	.	O
The	.	O
origin	.	O
of	DT	O
the	NN	O
cells	IN	O
may	DT	O
be	NNS	O
chosen	MD	O
by	VB	O
the	VBN	O
person	IN	O
skilled	DT	O
in	NN	O
the	VBD	O
art	IN	O
to	DT	O
be	NN	O
compatible	TO	O
with	VB	O
the	JJ	O
recombinant	IN	O
adenovirus	DT	O
of	JJ	O
choice.	NN	O
In	IN	O
one	.	O
aspect,	IN	O
the	CD	O
cells	,	O
are	DT	O
derived	NNS	O
from	VBP	O
primary	VBN	O
human	IN	O
retina	JJ	O
cells	JJ	O
(also	NN	O
referred	NNS	O
to	RB	O
as	VBN	O
HER	TO	O
cells).	IN	O
Immortalization	NNP	O
of	.	O
such	NN	O
cells	IN	O
with	JJ	O
adenoviral	NNS	O
E1	IN	O
sequences	JJ	O
has,	NNP	O
for	NNS	O
instance,	,	O
been	IN	O
described	,	O
in	VBN	O
U.S.	VBN	O
Pat.	IN	O
No.	NNP	O
5,994,128,	.	O
in	.	O
Byrd	,	B
et	IN	I
al.,	NNP	I
1982,	CC	I
1988,	,	I
and	,	O
Gallimore	,	B
et	CC	I
al.,	NNP	I
1986.	VBP	I
Primary	,	O
HER	.	O
cells	NNP	O
can	NNP	O
be	NNS	O
isolated	MD	O
from	VB	O
fetuses	VBN	O
Byrd	IN	B
et	NNS	I
al.,	NNP	I
1982,	RB	I
1988).(	,	O
In	,	O
other	.	O
embodiments,	IN	O
the	JJ	O
cells	,	O
are	DT	O
derived	NNS	O
from	VBP	O
primary	VBN	O
human	IN	O
embryonic	JJ	O
kidney	JJ	O
cells	JJ	O
(see,	NN	O
e.g.,	NNS	O
Graham	,	B
et	,	I
al.,	NNP	I
1977).In	FW	O
yet	,	O
other	.	O
embodiments,	IN	O
the	RB	O
cells	JJ	O
are	,	O
derived	DT	O
from	NNS	O
primary	VBP	O
amniocytes,	VBN	O
such	IN	O
as	JJ	O
human	,	O
primary	JJ	O
amniocytes	IN	O
(see,	JJ	O
e.g.,	NN	O
U.S.	NNS	O
Pat.	,	O
No.	,	O
6,558,948	NNP	O
for	.	O
methods	.	O
of	CD	O
immortalizing	IN	O
primary	NNS	O
amniocytes	IN	O
with	VBG	O
adenovirus	JJ	O
E1	NNS	O
sequences).	IN	O
Generation	JJ	O
of	NNP	O
Cells	.	O
The	NN	O
cells	IN	O
described	NNP	O
herein	DT	O
can	NNS	O
be	VBD	O
generated	NNS	O
by	MD	O
introducing	VB	O
adenovirus	VBN	O
E1A	IN	O
and	VBG	O
E1B-55K	NN	O
and	NNP	O
E1B-19K	CC	O
coding	NNP	O
sequences	CC	O
into	NNP	O
a	NN	O
precursor	NNS	O
or	IN	O
ancestor	DT	O
cell	NN	O
(hence,	CC	O
the	NN	O
cells	NN	O
are	,	O
derived	DT	O
from	NNS	O
the	VBP	O
precursor	VBN	O
or	IN	O
ancestor	DT	O
cell	NN	O
by	CC	O
introduction	NN	O
of	NN	O
the	IN	O
E1	NN	O
sequences	IN	O
therein).	DT	O
Described	NNP	O
herein,	NNS	O
E1A	.	O
and	NNP	O
at	,	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
are	NNP	O
to	NN	O
be	NNS	O
introduced	VBP	O
into	TO	O
the	VB	O
precursor	VBN	O
cells	IN	O
in	DT	O
an	NN	O
unlinked	NNS	O
manner.	IN	O
“Unlinked”	DT	O
as	JJ	O
used	.	O
in	NN	O
this	IN	O
connotation,	VBN	O
is	IN	O
meant	DT	O
to	,	O
refer	VBZ	O
to	VBN	O
a	TO	O
configuration	VB	O
that	TO	O
is	DT	O
different	NN	O
from	WDT	O
the	VBZ	O
natural	JJ	O
configuration	IN	O
of	DT	O
E1A	JJ	O
and	NN	O
E1B	IN	O
as	NNP	O
found	CC	O
in	NNP	O
an	IN	O
adenovirus,	VBN	O
i.e.,	IN	O
directly	DT	O
adjacent	,	O
to	,	O
each	RB	O
other	JJ	O
(see,	TO	O
e.g.,	DT	O
FIG.	JJ	O
14	,	O
where	,	O
the	.	O
natural,	CD	O
i.e.,	WRB	O
“linked,”	DT	O
configuration	,	O
of	,	O
E1A	JJ	O
and	NN	O
E1B	IN	O
is	NNP	O
shown	CC	O
as	NNP	O
present	VBZ	O
in	VBN	O
plasmid	IN	O
pIG.E1A.E1B).	NN	O
It	IN	O
is	JJ	O
to	.	O
be	PRP	O
noted	VBZ	O
that	TO	O
prior	VB	O
hereto,	VBN	O
the	IN	O
person	JJ	O
skilled	,	O
in	DT	O
the	NN	O
art	VBD	O
that	IN	O
wished	DT	O
to	NN	O
obtain	WDT	O
a	VBD	O
packaging	TO	O
cell	VB	O
comprising	DT	O
in	NN	O
its	NN	O
genome	VBG	O
adenovirus	IN	O
E1A	PRP$	O
and	NN	O
both	NN	O
E1B	NNP	O
coding	CC	O
sequences,	DT	O
would	NNP	O
not	NN	O
contemplate	,	O
introducing	MD	O
E1A	RB	O
and	VB	O
at	VBG	O
least	NNP	O
one	CC	O
E1B	IN	O
sequence	JJS	O
in	CD	O
an	NNP	O
unlinked	NN	O
manner,	IN	O
because:	DT	O
a)	JJ	O
it	,	O
is	:	O
more	)	O
work	PRP	O
and	VBZ	O
hence	RBR	O
less	NN	O
convenient,	CC	O
and	RB	O
b)	RBR	O
both	,	O
E1A	CC	O
and	)	O
E1B	DT	O
sequences	NNP	O
are	CC	O
required	NNP	O
for	NNS	O
immortalization.	VBP	O
Previous	VBN	O
studies,	IN	O
that	.	O
were	JJ	O
done	,	O
to	WDT	O
gain	VBD	O
insight	VBN	O
into	TO	O
the	VB	O
transforming	NN	O
capabilities	IN	O
of	DT	O
E1A	VBG	O
and	NNS	O
E1B	IN	O
proteins,	NNP	O
have	CC	O
demonstrated	NNP	O
that	,	O
introduction	VBP	O
of	VBN	O
E1A	IN	O
and	NN	O
at	IN	O
least	NNP	O
one	CC	O
E1B	IN	O
coding	JJS	O
sequence	CD	O
can	NNP	O
lead	VBG	O
to	NN	O
established	MD	O
clones	VB	O
van	TO	B
den	VBN	I
Elsen	NNS	I
et	JJ	I
al.,	NN	I
1982;	NNP	I
Gallimore	CC	B
et	,	I
al.,	:	I
1986;	NNP	I
Jochemsen	FW	B
et	,	I
al.,	:	I
1987;	NNP	I
Rao	FW	B
et	,	I
al.,	:	I
1992;	NNP	I
Nevels	FW	B
et	,	I
al.,	:	I
2001).(	NNP	O
However,	FW	O
the	,	O
simultaneous	.	O
introduction	,	O
of	DT	O
these	JJ	O
plasmids,	NN	O
and/or	IN	O
the	DT	O
overlap	,	O
between	VBP	O
the	DT	O
introduced	NN	O
sequences,	IN	O
e.g.,	DT	O
in	JJ	O
the	,	O
plasmid	,	O
sequences,	IN	O
the	DT	O
regulatory	NN	O
sequences	,	O
such	DT	O
as	JJ	O
promoter	NNS	O
and/or	JJ	O
polyadenylation	IN	O
signal,	NN	O
and	NN	O
the	NN	O
E1B-55K	,	O
and	CC	O
E1B-19K	DT	O
overlapping	NNP	O
sequence	CC	O
likely	NNP	O
results	VBG	O
in	NN	O
the	JJ	O
co-integration	NNS	O
of	IN	O
E1A	DT	O
and	NN	O
both	IN	O
E1B	NNP	O
coding	CC	O
regions	DT	O
in	NNP	O
the	NN	O
same	NNS	O
locus	IN	O
in	DT	O
the	JJ	O
genome.	NN	O
Indeed	IN	O
such	DT	O
co-integration	.	O
was	RB	O
observed	JJ	O
by	NN	O
van	VBD	O
den	VBN	B
Elsen	IN	I
et	NN	I
al.	NN	I
(1982).	NNP	I
In	CC	O
one	.	O
case	.	O
Jochemsen	IN	B
et	CD	I
al.,	NN	I
1987),(	NNP	O
baby	RB	O
rat	,	O
kidney	,	O
(BRK)	JJ	O
cells	NN	O
were	NN	O
first	)	O
transfected	NNS	O
with	VBD	O
E1A	RB	O
and	VBN	O
picked	IN	O
clones	NNP	O
were	CC	O
then	VBD	O
transfected	NNS	O
with	VBD	O
an	RB	O
E1B	VBN	O
plasmid	IN	O
to	DT	O
study	NNP	O
the	NN	O
influence	TO	O
of	VB	O
E1B	DT	O
expression	NN	O
on	IN	O
E1A	NNP	O
expression.	NN	O
Obviously,	IN	O
this	NNP	O
study	.	O
was	,	O
done	DT	O
on	NN	O
a	VBD	O
specific	VBN	O
type	IN	O
of	DT	O
cells	JJ	O
and	NN	O
for	IN	O
a	NNS	O
reason	CC	O
unrelated	IN	O
to	DT	O
the	NN	O
invention	JJ	O
described	TO	O
in	DT	O
this	NN	O
application.	VBN	O
Prior	IN	O
hereto,	DT	O
there	.	O
was	NNP	O
no	,	O
reason	EX	O
to	VBD	O
separately	DT	O
transfect	NN	O
E1A	TO	O
and	RB	O
at	VB	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
for	NNP	O
the	NN	O
purpose	NNS	O
of	IN	O
generating	DT	O
a	NN	O
packaging	IN	O
cell.	VBG	O
The	DT	O
formation	NN	O
of	.	O
HDEP	DT	O
in	NN	O
the	IN	O
absence	NNP	O
of	IN	O
substantial	DT	O
overlap	NN	O
between	IN	O
the	JJ	O
genome	NN	O
of	IN	O
the	DT	O
recombinant	NN	O
adenovirus	IN	O
and	DT	O
the	JJ	O
packaging	NN	O
cell	CC	O
was	DT	O
hitherto	NN	O
not	NN	O
described.	VBD	O
Furthermore,	JJ	O
the	RB	O
person	.	O
skilled	,	O
in	DT	O
the	NN	O
art	VBD	O
would,	IN	O
in	DT	O
fact,	NN	O
be	,	O
dissuaded	IN	O
to	,	O
use	VB	O
this	VBN	O
method	TO	O
for	VB	O
obtaining	DT	O
other	NN	O
than	IN	O
BRK-derived	VBG	O
cells,	JJ	O
such	IN	O
as,	NNP	O
for	,	O
instance,	JJ	O
human	,	O
cells,	IN	O
since	,	O
Gallimore	JJ	O
et	,	O
al.	IN	O
(1986)	NNP	O
had	FW	O
described	.	O
that	)	O
human	VBD	O
cells	VBN	O
were	IN	O
only	JJ	O
rarely	NNS	O
morphologically	VBD	O
transformed	RB	O
by	RB	O
expressing	RB	O
E1A	VBN	O
only	IN	O
and	VBG	O
most	NNP	O
clones	RB	O
died	CC	O
in	JJS	O
situ	NNS	O
or	VBD	O
immediately	IN	O
after	NN	O
isolation.	CC	O
The	RB	O
sole	IN	O
case	.	O
where	DT	O
an	JJ	O
Ad12	NN	O
(subgroup	WRB	O
A)	DT	O
E1A-expressing	NNP	O
plasmid	VB	O
resulted	)	O
in	NN	O
a	NN	O
clone	VBD	O
was	IN	O
identified	DT	O
114	NN	O
days	VBD	O
post-transfection	VBN	O
and	CD	O
could	NNS	O
only	NN	O
be	CC	O
picked	MD	O
after	RB	O
the	VB	O
clone	VBN	O
had	IN	O
overgrown	DT	O
the	NN	O
dish.	VBD	O
Clearly,	VBN	O
the	DT	O
person	.	O
skilled	,	O
in	DT	O
the	NN	O
art	VBD	O
would	IN	O
not	DT	O
be	NN	O
motivated	MD	O
to	RB	O
introduce	VB	O
E1A	VBN	O
and	TO	O
at	VB	O
least	NNP	O
one	CC	O
E1B	IN	O
gene	JJS	O
into	CD	O
precursor	NNP	O
cells	NN	O
on	IN	O
a	NN	O
separate	NNS	O
moment	IN	O
in	DT	O
time	JJ	O
based	NN	O
on	IN	O
the	NN	O
prior	VBN	O
art.	IN	O
It	DT	O
is	JJ	O
the	.	O
merit	PRP	O
of	VBZ	O
the	DT	O
invention	NN	O
to	IN	O
provide	DT	O
such	NN	O
methods	TO	O
for	VB	O
obtaining	JJ	O
cells	NNS	O
that	IN	O
have	VBG	O
E1A	NNS	O
and	WDT	O
at	VBP	O
least	NNP	O
one	CC	O
E1B	IN	O
coding	JJS	O
sequence	CD	O
separated	NNP	O
in	VBG	O
their	NN	O
genome.	VBN	O
In	IN	O
certain	PRP$	O
aspects,	.	O
the	IN	O
cells	JJ	O
hereof	,	O
are	DT	O
preferably	NNS	O
not	NN	O
baby	VBP	O
rat	RB	O
kidney	RB	O
(BRK)	JJ	O
cells.	NN	O
The	NN	O
cells	)	O
hereof	.	O
may	DT	O
be	NNS	O
human	NN	O
cells.	MD	O
Such	VB	O
cells	JJ	O
may	.	O
be	JJ	O
derived	NNS	O
from	MD	O
HER	VB	O
cells.	VBN	O
It	IN	O
will	NNP	O
be	.	O
clear	PRP	O
that	MD	O
the	VB	O
cells	JJ	O
wherein	IN	O
the	DT	O
E1	NNS	O
sequences	VBP	O
are	DT	O
introduced	NNP	O
according	NNS	O
to	VBP	O
the	VBN	O
invention,	VBG	O
before	TO	O
introducing,	DT	O
are	,	O
preferably	IN	O
free	,	O
from	VBP	O
adenovirus	RB	O
E1A	JJ	O
and	IN	O
E1B	JJ	O
coding	NNP	O
sequences	CC	O
in	NNP	O
their	VBG	O
genome	NNS	O
and,	IN	O
only	PRP$	O
upon	NN	O
introduction	,	O
of	RB	O
the	IN	O
sequences,	NN	O
will	IN	O
obtain	DT	O
the	,	O
E1	MD	O
sequences	VB	O
in	DT	O
their	NNP	O
genome,	NNS	O
thereby	IN	O
becoming	PRP$	O
immortalized	,	O
and	RB	O
capable	VBG	O
of	VBN	O
packaging	CC	O
recombinant	JJ	O
adenovirus	IN	O
with	VBG	O
deletions	JJ	O
in	NN	O
the	IN	O
E1	NNS	O
region.	IN	O
For	DT	O
instance,	NNP	O
WO	.	O
03/031633	IN	O
describes	,	O
the	NNP	O
introduction	CD	O
of	VBZ	O
Ad11	DT	O
E1B-55k	NN	O
into	IN	O
293	NNP	O
cells:	NNP	O
this	IN	O
will	CD	O
clearly	:	O
not	DT	O
lead	MD	O
to	RB	O
the	RB	O
advantages	VB	O
of	TO	O
the	DT	O
invention,	NNS	O
since	IN	O
the	DT	O
E1	,	O
sequences	IN	O
as	DT	O
already	NNP	O
present	NNS	O
in	IN	O
293	RB	O
remain	JJ	O
in	IN	O
the	CD	O
original	NN	O
configuration	IN	O
and	DT	O
will	JJ	O
have	NN	O
an	CC	O
E1B	MD	O
ORF	VB	O
less	DT	O
than	NNP	O
4	NNP	O
kb	JJR	O
apart	IN	O
from	CD	O
the	JJ	O
E1A	RB	O
ORF.	IN	O
In	DT	O
contrast,	NNP	O
the	.	O
invention	IN	O
provides	,	O
methods	DT	O
for	NN	O
generating	VBZ	O
cells	NNS	O
having	IN	O
adenovirus	VBG	O
E1A	NNS	O
and	VBG	O
E1B-19K	NN	O
and	NNP	O
E1B-55K	CC	O
coding	NNP	O
sequences	CC	O
in	NNP	O
their	NN	O
genome,	NNS	O
as	IN	O
well	PRP$	O
as	,	O
the	RB	O
resulting	RB	O
cells	IN	O
from	DT	O
the	VBG	O
methods,	NNS	O
so	IN	O
that	DT	O
the	,	O
nucleic	IN	O
acid	IN	O
sequences	DT	O
comprising	JJ	O
E1A	NN	O
and	NNS	O
at	VBG	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
are	NNP	O
sufficiently	NN	O
separated	NNS	O
from	VBP	O
each	RB	O
other	VBN	O
to	IN	O
prevent	DT	O
the	JJ	O
simultaneous	TO	O
introduction	VB	O
of	DT	O
all	JJ	O
E1A	NN	O
and	IN	O
E1B	DT	O
sequences	NNP	O
from	CC	O
the	NNP	O
genome	NNS	O
of	IN	O
the	DT	O
cells	NN	O
into	IN	O
the	DT	O
genome	NNS	O
of	IN	O
a	DT	O
single	NN	O
adenovirus	IN	O
particle.	DT	O
According	JJ	O
to	NN	O
a	.	O
first	VBG	O
embodiment	TO	O
for	DT	O
generating	JJ	O
cells	NN	O
hereof,	IN	O
the	VBG	O
E1A	NNS	O
and	,	O
at	DT	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
are	NNP	O
separately	NN	O
introduced	NNS	O
into	VBP	O
the	RB	O
precursor	VBN	O
cell,	IN	O
by	DT	O
placing	NN	O
them	,	O
on	IN	O
separate	VBG	O
molecules	PRP	O
that	IN	O
are	JJ	O
introduced	NNS	O
into	WDT	O
the	VBP	O
cell	VBN	O
on	IN	O
a	DT	O
different	NN	O
moment	IN	O
in	DT	O
time,	JJ	O
and	NN	O
the	IN	O
precursor	,	O
cells	CC	O
are	DT	O
not	NN	O
BRK	NNS	O
cells.	VBP	O
In	RB	O
one	NNP	O
embodiment	.	O
hereof,	IN	O
first	CD	O
the	NN	O
E1A	,	O
and	RB	O
E1B-21K	DT	O
coding	NNP	O
sequences	CC	O
are	NNP	O
introduced,	NN	O
while	NNS	O
the	VBP	O
E1B-55K	,	O
coding	IN	O
sequence	DT	O
is	NNP	O
introduced	NN	O
at	NN	O
a	VBZ	O
later	VBN	O
moment	IN	O
in	DT	O
time.	JJ	O
According	NN	O
to	IN	O
a	.	O
second	VBG	O
embodiment	TO	O
for	DT	O
generating	JJ	O
cells,	NN	O
at	IN	O
least	VBG	O
two	,	O
nucleic	IN	O
acid	JJS	O
molecules	CD	O
together	JJ	O
comprising	NNS	O
E1A	VBZ	O
and	RB	O
E1B	VBG	O
coding	NNP	O
sequences	CC	O
are	NNP	O
introduced	NN	O
into	NNS	O
the	VBP	O
precursor	VBN	O
cell,	IN	O
characterized	DT	O
in	NN	O
that	,	O
at	VBN	O
least	IN	O
two	DT	O
nucleic	IN	O
acid	JJS	O
molecules	CD	O
lack	JJ	O
substantial	NN	O
overlapping	NNS	O
sequences.	VBP	O
It	JJ	O
is	NN	O
believed	.	O
that	PRP	O
the	VBZ	O
presence	VBN	O
of	IN	O
such	DT	O
overlapping	NN	O
sequences	IN	O
would	JJ	O
enhance	JJ	O
the	NNS	O
possibility	MD	O
of	VB	O
at	DT	O
least	NN	O
some	IN	O
way	IN	O
of	JJS	O
interaction	DT	O
between	NN	O
at	IN	O
least	NN	O
two	IN	O
molecules	IN	O
and	JJS	O
the	CD	O
subsequent	NNS	O
co-integration	CC	O
of	DT	O
the	JJ	O
sequences	NN	O
on	IN	O
the	DT	O
molecules	NNS	O
into	IN	O
the	DT	O
same	NNS	O
locus	IN	O
of	DT	O
the	JJ	O
genome	NN	O
of	IN	O
the	DT	O
precursor	NN	O
cell	IN	O
into	DT	O
which	NN	O
the	NN	O
molecules	IN	O
are	WDT	O
introduced,	DT	O
whereas	NNS	O
it	VBP	O
is	,	O
an	IN	O
object	PRP	O
of	VBZ	O
the	DT	O
invention	NN	O
to	IN	O
circumvent	DT	O
this.	NN	O
In	TO	O
one	VB	O
embodiment	.	O
hereof,	IN	O
at	CD	O
least	NN	O
one	,	O
of	IN	O
the	JJS	O
E1A	CD	O
and	IN	O
E1B	DT	O
coding	NNP	O
regions	CC	O
are	NNP	O
placed	NN	O
under	NNS	O
control	VBP	O
of	VBN	O
different	IN	O
heterologous	NN	O
regulatory	IN	O
sequences,	JJ	O
such	JJ	O
as	JJ	O
promoters	,	O
and	JJ	O
polyadenylation	IN	O
sequences.	NNS	O
In	CC	O
another	NN	O
embodiment	.	O
hereof,	IN	O
the	DT	O
E1B-55K	NN	O
and	,	O
E1B-19K	DT	O
sequences,	NNP	O
which	CC	O
are	NNP	O
overlapping,	,	O
are	WDT	O
separated	VBP	O
and	,	O
all	VBP	O
overlap	VBN	O
between	CC	O
these	DT	O
coding	VBP	O
sequences	IN	O
is	DT	O
removed	VBG	O
by	NNS	O
genetic	VBZ	O
engineering	VBN	O
using	IN	O
knowledge	JJ	O
of	NN	O
the	VBG	O
redundancy	NN	O
of	IN	O
the	DT	O
genetic	NN	O
code,	IN	O
according	DT	O
to	JJ	O
methods	,	O
known	VBG	O
to	TO	O
the	NNS	O
person	VBN	O
skilled	TO	O
in	DT	O
the	NN	O
art,	VBD	O
thereby	IN	O
allowing	DT	O
the	,	O
introduction	RB	O
of	VBG	O
these	DT	O
E1B	NN	O
coding	IN	O
sequences	DT	O
independently	NNP	O
and	NN	O
unlinked	NNS	O
from	RB	O
each	CC	O
other.	JJ	O
Introduction	IN	O
of	DT	O
the	.	O
E1A	NN	O
and	IN	O
E1B	DT	O
coding	NNP	O
regions	CC	O
in	NNP	O
this	VBG	O
embodiment	NNS	O
may	IN	O
be	DT	O
at	NN	O
the	MD	O
same	VB	O
time,	IN	O
for	DT	O
instance,	JJ	O
by	,	O
co-transfection	IN	O
of	,	O
at	IN	O
least	NN	O
two	IN	O
molecules,	IN	O
but	JJS	O
obviously,	CD	O
the	,	O
first	CC	O
and	,	O
second	DT	O
embodiments	JJ	O
may	CC	O
also	JJ	O
be	NNS	O
combined,	MD	O
i.e.,	RB	O
introduction	VB	O
of	,	O
at	,	O
least	NN	O
two	IN	O
molecules	IN	O
comprising	JJS	O
nucleic	CD	O
acid	NNS	O
sequences	VBG	O
together	JJ	O
comprising	NN	O
E1A	NNS	O
and	RB	O
both	VBG	O
E1B	NNP	O
coding	CC	O
sequences,	DT	O
wherein	NNP	O
at	NN	O
least	,	O
two	NN	O
molecules	IN	O
lack	JJS	O
substantial	CD	O
overlap	NNS	O
with	VBP	O
respect	JJ	O
to	NN	O
each	IN	O
other,	NN	O
and	TO	O
wherein	DT	O
at	,	O
least	CC	O
two	NN	O
molecules	IN	O
are	JJS	O
introduced	CD	O
into	NNS	O
a	VBP	O
precursor	VBN	O
cell	IN	O
on	DT	O
a	NN	O
different	NN	O
moment	IN	O
in	DT	O
time.	JJ	O
In	NN	O
a	IN	O
third	.	O
embodiment,	IN	O
the	DT	O
sequences	JJ	O
encoding	,	O
E1A	DT	O
and	NNS	O
at	VBG	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
are	NNP	O
unlinked	NN	O
by	NNS	O
placing	VBP	O
them	VBN	O
on	IN	O
a	VBG	O
single	PRP	O
nucleic	IN	O
acid	DT	O
molecule,	JJ	O
wherein	NN	O
E1A	NN	O
and	,	O
at	NN	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
(obviously,	NNP	O
this	NN	O
may	NNS	O
as	,	O
well	DT	O
be	MD	O
both	RB	O
E1B	RB	O
coding	VB	O
sequences)	DT	O
are	NNP	O
separated	NN	O
by	)	O
at	VBP	O
least	VBN	O
4	IN	O
kb,	IN	O
preferably	JJS	O
at	CD	O
least	,	O
6	RB	O
kb,	IN	O
more	JJS	O
preferably	CD	O
at	,	O
least	JJR	O
8	RB	O
kb,	IN	O
still	JJS	O
more	CD	O
preferably	,	O
at	RB	O
least	RBR	O
10	RB	O
kb,	IN	O
even	JJS	O
still	CD	O
more	,	O
preferably	RB	O
at	RB	O
least	RBR	O
15	RB	O
kb,	IN	O
and	JJS	O
most	CD	O
preferably	,	O
at	CC	O
least	JJS	O
34.5	RB	O
kb	IN	O
of	JJS	O
nucleic	CD	O
acid,	NN	O
herein	IN	O
referred	JJ	O
to	,	O
as	RB	O
“spacer”	VBD	O
or	TO	O
“stuffer”	IN	O
nucleic	NN	O
acid.	CC	O
The	VB	O
spacer	JJ	O
nucleic	.	O
acid	DT	O
sequence	NN	O
may	JJ	O
advantageously	JJ	O
have	NN	O
the	MD	O
characteristics	RB	O
as	VB	O
described	DT	O
infra	NNS	O
for	IN	O
spacer	JJ	O
nucleic	NN	O
acid	IN	O
sequences,	NN	O
in	JJ	O
particular,	NN	O
the	,	O
sequence	IN	O
lacks	,	O
E1A	DT	O
and	NN	O
E1B	VBZ	O
coding	NNP	O
sequences,	CC	O
may	NNP	O
be	NN	O
built	,	O
up	MD	O
at	VB	O
least	VBN	O
in	RP	O
part	IN	O
of	JJS	O
intron	IN	O
sequences,	NN	O
and	IN	O
may	NN	O
comprise	,	O
regulatory	CC	O
sequences	MD	O
of	VB	O
the	JJ	O
E1A	NNS	O
and/or	IN	O
E1B	DT	O
coding	NNP	O
sequence.	NN	O
It	NNP	O
will	VBG	O
be	.	O
immediately	PRP	O
clear	MD	O
to	VB	O
the	RB	O
skilled	JJ	O
person	TO	O
that	DT	O
in	JJ	O
an	NN	O
equivalent	IN	O
variant	IN	O
of	DT	O
the	JJ	O
third	NN	O
embodiment,	IN	O
E1A	DT	O
and	JJ	O
at	,	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
may	NNP	O
be	NN	O
present	NNS	O
on	MD	O
different	VB	O
nucleic	JJ	O
acid	IN	O
molecules	JJ	O
instead	JJ	O
of	NN	O
on	NNS	O
one	RB	O
molecule	IN	O
(see,	IN	O
e.g.,	CD	O
FIG.	NN	O
13	,	O
I,	,	O
II,	.	O
and,	CD	O
for	,	O
instance,	,	O
Example	,	O
3),	IN	O
as	,	O
long	NNP	O
as	,	O
the	RB	O
sequences	RB	O
are	IN	O
still	DT	O
separated	NNS	O
by	VBP	O
at	RB	O
least	VBN	O
the	IN	O
indicated	IN	O
distance	JJS	O
when	DT	O
different	JJ	O
nucleic	NN	O
acid	WRB	O
molecules	JJ	O
would	JJ	O
form	NN	O
a	NNS	O
single	MD	O
molecule,	VB	O
e.g.,	DT	O
by	JJ	O
(homologous)	,	O
recombination	,	O
or	IN	O
ligation	)	O
or	NN	O
end-to-end	CC	O
joining.	NN	O
The	CC	O
idea	JJ	O
is	.	O
that	DT	O
also	NN	O
in	VBZ	O
such	IN	O
a	RB	O
case,	IN	O
the	JJ	O
E1A	DT	O
and	,	O
at	DT	O
least	NNP	O
one	CC	O
E1B	IN	O
coding	JJS	O
sequence	CD	O
will	NNP	O
still	VBG	O
be	NN	O
separated	MD	O
by	RB	O
at	VB	O
least	VBN	O
4	IN	O
kb,	IN	O
preferably	JJS	O
at	CD	O
least	,	O
6	RB	O
kb,	IN	O
more	JJS	O
preferably	CD	O
at	,	O
least	JJR	O
8	RB	O
kb,	IN	O
still	JJS	O
more	CD	O
preferably	,	O
at	RB	O
least	RBR	O
10	RB	O
kb,	IN	O
even	JJS	O
still	CD	O
more	,	O
preferably	RB	O
at	RB	O
least	RBR	O
15	RB	O
kb,	IN	O
and	JJS	O
most	CD	O
preferably	,	O
at	CC	O
least	JJS	O
34.5	RB	O
kb,	IN	O
when	JJS	O
integrating	CD	O
into	,	O
the	WRB	O
genome	VBG	O
of	IN	O
the	DT	O
precursor	NN	O
cell	IN	O
(see,	DT	O
e.g.,	NN	O
Example	NN	O
3	,	O
and	,	O
FIG.	NNP	O
21).	CD	O
In	CC	O
other	.	O
words,	.	O
the	IN	O
third	JJ	O
embodiment	,	O
of	DT	O
the	JJ	O
invention	NN	O
can,	IN	O
therefore,	DT	O
be	NN	O
performed	,	O
by	,	O
introducing	VB	O
into	VBN	O
a	IN	O
precursor	VBG	O
cell	IN	O
a	DT	O
single	NN	O
nucleic	NN	O
acid	DT	O
molecule	JJ	O
(“molecule	NN	O
A”)	NN	O
comprising	NN	O
the	NNP	O
E1A	)	O
and	VBG	O
E1B-19K	DT	O
and	NNP	O
E1B-55K	CC	O
coding	NNP	O
sequences,	CC	O
at	NNP	O
least	NN	O
two	,	O
of	IN	O
these	JJS	O
three	CD	O
coding	IN	O
sequences	DT	O
being	CD	O
separated	VBG	O
by	NNS	O
at	VBG	O
least	VBN	O
4	IN	O
kb	IN	O
(embodiment	JJS	O
3a),	CD	O
or	NN	O
equally	JJ	O
well	,	O
by	CC	O
introducing	RB	O
two	RB	O
or	IN	O
more	VBG	O
nucleic	CD	O
acid	CC	O
molecules	JJR	O
that	JJ	O
when	NN	O
these	NNS	O
would	WDT	O
form	WRB	O
a	DT	O
single	MD	O
nucleic	VB	O
acid	DT	O
molecule,	JJ	O
would	NN	O
form	NN	O
“molecule	,	O
A”	MD	O
(embodiment	VB	O
3b).	NN	O
In	NNP	O
certain	JJ	O
aspects	.	O
of	IN	O
the	JJ	O
third	NNS	O
embodiment,	IN	O
there	DT	O
are	JJ	O
no	,	O
substantially	EX	O
overlapping	VBP	O
sequences	DT	O
between	RB	O
the	VBG	O
spacer	NNS	O
nucleic	IN	O
acids	DT	O
flanking	NN	O
E1A	JJ	O
and	NNS	O
E1B,	VBG	O
nor	NNP	O
in	CC	O
the	,	O
regulatory	CC	O
sequences	IN	O
for	DT	O
the	JJ	O
E1A	NNS	O
and	IN	O
E1B	DT	O
coding	NNP	O
sequences,	CC	O
in	NNP	O
order	NN	O
to	,	O
reduce	IN	O
the	NN	O
chance	TO	O
of	VB	O
interaction	DT	O
and	NN	O
possible	IN	O
homologous	NN	O
recombination	CC	O
between	JJ	O
these	JJ	O
separated	NN	O
sequences.	IN	O
Recombinant	DT	O
Molecules	VBN	O
Encoding	.	O
E1A	JJ	O
and	NNP	O
E1B	NNP	O
In	NNP	O
one	CC	O
aspect,	NNP	O
provided	IN	O
is	CD	O
a	,	O
recombinant	VBN	O
molecule	VBZ	O
comprising	DT	O
nucleic	JJ	O
acid	NN	O
sequences	VBG	O
encoding	JJ	O
the	NN	O
adenoviral	NNS	O
E1A	VBG	O
proteins	DT	O
and	JJ	O
at	NNP	O
least	NNS	O
one	CC	O
adenoviral	IN	O
E1B	JJS	O
protein,	CD	O
characterized	JJ	O
in	NNP	O
that	,	O
the	VBN	O
nucleic	IN	O
acid	DT	O
sequence	DT	O
encoding	JJ	O
E1A	NN	O
proteins	NN	O
and	VBG	O
the	NNP	O
nucleic	NNS	O
acid	CC	O
sequence	DT	O
encoding	JJ	O
at	NN	O
least	NN	O
one	VBG	O
E1B	IN	O
protein	JJS	O
are	CD	O
separated	NNP	O
by	NN	O
at	VBP	O
least	VBN	O
4	IN	O
kb,	IN	O
preferably	JJS	O
at	CD	O
least	,	O
10	RB	O
kb,	IN	O
more	JJS	O
preferably	CD	O
at	,	O
least	JJR	O
34.5	RB	O
kb.	IN	O
Such	JJS	O
a	CD	O
molecule	.	O
may	JJ	O
be	DT	O
used	NN	O
in	MD	O
the	VB	O
method	VBN	O
described	IN	O
herein	DT	O
to	NN	O
generate	VBD	O
the	NN	O
cells	TO	O
described	VB	O
herein.	DT	O
Such	NNS	O
a	VBD	O
molecule	.	O
may	JJ	O
take	DT	O
various	NN	O
forms	MD	O
known	VB	O
to	JJ	O
the	NNS	O
person	VBN	O
skilled	TO	O
in	DT	O
the	NN	O
art,	VBD	O
such	IN	O
as	DT	O
a	,	O
plasmid,	JJ	O
cosmid,	IN	O
bacterial	DT	O
artificial	,	O
chromosome,	,	O
YAC,	JJ	O
and	JJ	O
the	,	O
like.	,	O
In	CC	O
an	DT	O
equivalent	.	O
embodiment,	IN	O
it	DT	O
is	JJ	O
also	,	O
possible	PRP	O
to	VBZ	O
have	RB	O
the	JJ	O
E1A	TO	O
and	VB	O
E1B	DT	O
protein-encoding	NNP	O
nucleic	CC	O
acid	NNP	O
initially	JJ	O
present	JJ	O
as	NN	O
separate	RB	O
molecules.	JJ	O
Such	IN	O
molecules	JJ	O
may	.	O
optionally	JJ	O
be	NNS	O
capable	MD	O
of	RB	O
forming	VB	O
a	JJ	O
single	IN	O
molecule	VBG	O
by	DT	O
homologous	JJ	O
recombination,	NN	O
ligation,	IN	O
site-specific	JJ	O
recombination,	,	O
end-to-end	,	O
joining,	JJ	O
and	,	O
the	JJ	O
like.	,	O
It	CC	O
is,	DT	O
therefore,	.	O
an	PRP	O
aspect	,	O
hereof	,	O
to	DT	O
provide	JJ	O
a	NN	O
set	TO	O
of	VB	O
at	DT	O
least	NN	O
two	IN	O
nucleic	IN	O
acid	JJS	O
molecules	CD	O
comprising:	JJ	O
a)	NN	O
a	NNS	O
nucleic	:	O
acid	)	O
molecule	DT	O
encoding	JJ	O
the	NN	O
E1A	NN	O
proteins	VBG	O
of	DT	O
an	NNP	O
adenovirus,	NNS	O
wherein	IN	O
the	DT	O
nucleic	,	O
acid	VBP	O
molecule	DT	O
has	JJ	O
at	NN	O
least	NN	O
5	VBZ	O
kb,	IN	O
preferably	JJS	O
at	CD	O
least	,	O
17	RB	O
kb	IN	O
of	JJS	O
spacer	CD	O
nucleic	NN	O
acid	IN	O
sequence	NN	O
on	JJ	O
both	JJ	O
sides	NN	O
of	IN	O
the	DT	O
E1A	NNS	O
coding	IN	O
sequence,	DT	O
the	NNP	O
spacer	NN	O
nucleic	,	O
acid	DT	O
not	NN	O
encoding	RB	O
an	VBZ	O
E1B	RB	O
protein;	VBG	O
and	DT	O
b)	NNP	O
a	:	O
nucleic	CC	O
acid	)	O
molecule	DT	O
encoding	JJ	O
an	NN	O
E1B	NN	O
protein	VBG	O
of	DT	O
an	NNP	O
adenovirus,	NN	O
wherein	IN	O
the	DT	O
nucleic	,	O
acid	VBP	O
molecule	DT	O
has	JJ	O
at	NN	O
least	NN	O
5	VBZ	O
kb,	IN	O
preferably	JJS	O
at	CD	O
least	,	O
17	RB	O
kb	IN	O
of	JJS	O
spacer	CD	O
nucleic	NN	O
acid	IN	O
sequence	NN	O
on	JJ	O
both	JJ	O
sides	NN	O
of	IN	O
the	DT	O
E1B	NNS	O
coding	IN	O
sequence,	DT	O
the	NNP	O
spacer	NN	O
nucleic	,	O
acid	DT	O
not	NN	O
encoding	RB	O
an	VBZ	O
E1A	RB	O
protein.	VBG	O
The	DT	O
spacer	NNP	O
nucleic	.	O
acid	DT	O
may	NN	O
be	JJ	O
any	NN	O
other	MD	O
nucleic	VB	O
acid	DT	O
and	JJ	O
preferably	JJ	O
is	NN	O
chosen	CC	O
such	NN	O
that	VBZ	O
it	VBN	O
is	JJ	O
inert,	IN	O
i.e.,	PRP	O
does	VBZ	O
not	,	O
contain	,	O
coding	VBZ	O
sequences,	RB	O
preferably	VB	O
no	VBG	O
known	,	O
regulatory	RB	O
elements,	DT	O
no	JJ	O
highly	JJ	O
repeated	,	O
regions	DT	O
that	RB	O
may	VBN	O
lead	NNS	O
to	WDT	O
chromosomal	MD	O
instability,	VB	O
and	TO	O
the	JJ	O
like.	,	O
Preferably,	CC	O
the	DT	O
spacer	.	O
nucleic	,	O
acid	DT	O
sequence	NN	O
flanking	JJ	O
E1A	JJ	O
encoding	NN	O
sequences	VBG	O
does	NNP	O
not	VBG	O
contain	NNS	O
substantial	VBZ	O
homology	RB	O
with	VB	O
the	JJ	O
spacer	NN	O
nucleic	IN	O
acid	DT	O
sequence	NN	O
flanking	JJ	O
an	JJ	O
E1B	NN	O
protein	VBG	O
encoding	DT	O
sequence.	NNP	O
The	NN	O
spacer	VBG	O
fragment	.	O
may	DT	O
include	NN	O
regulatory	NN	O
sequences	MD	O
of	VB	O
the	JJ	O
E1A	NNS	O
or	IN	O
E1B	DT	O
expression	NNP	O
cassettes,	CC	O
such	NNP	O
as	NN	O
a	,	O
heterologous	JJ	O
promoter	IN	O
and/or	DT	O
polyadenylation	JJ	O
site.	NN	O
The	NN	O
propagation	NN	O
of	.	O
the	DT	O
recombinant	NN	O
molecules	IN	O
in	DT	O
a	JJ	O
host	NNS	O
can	IN	O
usually	DT	O
conveniently	NN	O
be	MD	O
performed	RB	O
when	RB	O
the	VB	O
molecules	VBN	O
are	WRB	O
in	DT	O
circular	NNS	O
form.	VBP	O
In	IN	O
certain	JJ	O
aspects,	.	O
the	IN	O
recombinant	JJ	O
molecules	,	O
of	DT	O
the	JJ	O
invention	NNS	O
are	IN	O
in	DT	O
a	NN	O
linear	VBP	O
form.	IN	O
This	DT	O
may	JJ	O
aid	.	O
in	DT	O
the	MD	O
transfection	VB	O
of	IN	O
the	DT	O
precursor	NN	O
cell	IN	O
lines,	DT	O
which	NN	O
is	NN	O
generally	,	O
more	WDT	O
efficient	VBZ	O
when	RB	O
linear	RBR	O
molecules	JJ	O
are	WRB	O
used.	JJ	O
Linearization	NNS	O
may,	VBP	O
for	.	O
instance,	NN	O
be	,	O
effected	IN	O
by	,	O
digestion	VB	O
of	VBN	O
the	IN	O
recombinant	NN	O
molecule	IN	O
with	DT	O
one	JJ	O
or	NN	O
more	IN	O
convenient	CD	O
restriction	CC	O
enzymes,	JJR	O
as	JJ	O
known	NN	O
to	,	O
the	IN	O
person	VBN	O
skilled	TO	O
in	DT	O
the	NN	O
art.	VBD	O
Cell	IN	O
Lines	DT	O
Lacking	.	O
E1	NNP	O
Sequences	NNP	O
in	NNP	O
Inverted	NNP	O
Repeat	NNP	O
Orientation	IN	O
Whatever	NNP	O
the	NNP	O
mechanism	NNP	O
of	NNP	O
generating	DT	O
HDEP	NN	O
in	IN	O
the	VBG	O
absence	NNP	O
of	IN	O
substantial	DT	O
overlap	NN	O
between	IN	O
packaging	JJ	O
cell	NN	O
and	IN	O
recombinant	VBG	O
adenovirus,	NN	O
it	CC	O
is	JJ	O
likely	,	O
that	PRP	O
the	VBZ	O
first	JJ	O
step	IN	O
in	DT	O
this	JJ	O
process	NN	O
is	IN	O
an	DT	O
integration	NN	O
event	VBZ	O
of	DT	O
E1	NN	O
sequences	NN	O
from	IN	O
the	NNP	O
genome	NNS	O
of	IN	O
the	DT	O
packaging	NN	O
cell	IN	O
into	DT	O
the	NN	O
virus	NN	O
genome.	IN	O
To	DT	O
accommodate	NN	O
for	.	O
these	TO	O
extra	VB	O
sequences,	IN	O
the	DT	O
virus	JJ	O
must	,	O
subsequently	DT	O
delete	NN	O
adenovirus	MD	O
sequences	RB	O
Murakami	VB	B
et	NN	I
al.,	NNS	I
2002).(	NNP	O
This	RB	O
step	,	O
may	.	O
be	DT	O
more	NN	O
efficient	MD	O
when	VB	O
inverted	RBR	O
repeats	JJ	O
are	WRB	O
present	VBN	O
Steinwaerder	NNS	B
et	VBP	I
al.,	JJ	I
1999).(	NNP	O
The	VBZ	O
PER.C6®	,	O
cell	.	O
line	DT	O
contains	NNP	O
in	NN	O
its	NN	O
genome	VBZ	O
several	IN	O
repeats	PRP$	O
of	JJ	O
the	JJ	O
pIG.E1A.E1B	NNS	O
plasmid	IN	O
that	DT	O
was	NN	O
used	NN	O
for	WDT	O
the	VBD	O
generation	VBN	O
of	IN	O
the	DT	O
cell	NN	O
line,	IN	O
some	DT	O
of	NN	O
which	,	O
repeats	DT	O
are	IN	O
in	WDT	O
inverted	NNS	O
orientation	VBP	O
with	IN	O
respect	JJ	O
to	NN	O
each	IN	O
other.	NN	O
Hence,	TO	O
the	DT	O
presence	.	O
of	,	O
inverted	DT	O
repeats	NN	O
of	IN	O
the	JJ	O
E1	NNS	O
region	IN	O
in	DT	O
the	NNP	O
genome	NN	O
of	IN	O
PER.C6®	DT	O
cells	NN	O
may	IN	O
influence	NNP	O
the	NNS	O
frequency	MD	O
of	VB	O
generating	DT	O
HDEP.	NN	O
It	IN	O
should	VBG	O
be	.	O
noted	PRP	O
that	MD	O
the	VB	O
formation	VBN	O
of	IN	O
HDEP	DT	O
particles	NN	O
could	IN	O
also	NNP	O
occur	NNS	O
in	MD	O
other	RB	O
adenovirus	VB	O
packaging	IN	O
cell	JJ	O
lines,	JJ	O
but	NN	O
in	NN	O
such	,	O
cell	CC	O
lines	IN	O
goes	JJ	O
undetected	NN	O
due	NNS	O
to	VBZ	O
the	JJ	O
appearance	JJ	O
of	TO	O
classical	DT	O
RCA.	NN	O
The	IN	O
absence	JJ	O
of	.	O
E1	DT	O
sequences	NN	O
in	IN	O
inverted	NNP	O
repeat	NNS	O
orientation	IN	O
in	JJ	O
packaging	NN	O
cell	NN	O
lines	IN	O
will	NN	O
likely	NN	O
result	NNS	O
in	MD	O
a	RB	O
lower	VB	O
frequency	IN	O
or	DT	O
even	JJR	O
complete	NN	O
absence	CC	O
of	RB	O
generation	JJ	O
of	NN	O
HDEP	IN	O
when	NN	O
recombinant	IN	O
adenovirus	NNP	O
is	WRB	O
propagated	JJ	O
on	NN	O
such	VBZ	O
packaging	VBN	O
cells.	IN	O
When	JJ	O
new	NN	O
cell	.	O
lines	WRB	O
comprising	JJ	O
E1	NN	O
regions	NNS	O
in	VBG	O
their	NNP	O
genome	NNS	O
are	IN	O
generated	PRP$	O
or	NN	O
chosen,	VBP	O
it	VBN	O
may,	CC	O
therefore,	,	O
be	PRP	O
desirable	,	O
to	,	O
select	VB	O
clones	JJ	O
that	TO	O
lack	VB	O
inverted	NNS	O
repeats,	WDT	O
but	VBP	O
rather	JJ	O
have	,	O
only	CC	O
direct	RB	O
repeats,	VBP	O
or	RB	O
even	JJ	O
a	,	O
single	CC	O
integration	RB	O
of	DT	O
E1	JJ	O
sequences.	NN	O
It	IN	O
is,	NNP	O
therefore,	.	O
an	PRP	O
aspect	,	O
hereof	,	O
to	DT	O
provide	JJ	O
cells,	NN	O
as	TO	O
well	VB	O
as	,	O
a	RB	O
method	RB	O
for	IN	O
providing	DT	O
or	NN	O
generating	IN	O
cells	VBG	O
comprising	CC	O
adenoviral	VBG	O
E1	NNS	O
sequences,	VBG	O
characterized	JJ	O
in	NNP	O
that	,	O
the	VBN	O
method	IN	O
includes	DT	O
a	DT	O
step	NN	O
of	VBZ	O
selecting	DT	O
cells	NN	O
lacking	IN	O
inverted	VBG	O
repeats	NNS	O
comprising	VBG	O
the	JJ	O
E1	NNS	O
sequences.	VBG	O
Provided	DT	O
is	NNP	O
a	.	O
cell	VBN	O
comprising	VBZ	O
adenovirus	DT	O
E1	NN	O
sequences	VBG	O
in	JJ	O
its	NNP	O
genome,	NNS	O
wherein	IN	O
the	PRP$	O
E1	,	O
sequences	VBP	O
include	DT	O
at	NNP	O
least	NNS	O
one	VBP	O
functional	IN	O
copy	JJS	O
of	CD	O
the	JJ	O
E1A	NN	O
and	IN	O
E1B-19K	DT	O
and	NNP	O
E1B-55K	CC	O
coding	NNP	O
sequences,	CC	O
characterized	NNP	O
in	NN	O
that	,	O
the	VBN	O
E1	IN	O
sequences	DT	O
or	DT	O
part	NNP	O
thereof	NNS	O
are	CC	O
not	NN	O
present	NNS	O
in	VBP	O
the	RB	O
form	JJ	O
of	IN	O
inverted	DT	O
repeats	NN	O
in	IN	O
the	JJ	O
genome.	NNS	O
In	IN	O
this	DT	O
embodiment,	.	O
the	IN	O
cell	DT	O
is	,	O
not	DT	O
a	NN	O
293	VBZ	O
cell	RB	O
or	DT	O
a	CD	O
derivative	NN	O
thereof.	CC	O
If	DT	O
inverted	JJ	O
repeats	.	O
are	IN	O
present,	VBN	O
preferably	NNS	O
such	VBP	O
inverted	,	O
repeats	RB	O
are	JJ	O
not	JJ	O
present	NNS	O
within	VBP	O
10	RB	O
kb	JJ	O
in	IN	O
the	CD	O
cell	NNS	O
and,	IN	O
for	DT	O
the	NN	O
disclosure	,	O
herein,	IN	O
inverted	DT	O
repeats	NN	O
with	,	O
at	VBD	O
least	NNS	O
10	IN	O
kb	IN	O
of	JJS	O
non-E1	CD	O
intervening	NN	O
sequence	IN	O
are	JJ	O
not	NN	O
further	NN	O
considered	VBP	O
inverted	RB	O
repeats.	RB	O
The	VBN	O
rationale	JJ	O
is	.	O
that	DT	O
when	NN	O
one	VBZ	O
copy	IN	O
of	WRB	O
the	CD	O
E1	NN	O
sequence	IN	O
is	DT	O
integrated	NNP	O
somewhere	NN	O
on	VBZ	O
a	VBN	O
chromosome	RB	O
and	IN	O
an	DT	O
inverted	NN	O
copy	CC	O
would	DT	O
be	JJ	O
integrated	NN	O
on	MD	O
the	VB	O
same	VBN	O
chromosome	IN	O
but	DT	O
at	JJ	O
a	NN	O
distance	CC	O
large	IN	O
enough	DT	O
to	NN	O
prevent	JJ	O
uptake	RB	O
of	TO	O
the	VB	O
whole	NN	O
segment	IN	O
of	DT	O
DNA	JJ	O
comprising	NN	O
both	IN	O
repeats	NNP	O
in	VBG	O
an	DT	O
adenovirus	NNS	O
particle,	IN	O
no	DT	O
problem	NN	O
is	,	O
envisaged.	DT	O
Also	NN	O
when	VBZ	O
the	.	O
distance	RB	O
is	WRB	O
such	DT	O
that	NN	O
uptake	VBZ	O
of	JJ	O
the	IN	O
fragment	NN	O
is	IN	O
possible	DT	O
(i.e.,	NN	O
10	VBZ	O
kb),	JJ	O
the	,	O
duplication	CD	O
of	,	O
the	DT	O
left	NN	O
end	IN	O
resulting	DT	O
from	JJ	O
the	NN	O
inverted	VBG	O
repeat	IN	O
sequence	DT	O
gives	JJ	O
a	NN	O
virus	NN	O
genome	VBZ	O
that	DT	O
is	NN	O
too	NN	O
large	WDT	O
to	VBZ	O
be	RB	O
packaged	JJ	O
(exemplified	TO	O
in	VB	O
FIG.	VBN	O
13).	VBN	O
The	IN	O
site	.	O
of	.	O
insertion	DT	O
of	NN	O
E1	IN	O
sequences	NN	O
in	IN	O
the	NNP	O
virus	NNS	O
genome	IN	O
is	DT	O
important	NN	O
for	NN	O
the	VBZ	O
final	JJ	O
total	IN	O
length	DT	O
of	JJ	O
the	NN	O
HDEP.	NN	O
It	IN	O
is	DT	O
obvious	.	O
that	PRP	O
the	VBZ	O
chance	JJ	O
that	IN	O
incorporation	DT	O
of	NN	O
an	IN	O
E1-containing	NN	O
genomic	IN	O
fragment	DT	O
results	JJ	O
in	JJ	O
a	NN	O
packagable	NNS	O
genome	IN	O
increases	DT	O
when	JJ	O
the	NN	O
insertion	NNS	O
is	WRB	O
more	DT	O
to	NN	O
the	VBZ	O
left	RBR	O
end	TO	O
of	DT	O
the	JJ	O
virus.	NN	O
If	IN	O
the	DT	O
site	.	O
of	IN	O
insertion	DT	O
is	NN	O
just	IN	O
3′	NN	O
from	VBZ	O
the	RB	O
minimal	CD	O
packaging	IN	O
signal,	DT	O
then	JJ	O
the	NN	O
insert	,	O
can	RB	O
be	DT	O
as	NN	O
large	MD	O
as	VB	O
18.5	RB	O
kb	JJ	O
(including	IN	O
one	CD	O
copy	NNS	O
of	VBG	O
E1A	CD	O
and	NN	O
E1B	IN	O
and	NNP	O
an	CC	O
inverted	NNP	O
repeat	CC	O
sequence)	DT	O
and	JJ	O
still	NN	O
remain	)	O
packagable	CC	O
(assuming	RB	O
a	VB	O
left	JJ	O
to	VBG	O
right	DT	O
end	NN	O
duplication	TO	O
including	JJ	O
350	NN	O
by	NN	O
ITR	VBG	O
and	CD	O
packaging	IN	O
signal).	NNP	O
This	CC	O
does	VBG	O
not	.	O
mean	DT	O
that	VBZ	O
an	RB	O
insert	VB	O
of,	IN	O
e.g.,	DT	O
17	NN	O
kb	,	O
will	,	O
easily	CD	O
generate	NN	O
HDEPs	MD	O
since	RB	O
the	VB	O
possible	NNP	O
sites	IN	O
of	DT	O
integration	JJ	O
of	NNS	O
such	IN	O
a	NN	O
fragment	IN	O
that	PDT	O
still	DT	O
results	NN	O
in	WDT	O
a	RB	O
virus	NNS	O
of	IN	O
packagable	DT	O
size	NN	O
is	IN	O
limited	JJ	O
to	NN	O
1.5	VBZ	O
kb	VBN	O
just	TO	O
3′	CD	O
to	NN	O
the	RB	O
minimal	CD	O
packaging	TO	O
sequence.	DT	O
Thus,	JJ	O
the	NN	O
frequency	.	O
of	,	O
generation	DT	O
of	NN	O
HDEP	IN	O
will	NN	O
decrease	IN	O
with	NNP	O
increasing	MD	O
distance	VB	O
between	IN	O
the	VBG	O
E1A	NN	O
and	IN	O
E1B	DT	O
coding	NNP	O
regions	CC	O
and	NNP	O
may	VBG	O
very	NNS	O
well	CC	O
still	MD	O
be	RB	O
below	RB	O
detection	RB	O
when	VB	O
that	IN	O
distance	NN	O
is	WRB	O
much	DT	O
smaller	NN	O
than	VBZ	O
the	RB	O
mentioned	JJR	O
18.5	IN	O
kb.	DT	O
The	JJ	O
same	CD	O
reasoning	.	O
holds	DT	O
true	JJ	O
for	NN	O
direct	VBZ	O
insertion	JJ	O
of	IN	O
E1A	JJ	O
and	NN	O
E1B	IN	O
in	NNP	O
the	CC	O
absence	NNP	O
of	IN	O
inverted	DT	O
repeat	NN	O
sequences.	IN	O
In	JJ	O
that	NN	O
case,	.	O
the	IN	O
total	DT	O
insertion	,	O
in	DT	O
the	JJ	O
genome	NN	O
of	IN	O
an	DT	O
adenovirus	NN	O
cannot	IN	O
be	DT	O
larger	NN	O
than	RB	O
37.5	VB	O
kb	JJR	O
(including	IN	O
about	CD	O
3	NNS	O
kb	VBG	O
for	IN	O
the	CD	O
E1A	NN	O
and	IN	O
E1B	DT	O
region),	NNP	O
but	CC	O
only	NNP	O
when	,	O
it	CC	O
inserts	RB	O
directly	WRB	O
3′	PRP	O
from	VBZ	O
the	RB	O
minimal	CD	O
packaging	IN	O
signal.	DT	O
Therefore,	JJ	O
when	NN	O
E1A	.	O
and	,	O
at	WRB	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
are	NNP	O
separated	NN	O
by	NNS	O
at	VBP	O
least	VBN	O
34.5	IN	O
kb	IN	O
in	JJS	O
the	CD	O
genome	NN	O
of	IN	O
the	DT	O
packaging	NN	O
cell,	IN	O
insertion	DT	O
of	NN	O
both	,	O
of	NN	O
these	IN	O
sequences	DT	O
into	IN	O
a	DT	O
recombinant	NNS	O
adenovirus	IN	O
is	DT	O
prevented.	JJ	O
Furthermore,	NN	O
the	VBZ	O
whole	.	O
adenovirus	,	O
genome	DT	O
should	JJ	O
then	NN	O
be	NN	O
deleted	MD	O
in	RB	O
a	VB	O
subsequent	VBN	O
step,	IN	O
which	DT	O
process	JJ	O
may	,	O
further	WDT	O
be	NN	O
much	MD	O
less	RB	O
efficient	VB	O
in	RB	O
the	RBR	O
absence	JJ	O
of	IN	O
inverted	DT	O
repeat	NN	O
sequences	IN	O
Steinwaerder	JJ	B
et	NN	I
al.,	NNS	I
1999).(	NNP	O
In	VBZ	O
any	,	O
case,	.	O
irrespective	IN	O
of	DT	O
the	,	O
presence	NN	O
of	IN	O
inverted	DT	O
E1	NN	O
sequences	IN	O
in	JJ	O
the	NNP	O
genome,	NNS	O
the	IN	O
chance	DT	O
of	,	O
generating	DT	O
particles	NN	O
containing	IN	O
E1A	VBG	O
and	NNS	O
E1B	VBG	O
sequences	NNP	O
is	CC	O
reduced	NNP	O
when	NNS	O
the	VBZ	O
E1A	VBN	O
and	WRB	O
at	DT	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
are	NNP	O
further	NN	O
apart	NNS	O
in	VBP	O
the	JJ	O
genome.	RB	O
Hence,	IN	O
in	DT	O
certain	.	O
embodiments,	,	O
E1A	IN	O
and	JJ	O
at	,	O
least	NNP	O
one	CC	O
of	IN	O
E1B	JJS	O
coding	CD	O
sequences	IN	O
are	NNP	O
separated	VBG	O
by	NNS	O
at	VBP	O
least	VBN	O
4	IN	O
kb,	IN	O
6	JJS	O
kb,	CD	O
8	,	O
kb,	CD	O
10	,	O
kb,	CD	O
12	,	O
kb	CD	O
in	,	O
the	CD	O
genome	NN	O
of	IN	O
the	DT	O
cells	NN	O
according	IN	O
to	DT	O
the	NNS	O
invention.	VBG	O
In	TO	O
these	DT	O
embodiments,	.	O
preferably	IN	O
the	DT	O
E1	,	O
sequences	RB	O
are	DT	O
not	NNP	O
present	NNS	O
in	VBP	O
the	RB	O
form	JJ	O
of	IN	O
inverted	DT	O
repeats.	NN	O
Preferably,	IN	O
the	JJ	O
sequences	.	O
are	,	O
separated	DT	O
by	NNS	O
at	VBP	O
least	VBN	O
15	IN	O
kb	IN	O
and	JJS	O
no	CD	O
inverted	NNS	O
E1	CC	O
sequences	DT	O
are	JJ	O
present,	NNP	O
which	NNS	O
will	VBP	O
ensure	,	O
that	WDT	O
the	MD	O
theoretical	VB	O
possibility	IN	O
of	DT	O
generating	JJ	O
HDEP	NN	O
in	IN	O
such	VBG	O
a	NNP	O
cell	IN	O
line	JJ	O
by	DT	O
introduction	NN	O
of	NN	O
E1	IN	O
sequences	NN	O
from	IN	O
the	NNP	O
genome	NNS	O
of	IN	O
the	DT	O
cell	NN	O
line	IN	O
into	DT	O
an	NN	O
adenovirus	NN	O
is	IN	O
practically	DT	O
reduced	NN	O
to	VBZ	O
zero	RB	O
(see,	VBN	O
FIG.	TO	O
13).	CD	O
In	,	O
other	.	O
embodiments,	.	O
E1A	IN	O
and	JJ	O
at	,	O
least	NNP	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
are	NNP	O
separated	NN	O
by	NNS	O
at	VBP	O
least	VBN	O
18	IN	O
kb,	IN	O
20	JJS	O
kb,	CD	O
25	,	O
kb,	CD	O
30	,	O
kb.	CD	O
Most	,	O
preferably,	CD	O
the	.	O
sequences	JJS	O
are	,	O
separated	DT	O
by	NNS	O
at	VBP	O
least	VBN	O
34.5	IN	O
kb.	IN	O
This	JJS	O
will	CD	O
ensure	.	O
that	DT	O
no	MD	O
single	VB	O
integration	IN	O
of	DT	O
both	JJ	O
E1A	NN	O
and	IN	O
E1B	DT	O
derived	NNP	O
from	CC	O
the	NNP	O
genome	VBD	O
of	IN	O
the	DT	O
cell	NN	O
can	IN	O
result	DT	O
in	NN	O
the	MD	O
generation	VB	O
of	IN	O
HDEP.	DT	O
Obviously,	NN	O
as	IN	O
indicated	.	O
above,	,	O
in	IN	O
certain	VBN	O
equivalent	,	O
embodiments,	IN	O
E1A	JJ	O
and	JJ	O
at	,	O
least	NNP	O
one	CC	O
E1B	IN	O
coding	JJS	O
sequence	CD	O
are	NNP	O
present	VBG	O
on	NN	O
different	VBP	O
chromosomes	JJ	O
of	IN	O
the	JJ	O
genome	NNS	O
of	IN	O
the	DT	O
cell.	NN	O
Methods	IN	O
for	DT	O
screening	.	O
generated	NNS	O
clones	IN	O
for	VBG	O
the	VBN	O
presence	NNS	O
of	IN	O
inverted	DT	O
repeats	NN	O
of	IN	O
the	JJ	O
E1	NNS	O
sequences	IN	O
are	DT	O
known	NNP	O
to	NNS	O
the	VBP	O
person	VBN	O
skilled	TO	O
in	DT	O
the	NN	O
art,	VBD	O
and	IN	O
may	DT	O
include	,	O
PCR,	CC	O
Southern	MD	O
blotting,	VB	O
restriction	,	O
enzyme	NNP	O
analysis,	,	O
Fiber-FISH,	NN	O
and	NN	O
the	,	O
like.	,	O
Upon	CC	O
generating	DT	O
cell	.	O
clones	IN	O
using	VBG	O
a	NN	O
plasmid	NNS	O
containing	VBG	O
the	DT	O
E1	NN	O
genes,	VBG	O
such	DT	O
as	NNP	O
the	,	O
pIG.E1A.E1B	JJ	O
plasmid	IN	O
(U.S.	DT	O
Pat.	NN	O
No.	NN	O
5,994,128),	NNP	O
clones	.	O
can	.	O
be	,	O
first	NNS	O
established,	MD	O
and	VB	O
in	RB	O
a	,	O
screening	CC	O
round,	IN	O
those	DT	O
clones	NN	O
lacking	,	O
the	DT	O
inverted	NNS	O
repeat	VBG	O
are	DT	O
picked	JJ	O
for	NN	O
further	VBP	O
use.	VBN	O
The	IN	O
cells	JJ	O
from	.	O
the	DT	O
picked	NNS	O
clones	IN	O
can	DT	O
then	JJ	O
be	NNS	O
suitably	MD	O
used	RB	O
for	VB	O
the	RB	O
generation	VBN	O
of	IN	O
recombinant	DT	O
adenovirus,	NN	O
and	IN	O
it	JJ	O
is	,	O
expected	CC	O
that	PRP	O
the	VBZ	O
frequency	VBN	O
of	IN	O
generating	DT	O
HDEP	NN	O
on	IN	O
these	VBG	O
cells	NNP	O
will	IN	O
be	DT	O
significantly	NNS	O
lower	MD	O
(or	VB	O
even	RB	O
absent)	JJR	O
than	CC	O
in	RB	O
cells	)	O
that	IN	O
do	IN	O
contain	NNS	O
the	WDT	O
inverted	VBP	O
repeats.	VB	O
It	DT	O
is,	JJ	O
therefore,	.	O
another	PRP	O
aspect	,	O
hereof	,	O
to	DT	O
provide	NN	O
a	NN	O
cell	TO	O
comprising	VB	O
adenovirus	DT	O
E1A	NN	O
and	VBG	O
E1B	JJ	O
coding	NNP	O
sequences	CC	O
in	NNP	O
its	VBG	O
genome,	NNS	O
characterized	IN	O
in	PRP$	O
that	,	O
the	VBN	O
E1	IN	O
sequences	DT	O
are	DT	O
not	NNP	O
present	NNS	O
in	VBP	O
the	RB	O
form	JJ	O
of	IN	O
inverted	DT	O
repeats	NN	O
in	IN	O
the	JJ	O
genome.	NNS	O
For	IN	O
this	DT	O
aspect	.	O
hereof,	IN	O
sequences	DT	O
that	JJ	O
are	,	O
separated	NNS	O
by	WDT	O
at	VBP	O
least	VBN	O
10	IN	O
kb	IN	O
of	JJS	O
non-E1	CD	O
sequence	NN	O
are	IN	O
not	JJ	O
to	NN	O
be	VBP	O
considered	RB	O
as	TO	O
inverted	VB	O
repeats.	VBN	O
In	IN	O
a	JJ	O
specific	.	O
aspect,	IN	O
E1A	DT	O
and	JJ	O
E1B	,	O
sequences	NNP	O
are	CC	O
present	NNP	O
in	NNS	O
the	VBP	O
genome	JJ	O
in	IN	O
at	DT	O
least	NN	O
two	IN	O
copies	IN	O
per	JJS	O
genome.	CD	O
In	NNS	O
one	IN	O
aspect,	.	O
at	IN	O
least	CD	O
two	,	O
copies	IN	O
comprise	JJS	O
at	CD	O
least	NNS	O
two	VBP	O
copies	IN	O
present	JJS	O
on	CD	O
one	NNS	O
chromosome.	VBP	O
In	IN	O
another	CD	O
embodiment,	.	O
the	IN	O
cells	DT	O
comprise	,	O
in	DT	O
their	NNS	O
genome	VBP	O
only	IN	O
one	PRP$	O
copy	NN	O
of	RB	O
the	CD	O
E1	NN	O
A	IN	O
and	DT	O
E1B	NNP	O
coding	NNP	O
regions,	CC	O
while	NNP	O
lacking	VBG	O
sequences	,	O
encoding	IN	O
adenovirus	VBG	O
pIX.	NNS	O
Of	VBG	O
course,	NN	O
a	.	O
cell	IN	O
comprising	,	O
only	DT	O
one	NN	O
copy	VBG	O
of	RB	O
the	CD	O
E1	NN	O
sequences	IN	O
in	DT	O
its	NNP	O
genome	NNS	O
should	IN	O
be	PRP$	O
expected	NN	O
to	MD	O
have	VB	O
a	VBN	O
lower	TO	O
frequency	VB	O
(or	DT	O
even	JJR	O
absence)	NN	O
of	CC	O
HDEP	RB	O
generation.	)	O
Use	IN	O
of	NNP	O
the	.	O
Cells	NNP	O
In	IN	O
another	DT	O
aspect,	NNP	O
provided	IN	O
is	DT	O
a	,	O
method	VBN	O
for	VBZ	O
generating	DT	O
recombinant	NN	O
adenovirus	IN	O
in	VBG	O
the	JJ	O
cells	NN	O
hereof.	IN	O
This	DT	O
will	NNS	O
generate	.	O
recombinant	DT	O
adenovirus	MD	O
batches	VB	O
having	JJ	O
a	NN	O
significantly	NNS	O
reduced	VBG	O
frequency	DT	O
of	RB	O
HDEP	JJ	O
compared	NN	O
to	IN	O
the	NNP	O
batches	VBN	O
produced	TO	O
on	DT	O
the	NNS	O
systems	VBN	O
known	IN	O
in	DT	O
the	NNS	O
art,	VBN	O
preferably	IN	O
no	DT	O
HDEP	,	O
at	RB	O
all.	DT	O
In	NNP	O
particularly	IN	O
preferred	.	O
embodiments,	IN	O
the	RB	O
vector	JJ	O
and	,	O
packaging	DT	O
cell	NN	O
used	CC	O
for	NN	O
the	NN	O
generation	VBN	O
of	IN	O
the	DT	O
recombinant	NN	O
adenovirus	IN	O
lack	DT	O
substantial	JJ	O
sequence	NN	O
overlap	VBP	O
(i.e.,	JJ	O
preferably	NN	O
less	NN	O
than	,	O
10	RB	O
nt,	JJR	O
or	IN	O
more	CD	O
preferably,	,	O
no	CC	O
overlap	JJR	O
at	,	O
all),	DT	O
and	NN	O
preferably	IN	O
have	,	O
no	CC	O
overlap,	RB	O
thereby	VBP	O
minimizing	DT	O
the	,	O
chance	RB	O
of	VBG	O
homologous	DT	O
recombination	NN	O
between	IN	O
vector	JJ	O
and	NN	O
sequences	IN	O
in	NN	O
the	CC	O
packaging	NNS	O
cell,	IN	O
resulting	DT	O
in	NN	O
virus	,	O
batches	VBG	O
having	IN	O
no	NN	O
E1-containing	NNS	O
particles	VBG	O
(HDEP,	DT	O
RCA).	JJ	O
It	NNS	O
is	,	O
to	.	O
be	PRP	O
noted	VBZ	O
that	TO	O
the	VB	O
new	VBN	O
cells	IN	O
provided	DT	O
described	JJ	O
herein	NNS	O
may	VBN	O
also	JJ	O
be	NN	O
used	MD	O
for	RB	O
the	VB	O
production	VBN	O
of	IN	O
recombinant	DT	O
proteins	NN	O
as	IN	O
described	JJ	O
earlier	NNS	O
(WO	IN	O
00/63403)	VBN	O
and	RBR	O
for	NNP	O
producing	)	O
other	CC	O
(non-adenoviral)	IN	O
viruses	VBG	O
as	JJ	O
described	)	O
earlier	VBZ	O
(WO	IN	O
01/38362).	VBN	O
It	RBR	O
will	NNP	O
be	.	O
clear	PRP	O
to	MD	O
the	VB	O
person	JJ	O
skilled	TO	O
in	DT	O
the	NN	O
art	VBD	O
that	IN	O
the	DT	O
serotype	NN	O
or	IN	O
the	DT	O
nature	NN	O
of	CC	O
the	DT	O
transgene	NN	O
is	IN	O
not	DT	O
critical	NN	O
to	VBZ	O
the	RB	O
invention.	JJ	O
It	TO	O
will,	DT	O
for	.	O
instance,	PRP	O
be	,	O
immediately	IN	O
clear	,	O
that	VB	O
the	RB	O
adenoviral	JJ	O
E1	IN	O
coding	DT	O
sequences	JJ	O
that	NNP	O
are	NN	O
used	NNS	O
for	WDT	O
the	VBP	O
generation	VBN	O
of	IN	O
the	DT	O
cells	NN	O
can	IN	O
be	DT	O
taken	NNS	O
from	MD	O
any	VB	O
convenient	VBN	O
serotype	IN	O
compatible	DT	O
with	JJ	O
the	NN	O
adenovirus	NN	O
that	IN	O
is	DT	O
to	NN	O
be	WDT	O
propagated	VBZ	O
on	TO	O
the	VB	O
cells,	VBN	O
such	IN	O
as	DT	O
Ad5,	,	O
Ad35,	JJ	O
Ad11,	IN	O
Ad16,	,	O
Ad49	,	O
etc.,	,	O
or	,	O
combinations	NNP	O
thereof,	,	O
i.e.,	CC	O
E1A	NNS	O
from	,	O
one	,	O
serotype	NNP	O
and	IN	O
at	CD	O
least	NN	O
one	CC	O
of	IN	O
the	JJS	O
E1B	CD	O
coding	IN	O
sequences	DT	O
from	NNP	O
another	VBG	O
serotype	NNS	O
(see,	IN	O
e.g.,	DT	O
WO	NN	O
02/40665).	,	O
It	,	O
will	NNP	O
also	.	O
be	PRP	O
clear	MD	O
that	RB	O
in	VB	O
many	JJ	O
other	IN	O
aspects,	IN	O
the	JJ	O
invention	JJ	O
may	,	O
be	DT	O
varied	NN	O
without	MD	O
departing	VB	O
from	VBN	O
the	IN	O
scope	VBG	O
or	IN	O
the	DT	O
spirit	NN	O
thereof.	CC	O
The	DT	O
invention	NN	O
will	.	O
now	DT	O
be	NN	O
illustrated	MD	O
by	RB	O
the	VB	O
following	VBN	O
examples,	IN	O
which	DT	O
should	JJ	O
not	,	O
be	WDT	O
construed	MD	O
to	RB	O
limit	VB	O
the	VBN	O
scope	TO	O
thereof.	VB	O
EXAMPLES	DT	O
The	NN	O
practice	.	O
of	VB	O
this	DT	O
disclosure	NN	O
will	IN	O
typically	DT	O
employ,	NN	O
unless	MD	O
otherwise	RB	O
indicated,	,	O
conventional	IN	O
techniques	RB	O
of	,	O
molecular	JJ	O
biology,	NNS	O
cell	IN	O
biology,	JJ	O
and	,	O
recombinant	NN	O
DNA,	,	O
which	CC	O
are	JJ	O
within	,	O
the	WDT	O
skill	VBP	O
of	IN	O
the	DT	O
art.	NN	O
See,	IN	O
e.g.,	DT	O
Sambrook,	.	B
Fritsch	,	I
and	,	I
Maniatis,	,	I
Molecular	NNP	I
Cloning:	CC	I
A	,	I
Laboratory	NNP	I
Manual,	:	I
2nd	DT	I
edition,	NNP	I
1989;	,	I
Current	CD	B
Protocols	,	I
in	:	I
Molecular	NNP	I
Biology,	NNP	I
F.	IN	I
M.	NNP	I
Ausubel	,	I
et	NNP	I
al.,	NNP	I
eds.,	NNP	I
1987;	FW	I
the	,	O
series	,	O
Methods	:	B
in	DT	I
Enzymology	NN	I
(Academic	NNP	I
Press,	IN	I
Inc.);	NNP	I
PCR2:	NNP	B
A	,	I
Practical	:	I
Approach,	:	I
M.	DT	I
J.	NNP	I
MacPherson,	,	I
B.	NNP	I
D.	NNP	I
Hams,	,	I
G.	NNP	I
R.	NNP	I
Taylor,	,	I
eds.,	NNP	I
1995.
Example	NNP	O
1	,	O
Generation	,	O
of	.	O
Complementing	RB	O
Cell	CD	O
Lines	NNP	O
Using	IN	O
Separate	NNP	O
Nucleic	NNP	O
Acids	NNP	O
Encoding	NNP	O
E1A	NNP	O
And	NNP	O
E1B	NNP	O
Proteins	NNP	O
The	NNP	O
complete	CC	O
morphological	NNP	O
transformation	VBZ	O
of	DT	O
primary	JJ	O
cells	JJ	O
by	NN	O
adenovirus	IN	O
E1	JJ	O
genes	NNS	O
is	IN	O
the	NN	O
result	NNP	O
of	NNS	O
the	VBZ	O
combined	DT	O
activities	NN	O
of	IN	O
the	DT	O
proteins	JJ	O
encoded	NNS	O
by	IN	O
the	DT	O
E1A	NNS	O
and	VBN	O
E1B	IN	O
regions.	DT	O
The	NNP	O
roles	CC	O
of	NNP	O
the	.	O
different	DT	O
E1	NNS	O
proteins	IN	O
in	DT	O
lytic	JJ	O
infection	NNP	O
and	NNS	O
in	IN	O
transformation	JJ	O
have	NN	O
been	CC	O
studied	IN	O
extensively	NN	O
(reviewed	VBP	O
in	VBN	O
Zantema	VBN	B
and	RB	I
van	VBN	I
der	IN	I
Eb,	NNP	I
1995;	CC	I
White,	JJ	B
1995,	NN	I
1996).The	,	O
adenovirus	:	O
E1A	,	O
proteins	,	O
are	.	O
essential	DT	O
for	NN	O
transformation	NNP	O
of	NNS	O
primary	VBP	O
cells.	JJ	O
The	IN	O
concomitant	NN	O
induction	IN	O
of	JJ	O
apoptosis	.	O
is	DT	O
counteracted	JJ	O
by	NN	O
both	IN	O
E1B-19K	NN	O
and	VBZ	O
E1B-55K,	VBN	O
although	IN	O
by	DT	O
different	NNP	O
mechanisms.	CC	O
Although	,	O
the	IN	O
E1A	IN	O
region	JJ	O
encodes	.	O
several	IN	O
proteins,	DT	O
the	NNP	O
whole	NN	O
region	VBZ	O
is	JJ	O
usually	,	O
referred	DT	O
to	JJ	O
as	NN	O
the	VBZ	O
“E1A	RB	O
coding	VBN	O
region”	TO	O
and	IN	O
in	DT	O
all	NN	O
embodiments,	VBG	O
the	NN	O
“E1A	CC	O
coding	IN	O
sequence”	DT	O
as	,	O
used	DT	O
herein	NN	O
refers	VBG	O
to	NN	O
the	IN	O
sequences	VBN	O
encoding	NN	O
all	NNS	O
E1	TO	O
A	DT	O
proteins.	NNS	O
In	VBG	O
rodent	DT	O
cells,	NNP	O
the	NNP	O
activity	.	O
of	IN	O
E1A	NN	O
together	,	O
with	DT	O
either	NN	O
E1B-19K	IN	O
or	NNP	O
55K	RB	O
is	IN	O
sufficient	DT	O
for	NNP	O
full	CC	O
transformation,	CD	O
although	VBZ	O
expression	JJ	O
of	IN	O
both	JJ	O
E1B	,	O
proteins	IN	O
together	NN	O
is	IN	O
twice	DT	O
as	NNP	O
efficient	VBZ	O
Gallimore	RB	B
et	VBZ	I
al.,	RB	I
1985;	RB	I
Rao	JJ	I
et	NNP	I
al.,	FW	I
1992).(	,	O
In	:	O
human	NNP	O
cells,	FW	O
however,	,	O
the	.	O
activity	IN	O
of	JJ	O
the	,	O
E1B-55K	,	O
protein	DT	O
seems	NN	O
to	IN	O
be	DT	O
more	NNP	O
important,	NN	O
given	VBZ	O
the	TO	O
observation	VB	O
that	RBR	O
E1B-55K	,	O
is	VBN	O
indispensable	DT	O
for	NN	O
the	IN	O
establishment	NNP	O
of	VBZ	O
an	JJ	O
immortal	IN	O
transformed	DT	O
cell	NN	O
line	IN	O
Gallimore	DT	B
et	NN	I
al.,	VBD	I
1986).(	NN	O
In	NN	O
adenovirus	NNP	O
infection	FW	O
and	,	O
virus	.	O
propagation,	IN	O
the	JJ	O
E1A	NN	O
proteins	CC	O
function	NN	O
in	,	O
activation	DT	O
of	NNP	O
the	VBZ	O
adenovirus	NN	O
genes,	IN	O
including	NN	O
E1B	IN	O
and	DT	O
other	NN	O
early	,	O
regions,	VBG	O
probably	NNP	O
via	CC	O
interaction	JJ	O
with	JJ	O
the	,	O
TATA-binding	RB	O
protein	IN	O
(reviewed	NN	O
in	IN	O
Zantema	DT	B
and	JJ	I
van	NN	I
der	VBN	I
Eb,	IN	I
1995).E1B-55K	NNP	O
expression	CC	O
is	JJ	O
important	NN	O
in	,	O
the	.	O
late	JJ	O
phase	NN	O
of	VBZ	O
infection	JJ	O
for	IN	O
shut-off	DT	O
of	JJ	O
host	NN	O
protein	IN	O
synthesis	NN	O
and	IN	O
selective	NN	O
transport	IN	O
from	NN	O
the	NN	O
nucleus	NN	O
to	CC	O
the	JJ	O
cytoplasm	NN	O
of	IN	O
viral-encoded	DT	O
proteins	NN	O
Babiss	TO	B
et	DT	I
al.,	NN	I
1985;	IN	I
Pilder	JJ	B
et	NNS	I
al.,	NNP	I
1986).(	RB	O
Adenoviruses	,	O
that	:	O
are	NNP	O
deleted	FW	O
for	,	O
E1B-55K	.	O
show	NNS	O
decreased	WDT	O
replication	VBP	O
on	VBN	O
non-complementing	IN	O
human	NNP	O
cell	NN	O
lines	VBD	O
Harada	NN	B
and	IN	I
Berk,	JJ	I
1999).(	NN	O
Thus,	NN	O
the	NNS	O
E1A-	NNP	O
and	CC	O
E1B-55K-encoded	,	O
proteins	.	O
are	,	O
necessary	DT	O
for	NNP	O
transformation	CC	O
of	JJ	O
primary	NNS	O
human	VBP	O
cells	JJ	O
and	IN	O
for	NN	O
efficient	IN	O
virus	JJ	O
replication	JJ	O
in	NNS	O
human	CC	O
cells.	IN	O
Non-homologous	JJ	O
recombination	NN	O
can	NN	O
result	IN	O
in	JJ	O
incorporation	.	O
of	JJ	O
E1	NN	O
sequences	MD	O
from	VB	O
the	IN	O
cellular	NN	O
genome	IN	O
of	NNP	O
the	NNS	O
packaging	IN	O
cell	DT	O
into	JJ	O
the	NN	O
recombinant	IN	O
adenovirus.	DT	O
The	NN	O
helper-dependent	NN	O
E1-containing	IN	O
particles	DT	O
that	JJ	O
finally	.	O
result	DT	O
from	JJ	O
the	JJ	O
initial	NNS	O
recombined	WDT	O
adenovirus	RB	O
are	VBP	O
able	IN	O
to	DT	O
complement	JJ	O
replication	JJ	O
of	NN	O
the	VBP	O
replication-deficient	JJ	O
vector	TO	O
on	VB	O
non-complementing	NN	O
(human)	IN	O
cells,	DT	O
but	JJ	O
are	NN	O
incapable	IN	O
of	JJ	O
autonomous	)	O
replication.	,	O
This	CC	O
complementation	VBP	O
is	JJ	O
mediated	IN	O
by	JJ	O
both	.	O
E1A	DT	O
and	NN	O
E1B-55K	VBZ	O
and	VBN	O
possibly	IN	O
E1B-19K	DT	O
functions.	NNP	O
Thus,	CC	O
if	NNP	O
the	CC	O
chance	RB	O
that	NNP	O
both	.	O
E1A	,	O
and	IN	O
E1B-55K	DT	O
(and	NN	O
preferably	IN	O
E1B-19K)	DT	O
functions	NNP	O
end	CC	O
up	NNP	O
in	CC	O
the	RB	O
adenoviral	)	O
vector	NNS	O
is	VBP	O
eliminated	RP	O
or	IN	O
reduced,	DT	O
then	JJ	O
the	NN	O
formation	VBZ	O
of	VBN	O
HDEP	CC	O
will	,	O
be	RB	O
eliminated	DT	O
or	NN	O
reduced.	IN	O
Here,	NNP	O
we	MD	O
describe	VB	O
examples	VBN	O
of	CC	O
functional	.	O
plasmids	,	O
expressing	PRP	O
either	VBP	O
E1A,	NNS	O
E1A	IN	O
and	JJ	O
E1B-19K,	NNS	O
E1B	VBG	O
(E1B-19K+E1B-55K)	CC	O
or	,	O
E1B-55K	NNP	O
that	CC	O
are	,	O
used	NNP	O
to	)	O
generate	CC	O
adenoviral	JJ	O
packaging	WDT	O
cell	VBP	O
lines	VBN	O
with	TO	O
E1A	VB	O
and	JJ	O
E1B-55k	NN	O
regions	NN	O
separated	NNS	O
from	IN	O
each	NNP	O
other.	CC	O
Construct	NNP	O
pIG.E1A.E1B	NNS	O
(FIG.	VBD	O
14;	IN	O
SEQ	DT	O
ID	.	O
NO:1	NN	O
of	NN	O
the	.	O
accompanying	:	O
SEQUENCE	NNP	O
LISTING,	NNP	O
incorporated	NNP	O
herein	IN	O
by	DT	O
reference)	VBG	O
containing	NNP	O
the	,	O
Ad5-E1	VBN	O
region	NN	O
(nucl.	IN	O
459-3510	)	O
of	VBG	O
the	DT	O
Ad5	JJ	O
genome	NN	O
(Genbank	.	O
Acc.	CD	O
No.	IN	O
M73260)	DT	O
operatively	NNP	O
linked	NN	O
to	NNP	O
the	.	O
human	.	O
phosphoglycerate	)	O
kinase	RB	O
(PGK)	VBN	O
promoter	TO	O
and	DT	O
hepatitis	JJ	O
B	NN	O
virus	NN	O
poly-adenylation	)	O
sequence,	NN	O
has	CC	O
been	NN	O
described	NNP	O
previously	NN	O
(U.S.	NN	O
Pat.	,	O
No.	VBZ	O
5,994,128).	VBN	O
Generation	VBN	O
of	RB	O
Construct	NNP	O
pIG.E1A	.	O
Construct	.	O
pIG.E1A	.	O
was	NN	O
made	IN	O
by	NNP	O
digestion	FW	O
of	NNP	O
pIG.E1A.E1B	NN	O
with	VBD	O
Hincll	VBN	O
followed	IN	O
by	NN	O
purification	IN	O
of	NN	O
the	IN	O
resulting	NNP	O
5	VBN	O
kb	IN	O
fragment	NN	O
from	IN	O
gel	DT	O
using	VBG	O
QIAEX	CD	O
II	JJ	O
gel	NN	O
extraction	IN	O
kit	NN	O
(Qiagen)	VBG	O
according	NNP	O
to	NNP	O
the	NN	O
manufacturer's	NN	O
instructions.	NN	O
Religation	)	O
of	VBG	O
the	TO	O
isolated	DT	O
fragment	POS	O
and	.	O
transformation	NN	O
into	IN	O
STBL2-competent	DT	O
cells	JJ	O
(Invitrogen)	NN	O
gave	CC	O
pIG.E1A	NN	O
(FIG.	IN	O
1).	JJ	O
This	NNS	O
construct	)	O
contains	VBD	O
nt.	NN	O
459	.	O
to	.	O
1578	DT	O
from	NN	O
the	VBZ	O
Ad5	.	O
genome	CD	O
(Genbank	TO	O
Acc.	CD	O
No.	IN	O
M73260).	DT	O
Generation	NNP	O
of	NN	O
Construct	NNP	O
pIG.E1AB21	.	O
Construct	.	O
pIG.E1A	.	O
was	NN	O
digested	IN	O
with	NNP	O
XbaI	FW	O
and	NNP	O
HpaI	NN	O
and	VBD	O
the	VBN	O
resulting	IN	O
4.8	NNP	O
kb	CC	O
fragment	NNP	O
was	CC	O
isolated	DT	O
from	VBG	O
gel	CD	O
as	JJ	O
above.	NN	O
Construct	VBD	O
pIG.E1A.E1B	VBN	O
was	IN	O
digested	NN	O
with	IN	O
BsrGI	.	O
and	NNP	O
treated	NN	O
with	VBD	O
Klenow	VBN	O
enzyme	IN	O
(New	NNP	O
England	CC	O
Biolabs)	VBN	O
to	IN	O
blunt	NNP	O
the	FW	O
5′	NNP	O
protruding	NNP	O
ends.	)	O
DNA	TO	O
was	VB	O
then	DT	O
purified	CD	O
with	NN	O
the	.	O
QIAquick	NN	O
PCR	VBD	O
purification	RB	O
kit	VBN	O
(Qiagen)	IN	O
according	DT	O
to	NNP	O
the	NNP	O
manufacturer's	NN	O
instructions	NN	O
and	)	O
subsequently	VBG	O
digested	TO	O
with	DT	O
XbaI.	POS	O
The	NNS	O
resulting	CC	O
913	RB	O
by	VBN	O
fragment	IN	O
containing	.	O
the	DT	O
3′	VBG	O
part	CD	O
of	IN	O
E1A	NN	O
and	VBG	O
the	DT	O
E1B19K	CD	O
coding	NN	O
sequence	IN	O
was	NNP	O
isolated	CC	O
from	DT	O
gel	NNP	O
as	VBG	O
described.	NN	O
Ligation	VBD	O
of	VBN	O
the	IN	O
two	NN	O
isolated	IN	O
fragments	.	O
and	NN	O
transformation	IN	O
into	DT	O
DH5α-T1r	CD	O
cells	JJ	O
(Invitrogen)	NNS	O
gave	CC	O
construct	NN	O
pIG.E1AB21	IN	O
(FIG.	NNP	O
2).	NNS	O
This	)	O
construct	VBD	O
thus	NN	O
contains	NN	O
nt.	.	O
459	.	O
to	DT	O
2253	NN	O
from	RB	O
the	VBZ	O
Ad5	.	O
genome	CD	O
(Genbank	TO	O
Acc.	CD	O
No.	IN	O
M73260),	DT	O
so	NNP	O
that	NN	O
the	NNP	O
E1A	.	O
sequence	.	O
is	,	O
driven	RB	O
by	IN	O
the	DT	O
PGK	NNP	O
promoter	NN	O
and	VBZ	O
the	VBN	O
E1B	IN	O
promoter	DT	O
drives	NNP	O
the	NN	O
E1B-19K	CC	O
gene.	DT	O
The	NNP	O
Ad5	NN	O
E1B-19K	VBZ	O
gene	DT	O
is	JJ	O
sometimes	.	O
also	DT	O
referred	NNP	O
to	NNP	O
as	NN	O
the	VBZ	O
Ad5	RB	O
E1B-21K	RB	O
gene	VBN	O
because	TO	O
the	IN	O
predicted	DT	O
amino	NNP	O
acid	NNP	O
sequence	NN	O
constitutes	IN	O
a	DT	O
20.6	JJ	O
KD	NN	O
protein	JJ	O
(for	NN	O
instance,	VBZ	O
several	DT	O
of	CD	O
the	NNP	O
plasmids	NN	O
and	IN	O
primers	,	O
in	JJ	O
this	IN	O
application	DT	O
have	NNS	O
21K	CC	O
as	NNS	O
part	IN	O
of	DT	O
their	NN	O
names).	VBP	O
Generation	CD	O
of	IN	O
Construct	NN	O
pCR5B	IN	O
A	PRP$	O
construct	.	O
containing	NN	O
the	IN	O
Ad5-E1B	NNP	O
region	FW	O
was	NNP	O
then	NN	O
generated	VBG	O
as	DT	O
follows.	JJ	O
First,	NN	O
a	VBD	O
PCR	RB	O
fragment	VBN	O
was	IN	O
generated	.	O
with	,	O
primers	DT	O
5E1Bfor-1:	NNP	O
5′-CGG	NN	O
AAT	VBD	O
TCG	VBN	O
GCG	IN	O
TGT	NNS	O
TAA	:	O
ATG	JJ	O
GGG	NNP	O
CG-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:2)	NNP	O
and	NNP	O
5E1B-rev:	NNP	O
5′-TAG	NNP	O
CAG	NNP	O
GCG	NNP	O
ATT	)	O
CTT	CC	O
GTG	:	O
TC-3′	JJ	O
(SEQ	NNP	O
ID	NNP	O
NO:3),	NNP	O
using	NNP	O
pIG.E1A.E1B	NNP	O
DNA	NNP	O
as	NNP	O
template	NNP	O
and	,	O
Pwo	VBG	O
DNA	JJ	O
polymerase	NNP	O
(Roche)	IN	O
according	NN	O
to	CC	O
the	NNP	O
manufacturer's	NNP	O
instructions	NN	O
with	)	O
DMSO	VBG	O
at	TO	O
3%	DT	O
final	POS	O
concentration.	NNS	O
The	IN	O
amplification	NNP	O
program	IN	O
was	NN	O
94°	JJ	O
C.	.	O
for	DT	O
two	NN	O
minutes	NN	O
followed	VBD	O
by	CD	O
30	NNP	O
cycles	IN	O
of	CD	O
(94°	NNS	O
C.	VBN	O
for	IN	O
30	CD	O
seconds,	NNS	O
50°	IN	O
C.	CD	O
for	NNP	O
30	IN	O
seconds	CD	O
and	,	O
72°	CD	O
C.	NNP	O
for	IN	O
one	CD	O
minute)	NNS	O
and	CC	O
ended	CD	O
by	NNP	O
72°	IN	O
C.	CD	O
for	)	O
ten	CC	O
minutes.	VBN	O
The	IN	O
resulting	CD	O
481	NNP	O
by	IN	O
amplified	JJ	O
fragment	.	O
was	DT	O
purified	VBG	O
with	CD	O
the	IN	O
QIAquick	JJ	O
PCR	NN	O
purification	VBD	O
kit	VBN	O
(Qiagen)	IN	O
and	DT	O
ligated	NNP	O
to	NNP	O
the	NN	O
pCR-ScriptAmp	NN	O
vector	)	O
from	CC	O
the	VBN	O
PCR	TO	O
cloning	DT	O
kit	JJ	O
(Stratagene)	NN	O
in	IN	O
the	DT	O
presence	NNP	O
of	VBG	O
SrfI	NN	O
enzyme	)	O
according	IN	O
to	DT	O
the	NN	O
manufacturer's	IN	O
instructions.	NNP	O
The	FW	O
(blunt)	VBG	O
ligation	TO	O
gave	DT	O
two	POS	O
orientations	.	O
of	DT	O
the	)	O
insert	NN	O
in	VBD	O
the	CD	O
vector	NNS	O
of	IN	O
which	DT	O
the	NN	O
one	IN	O
with	DT	O
the	NN	O
largest	IN	O
fragment	WDT	O
between	DT	O
the	NN	O
EcoRI	IN	O
site	DT	O
in	JJS	O
the	NN	O
(5′)	IN	O
end	DT	O
of	NNP	O
the	NN	O
insert	IN	O
and	DT	O
the	)	O
EcoRI	NN	O
site	IN	O
in	DT	O
the	NN	O
vector	CC	O
was	DT	O
arbitrarily	NNP	O
chosen.	NN	O
This	IN	O
resulted	DT	O
in	NN	O
construct	VBD	O
pCR5B.	RB	O
Correct	.	O
amplification	DT	O
of	VBD	O
the	IN	O
target	NN	O
sequence	.	O
(between	JJ	O
KpnI	NN	O
and	IN	O
EcoRI	DT	O
sites)	NN	O
was	NN	O
verified	IN	O
by	NNP	O
sequencing.	CC	O
Generation	NNP	O
of	)	O
Construct	VBD	O
pE1B	VBN	O
pCR5B	IN	O
was	.	O
digested	NN	O
with	IN	O
KpnI	NNP	O
and	NN	O
EcoRI	NN	O
and	VBD	O
the	VBN	O
415	IN	O
by	NNP	O
fragment	CC	O
was	NNP	O
isolated	CC	O
from	DT	O
gel	CD	O
using	IN	O
the	NN	O
QIAquick	VBD	O
gel	VBN	O
extraction	IN	O
kit	NN	O
(Qiagen).	VBG	O
Construct	DT	O
pIG.E1A.E1B	NNP	O
was	NN	O
then	NN	O
also	NN	O
digested	.	O
with	NNP	O
EcoRI	NN	O
and	VBD	O
KpnI	RB	O
and	RB	O
the	VBN	O
resulting	IN	O
5.2	NNP	O
kb	CC	O
vector	NNP	O
fragment	CC	O
was	DT	O
isolated	VBG	O
from	CD	O
gel	NN	O
as	NN	O
above.	NN	O
Ligation	VBD	O
of	VBN	O
the	IN	O
isolated	NN	O
fragments	IN	O
and	.	O
transformation	NN	O
into	IN	O
DH5α-T1r	DT	O
cells	JJ	O
(Invitrogen)	NNS	O
resulted	CC	O
in	NN	O
construct	IN	O
pE1B	NNP	O
(FIG.	NNS	O
3).	)	O
The	VBD	O
E1B	IN	O
sequence	NN	O
in	NN	O
this	.	O
construct	.	O
constitutes	DT	O
nt.	NNP	O
1642	NN	O
to	IN	O
3510	DT	O
from	NN	O
the	VBZ	O
Ad5	.	O
genome.	CD	O
The	TO	O
new	CD	O
construct's	IN	O
transforming	DT	O
ability,	NNP	O
in	.	O
comparison	DT	O
with	JJ	O
the	POS	O
full	NN	O
length	,	O
Ad5E1	IN	O
expression	NN	O
construct,	IN	O
was	DT	O
then	JJ	O
tested.	NN	O
Hereto,	NNP	O
primary	NN	O
human	,	O
embryonic	VBD	O
retina	RB	O
(HER)	.	O
cells	,	O
were	JJ	O
isolated	JJ	O
(see,	JJ	O
e.g.,	NN	O
Byrd	)	B
et	NNS	I
al.,	VBD	I
1982,	VBN	I
1988)	,	I
and	,	O
seeded	NNP	O
in	FW	O
6	,	O
cm	,	O
dishes	)	O
in	CC	O
DMEM	VBN	O
medium	IN	O
(Gibco	CD	O
BRL),	NN	O
supplemented	NNS	O
with	IN	O
10%	NNP	O
heat-inactivated	NN	O
Fetal	NNP	O
Bovine	,	O
Serum	VBN	O
(FBS,	IN	O
Gibco	NN	O
BRL).	JJ	O
At	NNP	O
60	NNP	O
to	NNP	O
70%	,	O
confluency,	NNP	O
cells	.	O
were	IN	O
transfected	CD	O
with,	TO	O
in	NN	O
total,	,	O
20	NNS	O
μg	VBD	O
DNA/dish,	VBN	O
using	,	O
the	IN	O
CaPO4	,	O
co-precipitation	CD	O
kit	JJ	O
(Invitrogen)	,	O
according	VBG	O
to	DT	O
the	NNP	O
manufacturer's	NN	O
instructions.	NN	O
Two	)	O
weeks	VBG	O
later,	TO	O
transformed	DT	O
clones	POS	O
were	.	O
visible	CD	O
as	NNS	O
foci	,	O
in	VBD	O
a	NNS	O
monolayer	VBD	O
of	JJ	O
primary	IN	O
cells.	NN	O
Cells	IN	O
in	DT	O
a	NN	O
focus	IN	O
showed	JJ	O
a	.	O
clearly	NNS	O
different	IN	O
morphology	DT	O
compared	NN	O
with	VBD	O
the	DT	O
primary	RB	O
cells.	JJ	O
Table	NN	O
I	VBN	O
depicts	IN	O
the	DT	O
amounts	JJ	O
of	.	O
transformed	NN	O
clones	PRP	O
that	VBZ	O
were	DT	O
obtained	NNS	O
with	IN	O
each	JJ	O
of	NNS	O
the	WDT	O
transfections.	VBD	O
The	VBN	O
results	IN	O
confirm	DT	O
previous	IN	O
observations	DT	O
that	.	O
primary	DT	O
cells	NNS	O
can	VBP	O
be	JJ	O
transformed	NNS	O
with	WDT	O
Ad5-E1A	VBP	O
and	NNS	O
E1B19K	MD	O
genes	VB	O
(pIG.E1AB21).	VBN	O
It	IN	O
should	NNP	O
be	CC	O
noted	NNP	O
that	NNS	O
these	.	O
foci	PRP	O
were	MD	O
generally	VB	O
smaller	VBN	O
than	IN	O
the	DT	O
ones	NNS	O
obtained	VBD	O
with	RB	O
the	JJR	O
transfection	IN	O
where	DT	O
the	NNS	O
complete	VBN	O
E1B	IN	O
region	DT	O
was	NN	O
present.	WRB	O
Also,	DT	O
after	JJ	O
picking	NNP	O
the	NN	O
foci	VBD	O
resulting	.	O
from	,	O
transfections	IN	O
with	VBG	O
construct	DT	O
pIG.E1AB21	NN	O
and	VBG	O
seeding	IN	O
into	NNS	O
96-well	IN	O
plates,	NN	O
no	NN	O
sustained	CC	O
cell	VBG	O
growth	IN	O
was	NNP	O
obtained	,	O
and	DT	O
all	VBN	O
cells	NN	O
died.	NN	O
In	VBD	O
all	VBN	O
other	CC	O
cases,	DT	O
most	NNS	O
of	.	O
the	IN	O
picked	DT	O
foci	JJ	O
resulted	,	O
in	JJS	O
viable	IN	O
cell	DT	O
clones.	JJ	O
Since	NN	O
transfection	VBD	O
with	IN	O
pIG.E1AB21	JJ	O
initially	NN	O
resulted	.	O
in	IN	O
transformed	NN	O
cells,	IN	O
it	NN	O
is	RB	O
possible	VBD	O
to	IN	O
re-transfect	JJ	O
the	,	O
cells	PRP	O
with	VBZ	O
an	JJ	O
E1B-55K	TO	O
expression	VB	O
construct,	DT	O
e.g.	NNS	O
five	IN	O
to	DT	O
ten	JJ	O
days	NN	O
following	,	O
the	.	O
first	CD	O
transfection.	TO	O
This	VB	O
ensures	NNS	O
that	VBG	O
cells	DT	O
are	JJ	O
obtained	.	O
that	DT	O
have	VBZ	O
incorporated	IN	O
both	NNS	O
expression	VBP	O
cassettes	VBN	O
on	IN	O
different	VBP	O
loci	VBN	O
in	DT	O
the	NN	O
genome.	VBZ	O
This	IN	O
experiment	JJ	O
further	NN	O
confirms	IN	O
that	DT	O
it	.	O
is	DT	O
possible	NN	O
to	RB	O
generate	VBZ	O
and	IN	O
establish	PRP	O
transformed	VBZ	O
cell	JJ	O
clones	TO	O
by	VB	O
using	CC	O
two	VB	O
separate	VBN	O
plasmids	NN	O
for	NNS	O
the	IN	O
E1A	VBG	O
and	CD	O
E1B	JJ	O
genes	NNS	O
(pIG.E1A+pE1B).	IN	O
However,	DT	O
because	NNP	O
both	CC	O
plasmids	NNP	O
were	NNS	O
transfected	.	O
together	,	O
and	IN	O
contain	DT	O
considerable	NNS	O
sequence	VBD	O
overlap	VBN	O
(plasmid	RB	O
backbone	CC	O
and	VB	O
promoter/polyA),	JJ	O
it	NN	O
is	NN	O
possible	JJ	O
that	NN	O
integration	CC	O
of	,	O
E1A	PRP	O
and	VBZ	O
E1B	JJ	O
took	IN	O
place	NN	O
in	IN	O
the	NNP	O
same	CC	O
locus	NNP	O
in	VBD	O
the	NN	O
genome.	IN	O
This	DT	O
may	JJ	O
be	NN	O
avoided	IN	O
using	DT	O
fragments	.	O
with	DT	O
expression	MD	O
cassettes	VB	O
only	VBN	O
(no	VBG	O
vector	NNS	O
sequences)	IN	O
and	NN	O
having	NNS	O
no	RB	O
sequence	DT	O
overlap.	NN	O
The	)	O
sequence	CC	O
overlap	VBG	O
can	DT	O
be	NN	O
removed	.	O
from	DT	O
regulatory	NN	O
elements,	NN	O
such	MD	O
as	VB	O
the	VBN	O
promoters	IN	O
and	JJ	O
polyadenylation	,	O
(polyA)	JJ	O
sequences,	IN	O
by	DT	O
using	NNS	O
different	CC	O
regulatory	NN	O
sequences	)	O
for	,	O
the	IN	O
two	VBG	O
expression	JJ	O
constructs	JJ	O
with	NNS	O
the	IN	O
E1A	DT	O
and	CD	O
E1B	NN	O
sequences.	NNS	O
Preferably,	IN	O
these	DT	O
sequences	NNP	O
are	CC	O
sufficiently	NNP	O
divergent	.	O
to	,	O
prevent	DT	O
overlap	NNS	O
that	VBP	O
could	RB	O
lead	JJ	O
to	TO	O
the	VB	O
formation	NN	O
of	WDT	O
paired	MD	O
structures	VB	O
found	TO	O
during	DT	O
a	NN	O
homologous	IN	O
recombination	JJ	O
process.	NNS	O
Any	VBN	O
promoter	IN	O
and	DT	O
polyA	JJ	O
sequence	NN	O
can	.	O
be	DT	O
used.	NN	O
Preferably,	CC	O
the	JJ	O
regulatory	NN	O
sequences	MD	O
are	VB	O
different	.	O
from	,	O
those	DT	O
from	JJ	O
the	NNS	O
transgenes	VBP	O
in	JJ	O
the	IN	O
recombinant	DT	O
adenovirus	IN	O
that	DT	O
will	NNS	O
be	IN	O
propagated	DT	O
on	JJ	O
these	NN	O
cells.	WDT	O
Obviously,	MD	O
this	VB	O
can	VBN	O
only	IN	O
be	DT	O
determined	.	O
when	,	O
a	DT	O
given	MD	O
recombinant	RB	O
adenovirus	VB	O
is	VBN	O
propagated	WRB	O
on	DT	O
these	VBN	O
cells	NN	O
at	NN	O
a	VBZ	O
later	VBN	O
stage	IN	O
and	DT	O
will	NNS	O
depend	IN	O
on	DT	O
the	JJ	O
particular	NN	O
recombinant	CC	O
adenovirus.	MD	O
Hence,	VB	O
it	IN	O
is	DT	O
convenient	JJ	O
to	NN	O
choose	.	O
the	,	O
regulatory	PRP	O
sequence	VBZ	O
of	JJ	O
such	TO	O
transgenes	VB	O
later,	DT	O
such	JJ	O
that	NN	O
they	IN	O
differ	JJ	O
from	NNS	O
those	,	O
of	JJ	O
the	IN	O
E1A	PRP	O
and	VBP	O
E1B	IN	O
sequences	DT	O
in	IN	O
the	DT	O
cells	NNP	O
that	CC	O
are	NNP	O
established	NNS	O
by	IN	O
the	DT	O
invention.	NNS	O
However,	WDT	O
since	VBP	O
many	VBN	O
currently	IN	O
available	DT	O
recombinant	.	O
adenovirus	,	O
vectors	IN	O
carry	JJ	O
transgenes	RB	O
regulated	JJ	O
by	JJ	O
a	NN	O
CMV	NNS	O
promoter	VBP	O
and	NNS	O
an	VBN	O
SV40	IN	O
polyA	DT	O
sequence,	NNP	O
the	NN	O
preferred	CC	O
regulatory	DT	O
sequences	NNP	O
for	NN	O
the	,	O
E1A	DT	O
and	JJ	O
E1B	JJ	O
constructs	NNS	O
as	IN	O
exemplified	DT	O
herein	NNP	O
are	CC	O
different	NNP	O
from	NNS	O
the	IN	O
CMV	JJ	O
promoter	NN	O
and	VBP	O
the	JJ	O
SV40	IN	O
polyA	DT	O
sequence.	NNP	O
In	NN	O
view	CC	O
of	DT	O
regulatory	NNP	O
issues,	NN	O
these	.	O
regulatory	IN	O
sequences	NN	O
are	IN	O
preferably	JJ	O
not	,	O
of	DT	O
viral	JJ	O
origin.	NNS	O
To	VBP	O
this	RB	O
end,	RB	O
the	IN	O
plasmids	JJ	O
described	.	O
herein	TO	O
are	DT	O
further	,	O
modified	DT	O
as	NNS	O
described	VBD	O
below.	NNS	O
Generation	VBP	O
of	RB	O
Construct	VBN	O
pCC.E1A	IN	O
and	VBN	O
pCC.E1AB21	.	O
The	NN	O
E1A	IN	O
sequence	NNP	O
was	NN	O
amplified	CC	O
with	VB	O
the	DT	O
following	NNP	O
primers:	NN	O
5E1A-For:	VBD	O
5′-CCG	VBN	O
AAT	IN	O
TCG	DT	O
ATC	VBG	O
GTG	:	O
TAG	:	O
TG-3′	JJ	O
(SEQ	NNP	O
ID	NNP	O
NO:4)	NNP	O
and	NNP	O
5E1A-rev:	NNP	O
5′-CGG	NNP	O
GAT	NNP	O
CCA	NNP	O
TTT	)	O
AAC	CC	O
ACG	:	O
CCA	JJ	O
TGC	NNP	O
AAG-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:5).	NNP	O
The	NNP	O
reaction	NNP	O
was	NNP	O
done	NNP	O
on	NNP	O
pIG.E1A.E1B	.	O
template	DT	O
DNA	NN	O
using	VBD	O
Pwo	VBN	O
DNA	IN	O
polymerase	NN	O
(Roche)	NN	O
according	NNP	O
to	VBG	O
the	NNP	O
manufacturer's	NNP	O
instructions	NN	O
but	)	O
with	VBG	O
a	TO	O
final	DT	O
concentration	POS	O
of	NNS	O
3%	CC	O
DMSO.	IN	O
The	DT	O
PCR	JJ	O
program	NN	O
was	IN	O
set	NN	O
on	.	O
94°	DT	O
C.	NNP	O
for	NN	O
two	VBD	O
minutes	VBN	O
followed	IN	O
by	CD	O
30	NNP	O
cycles	IN	O
of	CD	O
(94°	NNS	O
C.	VBN	O
for	IN	O
30	CD	O
seconds,	NNS	O
58°	IN	O
C.	CD	O
for	NNP	O
30	IN	O
seconds	CD	O
and	,	O
72°	CD	O
C.	NNP	O
for	IN	O
120	CD	O
seconds)	NNS	O
and	CC	O
ended	CD	O
by	NNP	O
72°	IN	O
C.	CD	O
for	)	O
eight	CC	O
minutes.	VBN	O
The	IN	O
resulting	CD	O
1.2	NNP	O
kb	IN	O
fragment	CD	O
contains	.	O
the	DT	O
E1A	VBG	O
sequence	CD	O
from	JJ	O
Ad5	NN	O
(nucleotide	VBZ	O
459	DT	O
to	NNP	O
1655	NN	O
as	IN	O
in	NNP	O
Genbank	RB	O
Acc.	CD	O
No.	TO	O
M73260)	CD	O
flanked	IN	O
by	IN	O
EcoRI	NNP	O
(5′)	.	O
and	.	O
BamHI	)	O
(3′)	VBN	O
sites.	IN	O
A	NNP	O
second	)	O
PCR	CC	O
fragment	NNP	O
was	)	O
generated	.	O
using	DT	O
primer	JJ	O
5E1A-For	NNP	O
with	NN	O
reverse	VBD	O
primer:	VBN	O
5E1AB21-rev:	VBG	O
5′-CGG	JJ	O
GAT	JJ	O
CCT	IN	O
CAT	JJ	O
TCC	:	O
CGA	:	O
GGG	JJ	O
TCC	NNP	O
AG-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:6),	NNP	O
using	NNP	O
the	NNP	O
same	NNP	O
conditions.	NNP	O
The	NNP	O
resulting	,	O
1.8	VBG	O
kb	DT	O
fragment	JJ	O
contains	.	O
the	DT	O
E1A	VBG	O
and	CD	O
E1B-19K	JJ	O
sequence	NN	O
from	VBZ	O
Ad5	DT	O
(nucleotide	NNP	O
459	CC	O
to	NNP	O
2244	NN	O
as	IN	O
in	NNP	O
Genbank	RB	O
Acc.	CD	O
No.	TO	O
M73260)	CD	O
flanked	IN	O
by	IN	O
EcoRI	NNP	O
(5′)	.	O
and	.	O
BamHI	)	O
(3′)	VBN	O
sites.	IN	O
Both	NNP	O
PCR	)	O
fragments	CC	O
were	NNP	O
isolated	)	O
from	.	O
agarose	DT	O
gel,	NNP	O
purified	NNS	O
with	VBD	O
QIAEX	VBN	O
II	IN	O
gel	JJ	O
extraction	,	O
kit	VBN	O
(Qiagen)	IN	O
and	NNP	O
cloned	NNP	O
in	NN	O
a	NN	O
PCR	NN	O
cloning	)	O
vector;	CC	O
pCR-TOPOblunt	VBN	O
(Invitrogen)	IN	O
and	DT	O
the	NNP	O
sequence	NN	O
was	:	O
verified.	NN	O
The	)	O
constructs	CC	O
were	DT	O
then	NN	O
digested	VBD	O
with	.	O
EcoRI	DT	O
and	NNS	O
BamHI	VBD	O
and	RB	O
the	VBN	O
insert	IN	O
fragments	NNP	O
were	CC	O
isolated	NNP	O
from	CC	O
gel	DT	O
using	NN	O
the	NNS	O
QIAEX	VBD	O
II	VBN	O
gel	IN	O
extraction	NN	O
kit	VBG	O
(Qiagen)	DT	O
as	NNP	O
above.	NNP	O
Each	NN	O
of	NN	O
the	NN	O
isolated	)	O
fragments	IN	O
was	.	O
then	DT	O
ligated	IN	O
into	DT	O
vector	JJ	O
pCC101	NNS	O
(see	VBD	O
below)	RB	O
that	VBN	O
was	IN	O
first	NN	O
digested	NN	O
with	VB	O
EcoRI	)	O
and	WDT	O
BamHI	VBD	O
and	RB	O
purified	VBN	O
from	IN	O
gel	NNP	O
as	CC	O
above.	NNP	O
Transformation	CC	O
into	VBN	O
electro-competent	IN	O
DH10B	NN	O
cells	IN	O
(Invitrogen)	.	O
generated	NN	O
constructs	IN	O
pCC.E1A	JJ	O
(FIG.	NNP	O
4)	NNS	O
and	)	O
pCC.E1AB21	VBD	O
(FIG.	NNS	O
5).	FW	O
A	.	O
synthetic	)	O
polyadenylation	CC	O
signal	NN	O
(SPA)	.	O
is	.	O
present	DT	O
in	JJ	O
these	NN	O
plasmids	NN	O
(derived	)	O
from	VBZ	O
construct	JJ	O
pCC271	IN	O
as	DT	O
described	NNS	O
in	VBN	O
WO	IN	O
02/40665).	NN	O
Generation	NN	O
of	IN	O
pCC101	VBN	O
pCC	IN	O
100	NNP	O
(see	.	O
below)	NN	O
was	IN	O
digested	NN	O
with	NN	O
XbaI	CD	O
and	VB	O
the	)	O
resulting	VBD	O
linear	VBN	O
fragment	IN	O
was	NNP	O
purified	CC	O
from	DT	O
gel	VBG	O
using	JJ	O
the	NN	O
QIAEX	VBD	O
II	VBN	O
gel	IN	O
extraction	NN	O
kit	VBG	O
as	DT	O
above.	NNP	O
A	NNP	O
linker	NN	O
was	NN	O
prepared	NN	O
by	IN	O
annealing	.	O
the	DT	O
oligonucleotides	NN	O
X-SM-1:	VBD	O
5′-CTAGGTCGACCAATTG-3′	VBN	O
(SEQ	IN	O
ID	VBG	O
NO:7)	DT	O
with	JJ	O
X-SM-2:	:	O
5′-CTAGCAATTGGTCGAC-3′	JJ	O
(SEQ	NNP	O
ID	NNP	O
NO:8).	)	O
Hereto,	IN	O
1	:	O
μg	JJ	O
of	NNP	O
each	NNP	O
oligonucleotide	.	O
was	,	O
mixed	CD	O
with	NN	O
2	IN	O
μl	DT	O
10×NEB2	NN	O
buffer	VBD	O
(NEB)	JJ	O
and	IN	O
milliQ	CD	O
H2O	NNS	O
to	CD	O
a	NN	O
final	)	O
volume	CC	O
of	$	O
20	NNP	O
μl.	TO	O
The	DT	O
mixture	JJ	O
was	NN	O
placed	IN	O
at	CD	O
98°	.	O
C.	DT	O
and	NN	O
slowly	VBD	O
cooled	VBN	O
to	IN	O
4°	CD	O
C.	NNP	O
in	CC	O
a	RB	O
PCR	VBD	O
machine	TO	O
(cooling	CD	O
rate	NNP	O
of	IN	O
2°	DT	O
C./minute).	NNP	O
The	NN	O
annealed	VBG	O
linker	NN	O
was	IN	O
then	CD	O
ligated	.	O
to	DT	O
the	JJ	O
isolated	NN	O
XbaI-digested	VBD	O
fragment	RB	O
using	VBN	O
a	TO	O
4×	DT	O
molar	JJ	O
excess	JJ	O
of	NN	O
linker	VBG	O
over	DT	O
fragment.	CD	O
The	JJ	O
ligated	NN	O
DNA	IN	O
was	NN	O
purified	IN	O
with	.	O
the	DT	O
QIAquick	JJ	O
PCR	NNP	O
purification	VBD	O
kit	VBN	O
(Qiagen)	IN	O
according	DT	O
to	NNP	O
the	NNP	O
manufacturer's	NN	O
instructions	NN	O
and	)	O
digested	VBG	O
with	TO	O
XbaI	DT	O
to	POS	O
remove	NNS	O
self-ligated	CC	O
vector	VBN	O
DNA.	IN	O
Following	NNP	O
heat-inactivation	TO	O
of	VB	O
the	JJ	O
XbaI	NN	O
enzyme,	.	O
the	VBG	O
mixture	NN	O
was	IN	O
then	DT	O
used	NNP	O
to	,	O
transform	DT	O
DH5α-T1r-competent	NN	O
cells	VBD	O
resulting	RB	O
in	VBN	O
pCC101	TO	O
(FIG.	VB	O
6).	NNP	O
Generation	NNS	O
of	VBG	O
pCC100	IN	O
Construct	NN	O
pCC271	.	O
(described	.	O
in	NN	O
WO	IN	O
02/40665)	JJ	O
was	NNP	O
digested	NN	O
with	VBN	O
EcoRI	IN	O
and	NNP	O
PstI	)	O
and	VBD	O
the	VBN	O
3	IN	O
kb	NNP	O
vector	CC	O
fragment	NNP	O
was	CC	O
isolated	DT	O
from	CD	O
gel	NNS	O
as	JJ	O
described	NN	O
above.	VBD	O
A	VBN	O
linker	IN	O
was	NN	O
prepared	IN	O
by	VBN	O
annealing	.	O
oligonucleotide	DT	O
EcoPst-3:	NN	O
5′-AAT	VBD	O
TGA	VBN	O
TAT	IN	O
CGA	VBG	O
ATT	JJ	O
CGC	:	O
CGA	JJ	O
GCT	NNP	O
CGT	NNP	O
AAG	NNP	O
CTT	NNP	O
GGA	NNP	O
TCC	NNP	O
CTG	NNP	O
CA-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:9)	NNP	O
with	NNP	O
oligonucleotide	NNP	O
EcoPst-4:	NNP	O
5′-GGG	NNP	O
ATC	NNP	O
CAA	)	O
GCT	IN	O
TAC	JJ	O
GAG	:	O
CTC	JJ	O
GGC	NNP	O
GAA	NNP	O
TFC	NNP	O
GAT	NNP	O
ATC-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:10).	NNP	O
Hereto,	NNP	O
oligonucleotides	NNP	O
were	NNP	O
mixed	NNP	O
as	NNP	O
described	.	O
above	,	O
and	NNS	O
annealed	VBD	O
by	JJ	O
incubation	IN	O
at	VBN	O
98°	IN	O
C.	CC	O
for	VBN	O
two	IN	O
minutes,	NN	O
65°	IN	O
C.	CD	O
for	NNP	O
30	IN	O
minutes	CD	O
and	,	O
room	CD	O
temperature	NNP	O
for	IN	O
two	CD	O
hours.	NNS	O
The	CC	O
isolated	NN	O
vector	NN	O
fragment	IN	O
was	CD	O
then	.	O
ligated	DT	O
to	JJ	O
excess	NN	O
annealed	NN	O
oligo	VBD	O
and	RB	O
transformed	VBN	O
into	TO	O
DH5α-T1′-competent	VB	O
cells	JJ	O
resulting	NN	O
in	CC	O
construct	VBD	O
pCC100.	IN	O
Generation	NNP	O
of	NNS	O
pCC200	VBG	O
Plasmid	IN	O
pBR322	NN	O
(GenBank	.	O
J01749.1)	NN	O
was	IN	O
digested	NN	O
with	NNP	O
EcoRI	NN	O
and	NNP	O
then	)	O
blunted	VBD	O
with	VBN	O
Klenow	IN	O
enzyme,	NNP	O
followed	CC	O
by	RB	O
purification	VBD	O
with	IN	O
QIAquick	NNP	O
PCR	,	O
purification	VBN	O
kit	IN	O
(Qiagen).	NN	O
After	IN	O
a	NNP	O
second	NNP	O
digestion	NN	O
with	NN	O
NheI,	.	O
the	IN	O
4150	DT	O
by	JJ	O
vector	NN	O
fragment	IN	O
was	,	O
isolated	DT	O
from	CD	O
agarose	IN	O
gel	NN	O
using	NN	O
the	VBD	O
QIAEX	VBN	O
II	IN	O
gel	JJ	O
extraction	NNS	O
kit	VBG	O
(Qiagen).	DT	O
In	NNP	O
parallel,	NNP	O
construct	NN	O
pCC100	NN	O
was	NN	O
digested	.	O
with	IN	O
BsaAl,	,	O
blunted	NN	O
with	NN	O
Klenow	VBD	O
enzyme	VBN	O
and	IN	O
purified	,	O
with	VBD	O
the	IN	O
QIAquick	NNP	O
PCR	NN	O
purification	CC	O
kit	VBN	O
(Qiagen),	IN	O
followed	DT	O
by	NNP	O
a	NNP	O
second	NN	O
digestion	NN	O
with	,	O
XbaI	VBN	O
and	IN	O
isolation	DT	O
of	JJ	O
the	NN	O
350	IN	O
bp	NNP	O
fragment	CC	O
from	NN	O
agarose	IN	O
gel.	DT	O
The	CD	O
fragments	NN	O
were	NN	O
then	IN	O
ligated	JJ	O
and	.	O
transformed	DT	O
into	NNS	O
chemical-competent	VBD	O
STBL-2	RB	O
cells	VBN	O
(Invitrogen),	CC	O
resulting	VBN	O
in	IN	O
pCC200	JJ	O
(FIG.	JJ	O
15).	NNS	O
Generation	,	O
of	VBG	O
pCC105	IN	O
Construct	NN	O
pCC105	.	O
contains	.	O
the	NN	O
human	IN	O
PGK	JJ	O
promoter	NNP	O
and	NN	O
a	VBZ	O
poly-adenylation	DT	O
sequence	JJ	O
derived	NNP	O
from	NN	O
the	CC	O
human	DT	O
COL1A2	JJ	O
gene.	NN	O
First,	VBN	O
the	IN	O
COL1A2	DT	O
poly-adenylation	JJ	O
sequence	NNP	O
(Natalizio	.	O
et	,	O
al.,	DT	O
2002)	NNP	O
was	NN	O
amplified	NN	O
by	NNP	O
PCR	RB	O
from	,	O
human	)	O
genomic	VBD	O
DNA	VBN	O
as	IN	O
described	NNP	O
by	IN	O
the	JJ	O
authors	JJ	O
using	NN	O
recombinant	IN	O
Taq	VBN	O
polymerase	IN	O
(Invitrogen)	DT	O
and	NNS	O
primers	VBG	O
COL1A2F:	JJ	O
5′-CAG	NNP	O
CTA	NN	O
GCC	)	O
TGC	CC	O
AGG	NNS	O
AAG	:	O
TAT	JJ	O
GCA	NNP	O
GAT	NNP	O
TAT	NNP	O
TTG-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:11)	NNP	O
and	NNP	O
COL1A2R-sal:	NNP	O
5′-ACA	NNP	O
CGT	NNP	O
CGA	NNP	O
CGG	)	O
CTG	CC	O
GTA	:	O
GAG	JJ	O
ATG	NNP	O
C-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:12).	NNP	O
Herewith,	NNP	O
the	NNP	O
published	NNP	O
sequence	NNP	O
is	NNP	O
extended	.	O
at	,	O
the	DT	O
5′-end	VBN	O
by	NN	O
an	VBZ	O
SbfI	VBN	O
restriction	IN	O
sequence	DT	O
and	JJ	O
at	IN	O
the	DT	O
3′-end	NNP	O
by	NN	O
an	NN	O
SalI	CC	O
restriction	IN	O
sequence.	DT	O
The	JJ	O
resulting	IN	O
PCR	DT	O
fragment	NNP	O
was	NN	O
cloned	.	O
into	DT	O
pCR-TOPO-TA	VBG	O
using	NNP	O
the	NN	O
pCR-TOPO4	VBD	O
TA	VBN	O
cloning	IN	O
kit	JJ	O
(Invitrogen).	VBG	O
After	DT	O
verification	JJ	O
of	NNP	O
the	VBG	O
insert	NN	O
by	.	O
sequencing,	IN	O
the	NN	O
277	IN	O
bp	DT	O
insert	NN	O
was	IN	O
isolated	,	O
from	DT	O
the	CD	O
TOPO	NN	O
vector	NN	O
by	VBD	O
digestion	VBN	O
with	IN	O
SbfI	DT	O
and	NNP	O
SalI,	NN	O
and	IN	O
purified	NN	O
with	IN	O
the	NNP	O
QIAquick	CC	O
PCR	,	O
purification	CC	O
kit	VBD	O
(Qiagen).	IN	O
In	DT	O
parallel,	NNP	O
the	NNP	O
plasmid	NN	O
pCC101	NN	O
was	.	O
also	IN	O
digested	,	O
with	DT	O
SbfI	NN	O
and	NN	O
SalI,	VBD	O
followed	RB	O
by	VBN	O
gel	IN	O
electrophoresis.	NNP	O
The	CC	O
2965	,	O
by	VBN	O
vector	IN	O
fragment	JJ	O
was	.	O
isolated	DT	O
from	CD	O
agarose	IN	O
gel	NN	O
using	NN	O
a	VBD	O
GeneClean	VBN	O
Kit	IN	O
(Bio101)	JJ	O
according	NNS	O
to	VBG	O
the	DT	O
manufacturer's	JJ	O
instructions.	NNP	O
This	)	O
vector	VBG	O
fragment	TO	O
was	DT	O
ligated	POS	O
to	.	O
the	DT	O
purified	NN	O
COL1A2pA	NN	O
fragment	VBD	O
in	VBN	O
equimolar	TO	O
amounts	DT	O
and	VBN	O
transformed	NNP	O
to	NN	O
chemical-competent	IN	O
STBL-2	JJ	O
cells	NNS	O
(Invitrogen).	CC	O
This	VBN	O
gave	TO	O
plasmid	JJ	O
pCC105	JJ	O
(FIG.	NNS	O
7).	.	O
Generation	DT	O
of	VBD	O
pCC205	JJ	O
Construct	NN	O
pCC205	.	O
was	.	O
made	NN	O
by	IN	O
digestion	JJ	O
of	NNP	O
pCC200	NN	O
with	VBD	O
SalI	VBN	O
and	IN	O
EcoRI,	NN	O
followed	IN	O
by	NN	O
purification	IN	O
of	NNP	O
the	CC	O
4225	,	O
nt	VBN	O
vector	IN	O
fragment	NN	O
from	IN	O
agarose	DT	O
gel,	CD	O
using	NN	O
QIAEX	NN	O
II	NN	O
gel	IN	O
extraction	JJ	O
kit	,	O
(Qiagen).	VBG	O
In	NNP	O
parallel,	NNP	O
the	NN	O
310	NN	O
nt	NN	O
COL1A2	.	O
polyA	IN	O
was	,	O
isolated	DT	O
from	CD	O
construct	JJ	O
pCC105	NNP	O
by	NN	O
digestion	VBD	O
with	VBN	O
EcoRI	IN	O
and	NN	O
SalI,	NN	O
followed	IN	O
by	NN	O
gel	IN	O
electrophoresis	NNP	O
and	CC	O
purification	,	O
of	VBN	O
the	IN	O
fragment	JJ	O
using	NN	O
the	CC	O
QIAEX	NN	O
II	IN	O
gel	DT	O
extraction	NN	O
kit.	VBG	O
The	DT	O
two	NNP	O
fragments	NNP	O
were	NN	O
then	NN	O
ligated	.	O
in	DT	O
equimolar	CD	O
amounts	NNS	O
and	VBD	O
transformed	RB	O
to	VBN	O
DH5α-T1r,	IN	O
resulting	JJ	O
in	NNS	O
pCC205	CC	O
(FIG.	VBN	O
16).	TO	O
Cloning	,	O
of	VBG	O
pCC.55Kcol	IN	O
Vector	NN	O
pCC205	.	O
is	.	O
used	NN	O
for	IN	O
the	NN	O
construction	NNP	O
of	NN	O
a	VBZ	O
plasmid	VBN	O
expressing	IN	O
the	DT	O
Ad5	NN	O
E1B-55k	IN	O
protein.	DT	O
Hereto,	NN	O
a	VBG	O
PCR	DT	O
product	NNP	O
is	NNP	O
generated	.	O
using	,	O
the	DT	O
following	NNP	O
primers:	NN	O
55KforE:	VBZ	O
5′-GGA	VBN	O
ATT	VBG	O
CGC	DT	O
CAC	JJ	O
CAT	:	O
GGA	:	O
GCG	JJ	O
AAG	NNP	O
AAA	NNP	O
CCC	NNP	O
ATC	NNP	O
TGA-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:13)	NNP	O
and	NNP	O
55KrevB:	NNP	O
5′-gga	NNP	O
tcc	NNP	O
TCA	NNP	O
ATC	)	O
TGT	CC	O
ATC	:	O
TTC	JJ	O
ATC	NN	O
GCT	NNP	O
AGA	NNP	O
GCC-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:14).	NNP	O
PCR	NNP	O
is	NNP	O
performed	NNP	O
with	NNP	O
Pwo	NNP	O
DNA	.	O
polymerase	NNP	O
according	VBZ	O
to	VBN	O
the	IN	O
manufacturer's	NNP	O
protocol	NNP	O
in	NN	O
the	VBG	O
presence	TO	O
of	DT	O
3%	POS	O
DMSO.	NN	O
The	IN	O
amplification	DT	O
is	NN	O
done	IN	O
on	NN	O
pIG.E1A.E1B	.	O
and	DT	O
the	NN	O
program	VBZ	O
is	VBN	O
set	IN	O
at	NN	O
94°	CC	O
C.	DT	O
for	NN	O
two	VBZ	O
minutes	VBN	O
followed	IN	O
by	CD	O
30	NNP	O
cycles	IN	O
of	CD	O
(94°	NNS	O
C.	VBN	O
for	IN	O
30	CD	O
seconds,	NNS	O
60°	IN	O
C.	CD	O
for	NNP	O
30	IN	O
seconds	CD	O
and	,	O
72°	CD	O
C.	NNP	O
for	IN	O
90	CD	O
seconds)	NNS	O
and	CC	O
ended	CD	O
by	NNP	O
72°	IN	O
C.	CD	O
for	)	O
eight	CC	O
minutes.	VBN	O
The	IN	O
resulting	CD	O
1510	NNP	O
by	IN	O
amplified	CD	O
fragment	.	O
contains	DT	O
the	VBG	O
E1B-55K	CD	O
sequence	IN	O
nt.	JJ	O
2019	NN	O
to	VBZ	O
3510	DT	O
from	JJ	O
the	NN	O
Ad5	.	O
sequence.	CD	O
The	TO	O
fragment	CD	O
is	IN	O
purified	DT	O
with	NNP	O
the	.	O
QIAquick	DT	O
PCR	NN	O
purification	VBZ	O
kit	VBN	O
(Qiagen),	IN	O
digested	DT	O
with	NNP	O
EcoRI	NNP	O
and	NN	O
BamHI	NN	O
followed	,	O
by	VBN	O
gel	IN	O
electrophoresis	NNP	O
for	CC	O
the	NNP	O
removal	VBN	O
of	IN	O
the	JJ	O
cleaved	NN	O
ends.	IN	O
This	DT	O
fragment	NN	O
is	IN	O
then	DT	O
purified	JJ	O
from	.	O
agarose	DT	O
gel	NN	O
using	VBZ	O
the	RB	O
GeneCleanII	VBN	O
kit	IN	O
(Bio101)	JJ	O
and	NNS	O
ligated	VBG	O
to	DT	O
pCC205,	NNP	O
which	NN	O
is	)	O
also	CC	O
digested	VBN	O
with	TO	O
EcoRI	,	O
and	WDT	O
BamHI	VBZ	O
and	RB	O
isolated	VBN	O
from	IN	O
agarose	NNP	O
gel	CC	O
as	NNP	O
described	CC	O
above.	VBN	O
The	IN	O
ligation	JJ	O
mixture	NNS	O
is	IN	O
transformed	VBN	O
to	.	O
chemical-competent	DT	O
STBL2	NN	O
cells	NN	O
(Invitrogen)	VBZ	O
resulting	VBN	O
in	TO	O
construct	JJ	O
pCC.55Kcol	NNP	O
(FIG.	NNS	O
8).	)	O
Cloning	VBG	O
ofpIG.E1B	IN	O
A	NN	O
PCR	NN	O
fragment	.	O
was	.	O
generated	VBG	O
with	RP	O
Pwo	DT	O
DNA	NNP	O
polymerase	NN	O
(Roche)	VBD	O
according	VBN	O
to	IN	O
the	NNP	O
manufacturer's	NNP	O
instructions	NN	O
in	)	O
the	VBG	O
presence	TO	O
of	DT	O
3%	POS	O
DMSO.	NNS	O
The	IN	O
following	DT	O
primers	NN	O
were	IN	O
used	NN	O
in	.	O
the	DT	O
amplification	JJ	O
reaction:	NNS	O
5E1Bstart:	VBD	O
5′-GGA	VBN	O
ATT	IN	O
CCT	DT	O
CAT	NN	O
GGA	:	O
GGC	:	O
TTG	JJ	O
GG-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:15)	NNP	O
and	NNP	O
5E1Brev2:	NNP	O
5′-GTG	NNP	O
TCT	NNP	O
CAC	NNP	O
AAC	)	O
CGC	CC	O
TCT	:	O
C-3′	JJ	O
(SEQ	NNP	O
ID	NNP	O
NO:16).	NNP	O
The	NNP	O
amplification	NNP	O
was	NNP	O
done	NNP	O
on	NNP	O
pIG.E1A.E1B	.	O
and	DT	O
the	NN	O
program	VBD	O
was	VBN	O
set	IN	O
on	NN	O
94°	CC	O
C.	DT	O
for	NN	O
two	VBD	O
minutes	VBN	O
followed	IN	O
by	CD	O
five	NNP	O
cycles	IN	O
of	CD	O
(94°	NNS	O
C.	VBN	O
for	IN	O
30	CD	O
seconds,	NNS	O
56°	IN	O
C.	CD	O
for	NNP	O
30	IN	O
seconds	CD	O
and	,	O
72°	CD	O
C.	NNP	O
for	IN	O
60	CD	O
seconds)	NNS	O
these	CC	O
cycles	CD	O
were	NNP	O
then	IN	O
followed	CD	O
by	)	O
another	DT	O
35	NNS	O
cycles	VBD	O
(94°	RB	O
C.	VBN	O
for	IN	O
30	DT	O
seconds,	CD	O
60°	NNS	O
C.	CD	O
for	NNP	O
30	IN	O
seconds	CD	O
and	,	O
72°	CD	O
C.	NNP	O
for	IN	O
60	CD	O
seconds)	NNS	O
and	CC	O
ended	CD	O
by	NNP	O
68°	IN	O
C.	CD	O
for	)	O
eight	CC	O
minutes.	VBN	O
The	IN	O
390	CD	O
nt	NNP	O
PCR	IN	O
fragment	CD	O
was	.	O
then	DT	O
digested	CD	O
with	JJ	O
KpnI	NNP	O
and	NN	O
EcoRI	VBD	O
resulting	RB	O
in	VBN	O
a	IN	O
347	NNP	O
nt	CC	O
fragment	NNP	O
that	VBG	O
was	IN	O
isolated	DT	O
from	CD	O
agarose	JJ	O
gel	NN	O
using	WDT	O
the	VBD	O
QIAEX	VBN	O
II	IN	O
Gel	JJ	O
Extraction	NNS	O
Kit	VBG	O
(Qiagen).	DT	O
This	NNP	O
fragment	NNP	O
was	NNP	O
then	NNP	O
ligated	NNP	O
to	.	O
the	DT	O
5713	NN	O
by	VBD	O
pIG.E1A.E1B	RB	O
vector	VBN	O
fragment	TO	O
resulting	DT	O
from	CD	O
digestion	IN	O
with	NN	O
Kpnl	NN	O
and	NN	O
partially	VBG	O
with	IN	O
EcoRI,	NN	O
subsequent	IN	O
isolation	NNP	O
from	CC	O
gel	RB	O
and	IN	O
purified	,	O
with	JJ	O
the	NN	O
QIAEX	IN	O
II	NN	O
gel	CC	O
extraction	VBN	O
kit	IN	O
(Qiagen).	DT	O
After	NNP	O
ligation,	NNP	O
the	NN	O
mixture	NN	O
was	NN	O
transformed	.	O
into	IN	O
chemically	,	O
competent	DT	O
STBL-2	NN	O
cells,	VBD	O
resulting	VBN	O
in	IN	O
the	RB	O
plasmid	JJ	O
pIG.E1B	NNP	O
(FIG.	,	O
9).	VBG	O
pIG.E1B	IN	O
contains	DT	O
nt.	NN	O
2019	NN	O
to	.	O
3510	.	O
from	NN	O
the	VBZ	O
Ad5	.	O
genome.	CD	O
Cloning	TO	O
of	CD	O
pCC.E1Bcol	IN	O
For	DT	O
the	NNP	O
construction	.	O
of	NN	O
a	IN	O
plasmid	NN	O
carrying	IN	O
both	DT	O
the	NN	O
19K	IN	O
and	DT	O
55K	NN	O
Ad5	VBG	O
E1B	CC	O
coding	DT	O
sequences,	CD	O
the	CC	O
plasmid	CD	O
pCC.55Kcol	NNP	O
is	NNP	O
digested	VBG	O
with	,	O
EcoRI	DT	O
and	NN	O
KpnI.	NN	O
The	VBZ	O
5970	VBN	O
nt	IN	O
vector	NNP	O
fragment	CC	O
is	.	O
isolated	DT	O
by	CD	O
gel	NN	O
electrophoresis	NN	O
and	NN	O
purified	VBZ	O
from	VBN	O
agarose	IN	O
gel	JJ	O
with	NN	O
the	CC	O
GeneCleanII	VBN	O
kit	IN	O
(Bio101)	JJ	O
as	NN	O
above.	IN	O
Construct	DT	O
pIG.E1B	NNP	O
is	NN	O
then	)	O
also	IN	O
digested	.	O
with	NNP	O
KpnI	NN	O
and	VBZ	O
EcoRI	RB	O
and	RB	O
the	VBN	O
347	IN	O
nt	NNP	O
fragment	CC	O
is	NNP	O
isolated	CC	O
from	DT	O
gel	CD	O
and	JJ	O
purified	NN	O
with	VBZ	O
the	VBN	O
QIAquick	IN	O
gel	NN	O
extraction	CC	O
kit	VBN	O
(Qiagen).	IN	O
Ligation	DT	O
of	NNP	O
this	NN	O
insert	NN	O
and	NN	O
the	.	O
isolated	NN	O
pCC.55Kcol	IN	O
vector	DT	O
fragment	NN	O
and	CC	O
transformation	DT	O
into	JJ	O
STBL2	NN	O
cells	NN	O
gives	NN	O
construct	CC	O
pCC.E1Bcol	NN	O
(FIG.	IN	O
10).	NNP	O
This	NNS	O
construct	VBZ	O
contains	NN	O
nt.	NN	O
1711	.	O
to	.	O
3510	DT	O
from	NN	O
the	VBZ	O
Ad5	.	O
genome	CD	O
sequence.	TO	O
Cloning	CD	O
of	IN	O
pEC.E1B	DT	O
The	NNP	O
Human	NN	O
Elongation	.	O
Factor	NN	O
1-α	IN	O
promoter	NN	O
(EF1-α)	DT	O
is	NNP	O
isolated	NNP	O
from	NNP	O
plasmid	JJ	O
pEF/myc/nuc	NN	O
(Invitrogen)	)	O
by	VBZ	O
digestion	VBN	O
with	IN	O
EcoRI	JJ	O
and	NN	O
Pmll.	)	O
After	IN	O
digestion,	NN	O
the	IN	O
fragment	NNP	O
is	CC	O
blunted	.	O
with	IN	O
Klenow	,	O
enzyme	DT	O
and	NN	O
the	VBZ	O
1183	VBN	O
nt	IN	O
EF1-α	NNP	O
promoter	NN	O
fragment	CC	O
is	DT	O
then	CD	O
isolated	JJ	O
by	NNP	O
gel	NN	O
electrophoresis	NN	O
and	VBZ	O
purified	RB	O
with	VBN	O
the	IN	O
GeneCleanII	JJ	O
kit	NN	O
(Bio101).	CC	O
In	VBN	O
parallel,	IN	O
the	DT	O
vector	NNP	O
pCC.E1Bcol	NN	O
is	.	O
digested	IN	O
with	,	O
BstXI,	DT	O
followed	NN	O
by	NN	O
T4	VBZ	O
DNA	VBN	O
polymerase	IN	O
treatment	,	O
to	VBN	O
make	IN	O
the	NNP	O
ends	NNP	O
blunt	NN	O
and	NN	O
purified	TO	O
over	VB	O
a	DT	O
PCR	NNS	O
purification	NN	O
column	CC	O
(Qiagen).	VBD	O
Then,	IN	O
a	DT	O
second	NNP	O
digestion	NN	O
is	NN	O
performed	.	O
with	,	O
EcoRV,	DT	O
followed	JJ	O
by	NN	O
gel	VBZ	O
electrophoresis.	VBN	O
The	IN	O
5827	,	O
nt	VBN	O
vector	IN	O
fragment	JJ	O
is	.	O
then	DT	O
purified	CD	O
with	NN	O
the	NN	O
GeneCleanII	NN	O
kit	VBZ	O
(Bio101).	RB	O
Both	VBN	O
the	IN	O
EF1-α	DT	O
fragment	NNP	O
and	NN	O
vector	.	O
fragment	DT	O
are	DT	O
ligated	NNP	O
together	NN	O
in	CC	O
an	NN	O
equimolar	NN	O
amount	VBP	O
and	VBN	O
transformed	RB	O
to	IN	O
chemical-competent	DT	O
STBL-2	JJ	O
cells	NN	O
(Invitrogen),	CC	O
which	VBN	O
results	TO	O
in	JJ	O
the	JJ	O
plasmid	NNS	O
pEC.E1B	,	O
(FIG.	WDT	O
11)	NNS	O
that	IN	O
contains	DT	O
the	NN	O
same	NN	O
Ad5-E1B	.	O
sequence	)	O
as	WDT	O
in	VBZ	O
plasmid	DT	O
pCC.E1Bcol.	JJ	O
Cloning	NNP	O
of	NN	O
pSC.55K	IN	O
The	IN	O
SV40	NN	O
promoter	.	O
was	NN	O
amplified	IN	O
from	NN	O
pEF/myc/nuc	DT	O
plasmid	NNP	O
DNA	NN	O
(Invitrogen)	VBD	O
by	VBN	O
using	IN	O
recombinant	NN	O
Taq	NN	O
DNA	NNP	O
polymerase	)	O
(Invitrogen)	IN	O
and	VBG	O
the	JJ	O
following	NNP	O
primers:	NNP	O
SV40.forS:	NN	O
5′-CAA	)	O
CTA	CC	O
GTA	DT	O
CAT	JJ	O
GTG	:	O
GAA	:	O
TGT	JJ	O
GTG	NNP	O
TCA	NNP	O
GTT	NNP	O
AGG-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:17)	NNP	O
and	NNP	O
SV40.RevERI:	NNP	O
5′-GGA	NNP	O
ATT	NNP	O
CAG	NNP	O
CTT	)	O
TTT	CC	O
GCA	:	O
AAA	JJ	O
GCC	NNP	O
TAG	NNP	O
G-3′	NNP	O
(SEQ	NNP	O
ID	NNP	O
NO:18).	NNP	O
The	NNP	O
amplification	NNP	O
program	NNP	O
was	NNP	O
set	NNP	O
at	.	O
94°	DT	O
C.	NN	O
for	NN	O
two	VBD	O
minutes	VBN	O
followed	IN	O
by	CD	O
five	NNP	O
cycles	IN	O
of	CD	O
(94°	NNS	O
C.	VBN	O
for	IN	O
30	CD	O
seconds,	NNS	O
48°	IN	O
C.	CD	O
for	NNP	O
30	IN	O
seconds	CD	O
and	,	O
72°	CD	O
C.	NNP	O
for	IN	O
45	CD	O
seconds)	NNS	O
then	CC	O
25	CD	O
additional	NNP	O
cycles	IN	O
of	CD	O
(94°	)	O
C.	RB	O
for	CD	O
30	JJ	O
seconds,	NNS	O
58°	IN	O
C.	CD	O
for	NNP	O
30	IN	O
seconds	CD	O
and	,	O
72°	CD	O
C.	NNP	O
for	IN	O
45	CD	O
seconds)	NNS	O
and	CC	O
ended	CD	O
by	NNP	O
68°	IN	O
C.	CD	O
for	)	O
eight	CC	O
minutes.	VBN	O
The	IN	O
resulting	CD	O
357	NNP	O
by	IN	O
amplified	CD	O
fragment	.	O
(nucleotide	DT	O
266	VBG	O
to	CD	O
−71	IN	O
from	JJ	O
SV40	NN	O
sequence	RB	O
GenBank	CD	O
Acc.	TO	O
No.	VB	O
J02400)	IN	O
was	NNP	O
isolated	NN	O
from	NNP	O
agarose	.	O
gel	.	O
with	)	O
the	VBD	O
QIAEX	VBN	O
II	IN	O
gel	JJ	O
extraction	NN	O
kit	IN	O
(Qiagen).	DT	O
This	NNP	O
fragment	NNP	O
was	NN	O
then	NN	O
cloned	NN	O
into	.	O
pCR-TOPO,	DT	O
using	NN	O
the	VBD	O
PCR	RB	O
TOPO4	VBN	O
blunt	IN	O
cloning	,	O
kit	VBG	O
(Invitrogen).	DT	O
After	NNP	O
sequence	NNP	O
verification,	NN	O
the	VBG	O
357	NN	O
by	.	O
insert	IN	O
was	NN	O
isolated	,	O
from	DT	O
the	CD	O
TOPO	IN	O
vector	NN	O
by	VBD	O
digestion	VBN	O
with	IN	O
EcoRI	DT	O
and	NNP	O
SpeI,	NN	O
and	IN	O
isolated	NN	O
from	IN	O
agarose	NNP	O
gel	CC	O
with	,	O
the	CC	O
QIAEX	VBD	O
II	IN	O
gel	JJ	O
extraction	NN	O
kit	IN	O
(Qiagen).	DT	O
In	NNP	O
parallel,	NNP	O
the	NN	O
plasmid	NN	O
pCC.55Kcol	NN	O
(which	.	O
has	IN	O
a	,	O
pBR322-backbone)	DT	O
is	NN	O
digested	NN	O
with	WDT	O
AvrII	VBZ	O
and	DT	O
EcoRI	)	O
followed	VBZ	O
by	VBN	O
gel	IN	O
electrophoresis.	NNP	O
The	CC	O
5508	NNP	O
nt	VBN	O
vector	IN	O
fragment	JJ	O
is	.	O
isolated	DT	O
from	CD	O
gel	NN	O
as	NN	O
described	NN	O
above	VBZ	O
and	VBN	O
ligated	IN	O
in	NN	O
equimolar	IN	O
amount	VBN	O
to	IN	O
the	CC	O
digested	VBN	O
PCR	IN	O
fragment.	JJ	O
The	NN	O
ligation	TO	O
mixture	DT	O
is	VBN	O
transformed	NNP	O
into	.	O
chemical-competent	DT	O
STBL-2	NN	O
cells,	NN	O
resulting	VBZ	O
in	VBN	O
the	IN	O
plasmid	JJ	O
pSC.55K	NNP	O
(FIG.	,	O
12)	VBG	O
that	IN	O
contains	DT	O
the	NN	O
same	NN	O
Ad5	.	O
E1B-55K	)	O
sequence	WDT	O
as	VBZ	O
in	DT	O
pCC.55Kcol.	JJ	O
To	NNP	O
generate	NNP	O
transformed	NN	O
clones	IN	O
from	IN	O
primary	.	O
HER	TO	O
cells,	VB	O
DNA	JJ	O
fragments	NNS	O
containing	IN	O
the	JJ	O
appropriate	NNP	O
expression	,	O
cassettes	NNP	O
are	VBZ	O
isolated	VBG	O
from	DT	O
gel.	JJ	O
The	NN	O
elimination	NNS	O
of	VBP	O
(overlapping)	VBN	O
vector	IN	O
sequences	.	O
is	DT	O
believed	NN	O
to	IN	O
reduce	)	O
the	NN	O
chance	NNS	O
of	VBZ	O
co-integration.	VBN	O
Hereto,	TO	O
pCC.E1A	VB	O
and	DT	O
pCC.E1AB21	NN	O
are	IN	O
digested	.	O
with	,	O
BsaAI	NN	O
and	CC	O
AflIII	NN	O
and	VBP	O
the	VBN	O
insert	IN	O
fragments	NNP	O
are	CC	O
purified	NNP	O
from	CC	O
gel	DT	O
using	NN	O
an	NNS	O
ELU-Trap	VBP	O
apparatus	VBN	O
(Schleier	IN	O
and	NN	O
Schuell)	VBG	O
according	DT	O
to	JJ	O
the	NN	O
manufacturer's	NNP	O
instructions.	CC	O
This	)	O
apparatus	VBG	O
enables	TO	O
isolation	DT	O
of	POS	O
large	.	O
amounts	DT	O
of	NN	O
DNA	VBZ	O
fragments.	NN	O
Constructs	IN	O
pEC.E1B	JJ	O
and	NNS	O
pSC.55K	IN	O
are	NN	O
digested	.	O
with	NNS	O
AflIII/HincII	NN	O
and	CC	O
AflIII/HincII,	NN	O
respectively,	VBP	O
and	VBN	O
insert	IN	O
fragments	NNP	O
are	CC	O
isolated	,	O
as	,	O
above.	CC	O
Primary	JJ	O
HER	NNS	O
cells	VBP	O
are	VBN	O
cultured	IN	O
and	.	O
transfected	NNP	O
as	NNP	O
described	NNS	O
above.	VBP	O
Fragments	VBN	O
isolated	CC	O
from	VBN	O
pCC.E1A	IN	O
and	VBN	O
pEC.E1B	.	O
are	NNS	O
combined	VBN	O
for	IN	O
transfection.	NN	O
The	CC	O
DNA	NN	O
fragments	VBP	O
isolated	VBN	O
from	IN	O
pCC.E1AB21	.	O
are	DT	O
combined	NN	O
with	NNS	O
pSC.55K	VBN	O
or	IN	O
transfected	NN	O
alone.	VBP	O
The	VBN	O
latter	IN	O
cultures	NN	O
are	CC	O
then	VBN	O
retransfected	.	O
with	DT	O
the	JJ	O
DNA	NNS	O
fragment	VBP	O
isolated	RB	O
from	VBN	O
pSC.55K	IN	O
seven	DT	O
to	NNP	O
ten	NN	O
days	VBD	O
following	IN	O
the	JJ	O
first	CD	O
transfection,	TO	O
depending	VB	O
on	NNS	O
the	VBG	O
size	DT	O
of	JJ	O
the	,	O
observed	VBG	O
clones.	IN	O
One	DT	O
day	NN	O
before	IN	O
transfection,	DT	O
half	JJ	O
of	.	O
the	CD	O
dishes	NN	O
transfected	IN	O
with	,	O
E1AB21	NN	O
alone	IN	O
is	DT	O
passed	NNS	O
to	VBD	O
10	IN	O
cm	NNP	O
dishes	RB	O
and	VBZ	O
then	VBN	O
re-transfected,	TO	O
the	CD	O
other	NN	O
half	NNS	O
of	CC	O
the	RB	O
dishes	,	O
is	DT	O
re-transfected	JJ	O
without	NN	O
prior	IN	O
passage.	DT	O
The	NNS	O
transformed	VBZ	O
clones	JJ	O
that	IN	O
result	JJ	O
from	.	O
these	DT	O
transfections	JJ	O
are	NNS	O
picked	WDT	O
and	VBP	O
further	IN	O
expanded	DT	O
in	NNS	O
96-well	VBP	O
plates	VBN	O
and	CC	O
subsequent	RBR	O
larger	VBN	O
formats.	IN	O
The	CD	O
integration	NNS	O
site	CC	O
and	JJ	O
copy	JJR	O
number	.	O
of	DT	O
the	NN	O
fragments	NN	O
is	CC	O
investigated	JJ	O
with	NN	O
Southern	IN	O
blots	DT	O
and	NNS	O
by	VBZ	O
PCR	VBN	O
to	IN	O
reveal	NNP	O
whether	NNS	O
insertions	CC	O
occurred	IN	O
in	NNP	O
close	TO	O
vicinity.	VB	O
Clones	IN	O
where	NNS	O
E1A	VBD	O
and	IN	O
E1B	JJ	O
55K	.	O
are	NNS	O
present	WRB	O
in	NNP	O
single	CC	O
copy,	NNP	O
or	CD	O
present	VBP	O
in	JJ	O
more	IN	O
than	JJ	O
one	,	O
copy	CC	O
but	JJ	O
without	IN	O
inverted	JJR	O
repeat	IN	O
conformation	CD	O
of	NN	O
these	CC	O
sequences	IN	O
in	JJ	O
the	NN	O
genome	NN	O
of	IN	O
the	DT	O
transfected	NNS	O
cells,	IN	O
or	DT	O
wherein	NN	O
E1A	IN	O
and	DT	O
at	JJ	O
least	,	O
one	CC	O
of	VB	O
the	NNP	O
E1B	CC	O
coding	IN	O
sequences	JJS	O
(in	CD	O
this	IN	O
case	DT	O
E1B-55K)	NNP	O
are	NN	O
separated	NNS	O
by	IN	O
at	DT	O
least	NN	O
4	)	O
kb,	VBP	O
preferably	VBN	O
by	IN	O
at	IN	O
least	JJS	O
10	CD	O
kb,	,	O
more	RB	O
preferably	IN	O
by	IN	O
at	JJS	O
least	CD	O
34.5	,	O
kb,	JJR	O
are	RB	O
preferably	IN	O
used	IN	O
further.	JJS	O
Example	CD	O
2	,	O
Generation	VBP	O
of	RB	O
Complementing	VBN	O
Cell	.	O
Lines	RB	O
Using	CD	O
Nucleic	NNP	O
Acids	IN	O
that	NNP	O
have	NNP	O
E1A	NNP	O
and	NNP	O
E1B	NNP	O
Regions	NNP	O
Separated	WDT	O
by	VBP	O
Large	NNP	O
Spacer	CC	O
Sequences	NNP	O
As	NNP	O
described	VBN	O
in	IN	O
the	NNP	O
previous	NNP	O
example,	NNP	O
it	IN	O
is	VBN	O
possible	IN	O
to	DT	O
generate	JJ	O
stably	,	O
transformed	PRP	O
cell	VBZ	O
clones	JJ	O
from	TO	O
primary	VB	O
cells	RB	O
using	VBN	O
separate	NN	O
plasmids	NNS	O
for	IN	O
E1A	JJ	O
and	NNS	O
E1B.	VBG	O
However,	JJ	O
when	NNS	O
DNA	IN	O
fragments	NNP	O
are	CC	O
transfected	.	O
together,	,	O
there	WRB	O
is	NN	O
still	NNS	O
a	VBP	O
chance	VBN	O
that	,	O
the	EX	O
transfected	VBZ	O
fragments	RB	O
end	DT	O
up	NN	O
in	IN	O
near	DT	O
proximity	JJ	O
of	NNS	O
each	VBP	O
other,	RP	O
although	IN	O
this	JJ	O
chance	NN	O
is	IN	O
reduced	DT	O
in	,	O
the	IN	O
absence	DT	O
of	NN	O
considerable	VBZ	O
sequence	VBN	O
overlap.	IN	O
The	DT	O
possibility	NN	O
of	IN	O
E1A	JJ	O
and	NN	O
E1B	.	O
expression	DT	O
cassette	NN	O
integration	IN	O
with	NNP	O
less	CC	O
than	NNP	O
30	NN	O
kb	NN	O
non-E1	NN	O
sequence	IN	O
in	JJR	O
between	IN	O
in	CD	O
the	JJ	O
chromosome	JJ	O
can	NN	O
be	IN	O
avoided	IN	O
by	IN	O
flanking	DT	O
the	NN	O
different	MD	O
E1	VB	O
expression	VBN	O
cassettes	IN	O
with	VBG	O
large	DT	O
pieces	JJ	O
of	NNP	O
non-(E1-)coding	NN	O
DNA	VBZ	O
sequences	IN	O
(so	JJ	O
called	NNS	O
“spacer”	IN	O
fragments).	VBG	O
If	NN	O
an	NNS	O
E1A-carrying	RB	O
fragment	VBN	O
integrates	NN	O
next	.	O
to	IN	O
an	DT	O
E1B-containing	JJ	O
fragment	NN	O
in	NNS	O
the	IN	O
genome	TO	O
of	DT	O
the	JJ	O
generated	NN	O
packaging	IN	O
cell,	DT	O
the	NN	O
large	IN	O
flanking	DT	O
sequences	JJ	O
should	NN	O
create	,	O
enough	DT	O
distance	JJ	O
to	NN	O
eliminate	NNS	O
the	MD	O
chance	VB	O
that	JJ	O
the	NN	O
E1A	TO	O
and	VB	O
E1B	DT	O
encoding	NN	O
sequences	IN	O
recombine	DT	O
into	NNP	O
the	CC	O
same	NNP	O
recombinant	VBG	O
vector	NNS	O
molecule	VBP	O
upon	IN	O
propagation	DT	O
of	JJ	O
a	JJ	O
recombinant	NN	O
adenoviral	NN	O
vector	IN	O
in	NN	O
the	IN	O
packaging	DT	O
cell.	JJ	O
Non-limiting	JJ	O
examples	NN	O
of	IN	O
large	DT	O
spacer	NN	O
DNA	.	O
fragments	JJ	O
that	NNS	O
can	IN	O
be	JJ	O
used	NN	O
are	NN	O
large	NNS	O
sequences	WDT	O
derived	MD	O
from,	VB	O
e.g.,	VBN	O
the	VBP	O
human	JJ	O
dystrophin	NNS	O
gene	VBN	O
or	,	O
the	,	O
human	DT	O
Apo-E1	JJ	O
gene.	JJ	O
Other	NN	O
spacing	CC	O
molecules	DT	O
can	JJ	O
also	NNP	O
be	.	O
used,	JJ	O
even	VBG	O
from	NNS	O
non-human	MD	O
sources.	RB	O
Preferably,	VB	O
the	,	O
flanking	RB	O
sequences	IN	O
do	JJ	O
not	.	O
contain	,	O
coding	DT	O
regions	NN	O
for	NNS	O
functional	VBP	O
proteins	RB	O
and	VB	O
can	VBG	O
thus	NNS	O
be	IN	O
derived	JJ	O
from	NNS	O
intron	CC	O
sequences.	MD	O
Also,	RB	O
the	VB	O
E1A	VBN	O
and	IN	O
E1B	NN	O
sequences	.	O
do	,	O
not	DT	O
need	NNP	O
to	CC	O
be	NNP	O
on	NNS	O
different	VBP	O
molecules	RB	O
but	VB	O
may	TO	O
be	VB	O
situated	IN	O
on	JJ	O
the	NNS	O
same	CC	O
large	MD	O
molecule,	VB	O
such	VBN	O
as	IN	O
a	DT	O
cosmid.	JJ	O
Examples	JJ	O
of	,	O
these	JJ	O
E1A-	IN	O
and	DT	O
E1B-carrying	.	O
molecules	NNS	O
are	IN	O
given	DT	O
in	NNP	O
FIG.	CC	O
13.	NNP	O
In	NNS	O
preferred	VBP	O
embodiments,	VBN	O
the	IN	O
distance	.	O
between	.	O
the	IN	O
E1A	JJ	O
and	,	O
E1B	DT	O
coding	NN	O
regions	IN	O
is	DT	O
>34.5	NNP	O
kb	CC	O
because	NNP	O
then	VBG	O
co-insertion	NNS	O
of	VBZ	O
the	CD	O
two	NN	O
regions	IN	O
into	RB	O
a	NN	O
virus	IN	O
results	DT	O
in	CD	O
a	NNS	O
genome	IN	O
that	DT	O
is	NN	O
too	NNS	O
large	IN	O
to	DT	O
be	NN	O
packaged.	WDT	O
This	VBZ	O
situation	RB	O
will,	JJ	O
for	TO	O
instance,	VB	O
be	.	O
reached	DT	O
when	NN	O
two	,	O
separate	IN	O
cosmid	,	O
fragments	VB	O
of	VBN	O
approximately	WRB	O
40	CD	O
kb	JJ	O
having	NN	O
the	NNS	O
expression	IN	O
cassettes	RB	O
roughly	CD	O
in	NNS	O
the	VBG	O
middle	DT	O
are	NN	O
used.	VBZ	O
However,	RB	O
assuming	IN	O
that	DT	O
E1	NN	O
in	VBP	O
the	.	O
form	,	O
of	VBG	O
inverted	IN	O
repeat	NNP	O
structures	IN	O
contributes	DT	O
to	NN	O
the	IN	O
frequency	JJ	O
of	NN	O
HDEP	NNS	O
generation,	VBZ	O
then	TO	O
a	DT	O
construct	NN	O
where	IN	O
E1A	NNP	O
and	,	O
E1B	RB	O
cassettes	DT	O
are	NN	O
located	WRB	O
on	NNP	O
a	CC	O
single	NNP	O
cosmid	NNS	O
fragment	VBP	O
of	VBN	O
a	IN	O
total	DT	O
length	JJ	O
of	NN	O
approximately	NN	O
22	IN	O
kb	DT	O
(like	JJ	O
in	NN	O
FIG.	IN	O
13,	RB	O
Panel	CD	O
I)	NNS	O
suffices	IN	O
even	IN	O
when	.	O
a	,	O
second	NNP	O
copy	)	O
would	NNS	O
become	RB	O
located	WRB	O
in	DT	O
the	JJ	O
genome	NN	O
of	MD	O
the	VB	O
cell	VBN	O
in	IN	O
inverted	DT	O
orientation	NN	O
next	IN	O
to	DT	O
the	NN	O
first.	IN	O
Full	JJ	O
integration	NN	O
of	IN	O
the	TO	O
mirror-imaged	DT	O
structure	.	O
would	NNP	O
then	NN	O
also	IN	O
involve	DT	O
a	JJ	O
fragment	NN	O
of	MD	O
>38	RB	O
kb.	RB	O
Also,	VBP	O
if	DT	O
the	NN	O
presence	IN	O
of	CD	O
inverted	.	O
repeats	,	O
increases	IN	O
the	DT	O
frequency	NN	O
of	IN	O
HDEP	JJ	O
formation,	NNS	O
then	VBZ	O
a	DT	O
situation	NN	O
where	IN	O
multiple	NNP	O
copies	,	O
are	RB	O
integrated	DT	O
as	NN	O
direct	WRB	O
repeats	JJ	O
is	NNS	O
considered	VBP	O
less	VBN	O
of	IN	O
a	JJ	O
problem	NN	O
even	VBZ	O
when	VBN	O
the	JJR	O
DNA	IN	O
fragment	DT	O
that	NN	O
includes	RB	O
two	WRB	O
full	DT	O
copies	NNP	O
of	NN	O
E1A	WDT	O
and	VBZ	O
E1B	CD	O
has	JJ	O
a	NNS	O
length	IN	O
of	NNP	O
<20	CC	O
kb.	NNP	O
In	VBZ	O
the	DT	O
absence	NN	O
of	IN	O
inverted	CD	O
repeats,	.	O
integration	IN	O
of	DT	O
any	NN	O
E1-containing	IN	O
fragment	JJ	O
larger	,	O
than	NN	O
the	IN	O
space	DT	O
left	JJ	O
in	NN	O
the	JJR	O
recombinant	IN	O
virus	DT	O
(i.e.,	NN	O
38	VBD	O
kb	IN	O
minus	DT	O
actual	JJ	O
genome	NN	O
length	,	O
of	CD	O
recombinant	NN	O
virus)	CC	O
into	JJ	O
the	NN	O
recombinant	NN	O
virus	IN	O
forces	JJ	O
it	)	O
to	IN	O
delete	DT	O
parts	JJ	O
of	NN	O
the	NNS	O
essential	PRP	O
viral	TO	O
sequences	VB	O
as	NNS	O
a	IN	O
sequential	DT	O
step	JJ	O
to	JJ	O
ensure	NNS	O
packaging	IN	O
and	DT	O
thus	JJ	O
propagation.	NN	O
Analysis	TO	O
of	VB	O
the	NN	O
first	CC	O
HDEP	RB	O
genome	.	O
that	NN	O
arose	IN	O
via	DT	O
homologous	JJ	O
recombination	NNP	O
(Murakami	NN	O
et	WDT	O
al.,	VBD	O
2002)	IN	O
showed	JJ	O
that	NN	O
deletion	NNP	O
of	RB	O
viral	,	O
sequences	)	O
is	VBD	O
possible.	IN	O
DNA	NN	O
sequences	IN	O
that	JJ	O
integrate	NNS	O
into	VBZ	O
the	.	O
genome	NN	O
of	NNS	O
a	WDT	O
cell	VBP	O
are	IN	O
not	DT	O
always	NN	O
accessible	IN	O
for	DT	O
activating	NN	O
transcription	VBP	O
factors	RB	O
due	RB	O
to	JJ	O
chromatin-associated	IN	O
repression.	VBG	O
Especially	NN	O
when	NNS	O
large	JJ	O
fragments	TO	O
of	JJ	O
intron	.	O
DNA	RB	O
are	WRB	O
used	JJ	O
that	NNS	O
originate	IN	O
from	NN	O
genomic	NN	O
regions	VBP	O
that	VBN	O
are	IN	O
normally	NN	O
not	IN	O
active	JJ	O
in	NNS	O
the	WDT	O
cell	VBP	O
that	RB	O
will	RB	O
be	JJ	O
transduced	IN	O
with	DT	O
these	NN	O
sequences,	WDT	O
gene	MD	O
expression	VB	O
may	VBN	O
be	IN	O
shut-off	DT	O
due	,	O
to	NN	O
inactive	NN	O
chromatin.	MD	O
Recently,	VB	O
sequences	JJ	O
were	JJ	O
identified	TO	O
that	JJ	O
can	.	O
inhibit	,	O
this	NNS	O
repression.	VBD	O
Examples	VBN	O
are	IN	O
the	MD	O
chicken	VB	O
β-globin	DT	O
HS4	.	O
element	NNS	O
(U.S.	VBP	O
Pat.	DT	O
No.	JJ	O
5,610,053)	JJ	O
that	NNP	O
functions	NN	O
as	NNP	O
an	.	O
insulator	.	O
sequence,	)	O
a	WDT	O
Drosophila	VBZ	O
scs	IN	O
or	DT	O
scs′	NN	O
element	,	O
Kellum	DT	B
et	NNP	I
al.,	NN	I
1991;	CC	I
Farkas	JJ	B
et	NN	I
al.,	NNP	I
1992),(	RB	O
and	,	O
a	:	O
series	NNP	O
of	FW	O
sequences	,	O
in	,	O
the	CC	O
human	DT	O
genome	NN	O
(so-called	IN	O
anti-repressor	NNS	O
elements	IN	O
or	DT	O
STAR	JJ	O
elements)	NN	O
identified	JJ	O
by	NN	O
a	NNS	O
specific	CC	O
screen	NNP	O
for	)	O
anti-repressor	VBN	O
elements	IN	O
Kwaks	DT	B
et	JJ	I
al.,	NN	I
2003;	IN	I
